PAHO Core Indicators provide the technical specifications for each indicator. These specifications give essential information such as definition, purpose, estimation method, limitations, and data source.
To search a specific indicator, use Ctl+F
Adolescent fertility rate (births per 1 000 women aged 15-19 years)
In addition, women who have children at an early age experience reduced opportunities for socioeconomic improvement, particularly because young mothers are unlikely to continue studying and, if they need to work, may find it especially difficult to combine family and work responsibilities.
The adolescent fertility rate also provides indirect evidence on access to relevant health services since young people, particularly single adolescent girls, often experience difficulties in accessing sexual and reproductive health services.
The value of this indicator comes from United Nations estimates, based on data representing estimated mid-year values, obtained by linear interpolation of the corresponding United Nations five-year medium-variant population projections.
Estimation method for global and regional aggregates:
World Population Prospects (WPP) age-specific fertility rates are calculated according to population reconstruction at the country level and provide a better estimate based on all available demographic information. WPP potentially considers as many types and sources of empirical estimates as possible (including retrospective birth histories, and direct and indirect fertility estimates). Final estimates are derived to ensure the greatest possible internal consistency with all other demographic components and intercensal cohorts listed in successive censuses.
The estimated value of this indicator may differ from country statistics due to factors such as methodological differences in developing population estimates and projections.
https://population.un.org/wpp/
Sustainable Development Goals (SDG)
Indicator 3.7.2 Adolescent fertility rate (10-14 years; 15 to 19 years) per 1 000 women in that age group.
Available from: https://unstats.un.org/sdgs/metadata/
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 2.b Fertility rate in women 10-19 years of age (disaggregated by 10-14 and 15-19 years) in Latin America and the Caribbean
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
https://www.who.int/data/gho/data/indicators
United Nations, Department of Economic and Social Affairs, Population Division. Handbook on the Collection of Fertility and Mortality Data. For a complete information on the different calculation methods, see United Nations Publication, No. E.03.XVII.11. Available from: https://unstats.un.org/unsd/publication/seriesf/seriesf_92e.pdf
United Nations. Indirect estimation methods are discussed in Manual X: Manual X: Indirect Techniques for Demographic Estimation, United Nations, N°: E.83.XIII.2. Available from:
https://www.un.org/en/development/desa/population/publications/pdf/mortality/Manual_X.pdf
Alzheimer disease and other dementias mortality rate (age-adjusted per 100 000 pop)
The age-adjusted Alzheimer disease and other dementias mortality rate allows for the comparison of this indicator across populations or in the same population over time.
The underlying causes of death correspond to codes F01 - F03, G30 - G31 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the age-adjusted Alzheimer disease mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The mortality rate from Alzheimer disease and other dementias is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The value of the age-adjusted Alzheimer disease and other dementias mortality rate will depend on the standard population used for adjustment.
The estimated value of this indicator may differ from each country’s estimates due to methodological considerations, such as: the use of a different group of ICD-10 codes for the underlying cause of death, the method for preparing population estimates and projections, or the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the Alzheimer disease and other dementias mortality rate requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in this system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
https://www.who.int/data/global-health-estimates
- Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Annual GDP growth (%)
GDP at buyer's prices is the sum of the gross value added of all products in the economy, plus any taxes on the products and minus any subsidies not included in the value of the products. GDP is calculated without deductions for depreciation of manufactured assets or for depletion and degradation of natural resources. Value added is the value of producers' gross output minus the value of intermediate goods and services consumed in production, before accounting for consumption of fixed capital in production.
It contributes to evaluating changes in a country's productive capacity and eventually, alongside other indicators, its population's standard of living.
The United Nations System of National Accounts requires that value added be valued at basic prices (excluding net taxes on products) or producer prices (including net taxes on products paid by producers, but excluding sales or value-added taxes). Both valuations exclude transport costs that producers invoice separately. Total GDP is measured at buyer's prices. Value added by industry is normally measured at basic production prices. GDP growth rates and their components are calculated using the least squares method and constant price data in the local currency. Constantly priced US dollar series are used to calculate regional and income group growth rates. Local currency series are converted to constant U.S. dollars using an exchange rate in the common reference year.
The growth rate per least squares is estimated by adjusting a linear regression trend line to the annual logarithmic values of the variable in the relevant period. The calculated growth rate is an average rate that represents the observations available throughout the period. The value obtained may differ from the actual growth rate between two periods
An increase in the percentage annual growth rate of a country's GDP between two periods may be due to a greater concentration of wealth in the higher economic strata. This may mask situations of extreme poverty or deterioration of the wellbeing and social development of its inhabitants.
The frequency with which countries' National Accounts are updated—sometimes a matter of years—is one of the methodological aspects that limit the estimates of this indicator. Another challenge is estimating the added value of the industry, since this requires detailed information on the price structure of inputs and products. This information is not always available.
https://data.worldbank.org/indicator
Indicator 8.1.1 Annual growth rate of real GDP per capita.
Available from: https://sdgs.un.org/goals
https://statistics.cepal.org/portal/cepalstat/dashboard.html?lang=en
Annual parasite incidence (1 000 pop)
API highlights clinical malaria and provides less information about the potential number of asymptomatic infections. It is useful as a surveillance technique to monitor increasing or decreasing trends in malaria burden.
This indicator is used to monitor countries progressing towards targets established in the Global Technical Strategy for Malaria 2016–2030. It also contributes to monitoring national progress on the objectives of the Monitoring Framework for Universal Health in the Americas.
The indicator makes it possible to assess the temporal and geographical trends of malaria and identify at-risk populations in need of strengthened surveillance programs, disease elimination activities, and access to interventions, especially integrated and quality diagnosis and treatment. The value of the indicator is considered when allocating economic, human, and technological resources.
Formula:
(A/B) x 1 000
Numerator (A):
Confirmed cases for 1 year in a given country, territory, or geographic area.
Denominator (B):
Population under surveillance in a given country, territory, or geographic area.
API is mainly calculated from confirmed and reported symptomatic cases of parasitological malaria. As a result, API may underestimate infection incidence in highly endemic areas, and be especially inaccurate in less endemic areas.
Pan American Health Organization (PAHO). Regional Program on Malaria. Available from: https://www3.paho.org/hq/index.php?option=com_content&view=article&id=1979:2010-regional-program-on-malaria&Itemid=2153&lang=en
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). The Seventy-fourth World Health Assembly. Recommitting to accelerate progress towards malaria elimination. Draft Resolution A74/B/CONF./2. May 2021. Avaialbe from: https://apps.who.int/gb/ebwha/pdf_files/WHA74/A74_BCONF2-en.pdf
World Health Organization (WHO). WHO malaria terminology. Geneva, 2022. Updated in November 2021. Available from: https://www.who.int/publications/i/item/9789240038400
Annual population growth rate (%)
The annual increase in population size is defined as the sum of differences: births minus deaths and immigrants minus emigrants, in a given country, territory, or geographical area in a given year.
Average population: assuming the reference period is year z and that births are evenly distributed throughout that period, the average population will be represented by a mid-year estimate, that is, on 1 July.
It is used to analyze the temporal and geographical variations of a population's growth.
Results can be directly applied to plan and assess health and other specific public policies, such as territorial planning and resource allocation.
The value of this indicator comes from United Nations estimates, based on data representing estimated mid-year values, obtained by linear interpolation of the corresponding United Nations five-year medium-variant population projections.
Since population estimates are used to calculate the annual population growth rate, its outcome depends on the method used to develop population estimates, and projections and may differ from the results obtained at the country level.
The use of the rate in population projections for years significantly separated from the last demographic census means that recent changes in demographic dynamics may not be reflected. This tends to be higher in small populations.
https://population.un.org/wpp/
https://www.who.int/data/gho/indicator-metadata-registry
United Nations, Department of Economic and Social Affairs. 2019 Demographic Yearbook, 70th Issue. New York, 2020. Available from: https://unstats.un.org/unsd/demographic-social/products/dyb/
United States Census Bureau. International Database. Glossary. Available from: https://www.census.gov/glossary/
United Nations, Department of Economic and Social Affairs, Population Divions. Glossary of Demographic Terms. Available from:
https://population.un.org/wpp/GlossaryOfDemographicTerms/
Economic Commission for Latin America and the Caribbean (ECLAC) - CEPALSTAT. Statistical Databases and Publications. Available from:
https://statistics.cepal.org/portal/cepalstat/dashboard.html?lang=en
Pan American Health Organization. Basic Health Indicators in Brazil: concepts and applications, 2nd edition. Brasilia, 2008. Available from: https://www.paho.org/bra/dmdocuments/indicadores.pdf
Antenatal care coverage -at least 4 visits (%)
This indicator makes it possible to identify populations that need increased coverage, availability, and access to maternal and child health services, and raises awareness of inequities in health. It can be applied during planning, management, and evaluation of health policies and maternal and child health services.
Denominator: Total number women with a live birth during the same period.
The data comes from countries' routine information systems.
The outcome of this indicator is limited by the country's ability to record in a timely manner all prenatal checkups and live births that occurred during a given period. The definition of live birth may differ between countries.
https://opendata.paho.org/en/core-indicators
WHO. 2018 Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Available from: https://apps.who.int/iris/bitstream/handle/10665/259951/WHO-HIS-IER-GPM-2018.1-eng.pdf?sequence=1&isAllowed=y
World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva, 2016. Available from: https://www.who.int/publications/i/item/9789241549912
UNICEF. Antenatal care. Available from: https://data.unicef.org/topic/maternal-health/antenatal-care/
Births (thousands)
The estimated value of this indicator may differ from country statistics due to factors such as methodological differences in developing population estimates and projections.
Other influencing factors are differences in how life events are defined, geographical coverage, and tabulation procedures applied in each country.
https://population.un.org/wpp/
https://www.census.gov/programs-surveys/international-programs/about/glossary.html
United Nations, Department of Economic and Social Affairs, Statistics Division. Demographic and Social Statistics. Glossary of Demographic Terms. Available from:
https://population.un.org/wpp/GlossaryOfDemographicTerms/
United Nations, Department of Economic and Social Affairs. 2019 Demographic Yearbook, 70th Issue. New York, 2020. Available from: https://unstats.un.org/unsd/demographic-social/products/dyb/
Births attended at health facilities (%)
This indicator makes it possible to identify those populations in which health facility coverage, availability, and accessibility for childbirth care needs to be improved and maternal and child health programs need to be strengthened. It helps to highlight health inequities and to estimate the need for health facilities and their distribution for maternal and childcare.
In countries where the indicator of births attended by trained personnel is not actively reported, the proportion of births attended at health facilities is used as a proxy indicator. This is common when a high proportion of births are attended by health professionals.
Denominator: Total number of births in the country, territory, or geographic area in the same period.
Health facilities are defined as sites that provide health care and have the resources to provide safe maternal care. They include hospitals, clinics, outpatient care centers, and specialized care centers such as birthing centers.
The data are from countries’ routine information systems or surveys.
This indicator may underestimate the percentage of births attended by trained personnel, particularly in the case of home births attended by trained personnel.
This indicator’s result is influenced by the country’s capacity to register in a timely manner all births and live births that occurred in a given period of time.
Indicator 3.1.2: Proportion of births attended by skilled health personnel [Proporción de partos atendidos por personal sanitario especializado].
Available from: https://sdgs.un.org/goals/goal3
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 2.c Proportion of births attended at health facilities
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
WHO. 2018 Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Available from: https://apps.who.int/iris/bitstream/handle/10665/259951/WHO-HIS-IER-GPM-2018.1-eng.pdf?sequence=1&isAllowed=y
UNICEF. Delivery care. Available from: https://data.unicef.org/topic/maternal-health/delivery-care/
Births attended by skilled health personnel (%)
This indicator makes it possible to identify populations that need improved coverage, availability, and access to skilled childbirth care to strengthen maternal and child health programs. Health inequities are exposed and specialized training needs for health professionals in maternal and child issues can be estimated.
Denominator: Total number of births during the same period. Trained staff include obstetricians, doctors and nurses trained in pregnant woman care, university midwives, and midwives who have graduated with diplomas; this does not include trained or untrained traditional birth attendants.
The data comes from countries' routine information systems.
The outcome of this indicator is influenced by the country's ability to record in a timely manner all births and live births that occurred during a given period.
Sustainable Development Goals (SDG)
Indicator 3.1.2: Indicator 3.1.2: Proportion of births attended by skilled health personnel.
Available from: https://sdgs.un.org/goals/goal3
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 2.d Proportion of births attended by skilled health personnel
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
https://opendata.paho.org/en/core-indicators
WHO. 2018 Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Available from: https://apps.who.int/iris/bitstream/handle/10665/259951/WHO-HIS-IER-GPM-2018.1-eng.pdf?sequence=1&isAllowed=y
UNICEF. Delivery care. Available from: https://data.unicef.org/topic/maternal-health/delivery-care/
Breast cancer incidence rate (age-adjusted per 100 000 pop); female
The data used to estimate this indicator come from cancer registries that identify new cases occurring in a well-defined population, generating statistics to evaluate and control the impact of the disease in the population.
The age-adjusted breast cancer incidence rate provides an estimate of the average risk women have of developing this type of cancer in a given country, territory, or geographic area. Its results are used to planning and allocating economic, human, and technological resources to fight breast cancer.
As the breast cancer incidence rate is age-adjusted, comparisons can be made both within and between populations over time. Inequities in health and at-risk groups can be identified.
This indicator supports public policy-making and is essential for planning and evaluating breast cancer screening, early diagnosis, treatment, and control. It helps to focus efforts such as identifying the need to strengthen and implement cancer registries in a given population.
The methods used to estimate the breast cancer incidence rate in a specific country depend on available data sources. These include projections of observed incidence rates at the national level, statistical models derived from incidence rates in the country's cancer registries or neighboring country registries, and average incidence rates in neighboring countries, among other metrics.
The breast cancer incidence rate is age-standardized and results are based on rates in populations with a standard age structure.
Standardization is necessary when comparing several populations that differ in age, as age is a major factor when determining cancer risk. An age-standardized rate is a weighted average of age-specific rates based on a standard population distribution.
In addition, the age-adjusted breast cancer incidence rate is not a real value. Its main purpose is to allow comparisons over time between different populations or within the same population. This indicator reflects the average risk women have of developing breast cancer in a particular country. It should not be interpreted as the individual risk of developing the cancer.
The estimated value of the age-adjusted breast cancer incidence rate depends on the standard population used for its adjustment; it may therefore differ from the calculations made by each country.
The calculation method is based on new cases of breast cancer in women. It should be noted that men can also acquire a cancer of this type; however, the number of men with breast cancer is minimal compared to women, and there is no effect on the final estimated value of the indicator.
https://ci5.iarc.fr/CI5plus/Default.aspx
Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J, editors (2021). Cancer Incidence in Five Continents, Vol. XI. IARC Scientific Publication No. 166. Lyon: International Agency for Research on Cancer. Available from: https://publications.iarc.fr/597
Pan American Health Organization (PAHO)/World Health Organization (WHO). Core indicators Portal. Available from: https://opendata.paho.org/en/core-indicators
Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Available from: https://apps.who.int/iris/handle/10665/259951
Breast cancer mortality rate (age-adjusted per 100 000 pop); female
Its result is applicable to the design, implementation, and evaluation of health policies for the prevention and control of breast cancer and the distribution of economic, human, and technological resources, among others. Its applications include, for example, evaluating over time the effect of screening strategies on reducing mortality from this type of cancer.
It helps to identify groups of women at higher risk of dying from breast cancer and to assess the presence of specific risk factors for certain population groups and the opportunity for access to timely detection, diagnosis and treatment.
The underlying cause of death corresponds to code C50 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the breast cancer mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
The breast cancer mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates to the World Health Organization (WHO) World Standard Population.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
Due to the application of advanced statistical models, estimates may differ from each country’s results. The estimated value of the age-adjusted breast cancer mortality rate will depend on the standard population used for its adjustment; therefore, it may differ from each country’s estimates. Another methodological consideration that influences its result is the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
The calculation method is based on breast cancer deaths in women.
Estimating the breast cancer mortality rate requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in that system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Cervical cancer incidence rate (age-adjusted per 100 000 pop); female
The data used to estimate this indicator come from cancer registries that identify new cases occurring in a well-defined population, generating statistics to evaluate and control the impact of the disease in the population.
The age-adjusted cervical cancer incidence rate provides an estimate of the average risk women have of developing this type of cancer in a given country, territory, or geographic area. Results of the indicator are used to planning and allocating economic, human, and technological resources to fight cervical cancer. It can be applied, for example, to evaluate over time of the effect of implementing immunoprevention strategies against this cancer.
As the cervical cancer incidence rate is age-adjusted, comparisons can be made both within and between populations over time. It helps to identify groups of at-risk women, determine the presence of specific risk factors for particular groups, and assess timely access to diagnosis and treatment.
This indicator supports public policy-making and is essential for planning and evaluating cervical cancer screening, early diagnosis, treatment, and control. It helps to focus efforts such as identifying the need to strengthen and implement cancer registries in a given population.
The methods used to estimate the cervical cancer incidence rate in a specific country depend on available data sources. These include projections of observed incidence rates at the national level, statistical models derived from incidence rates in the country's cancer registries or neighboring country registries, and average incidence rates in neighboring countries, among other metrics.
The cervical cancer incidence rate is age-standardized and results are based on rates in populations with a standard age structure.
The age-standardized rate is a summary measure of the rate that would have been observed in a population with a standard age structure. Standardization is necessary when comparing several populations that differ in age, as age is a major factor when determining cancer risk. An age-standardized rate is a weighted average of age-specific rates based on a standard population distribution.
In addition, the age-adjusted cervical cancer incidence rate is not a real value. Its main purpose is to allow comparisons between different populations or within the same population over time therefore, its interpretation must be done with caution. This indicator reflects the average risk women have of developing cervical cancer in a particular country. It should not be interpreted as the individual risk of developing the cancer.
The estimated value of the age-adjusted cervical cancer incidence rate depends on the standard population used for its adjustment; it may therefore differ from the calculations made by each country.
https://ci5.iarc.fr/CI5plus/Default.aspx
Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J, editors (2021). Cancer Incidence in Five Continents, Vol. XI. IARC Scientific Publication No. 166. Lyon: International Agency for Research on Cancer. Available from: https://publications.iarc.fr/597
Pan American Health Organization (PAHO)/World Health Organization (WHO). Core Indicators. Available from: https://opendata.paho.org/en/core-indicators/core-indicators-dashboard
Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Available from: https://apps.who.int/iris/handle/10665/259951
Cervical cancer mortality rate (age-adjusted per 100 000 pop); female
Its result is applicable to the design, implementation, and evaluation of health policies for the prevention, screening, diagnosis, treatment, and control of cervical cancer and the distribution of economic, human, and technological resources, among others. Its applications include, for example, evaluating over time the effect of implementing strategies for immunoprevention, screening, and early diagnosis of this type of cancer.
Removing the effect of a different age structure by using a standard population makes it possible to analyze the cervical cancer mortality rate across populations or in the same population over time.
The underlying cause of death corresponds to code C53 of the International Classification of Diseases, Tenth Revision (ICD-10). Deaths assigned to ICD code C55, cancer of the uterus, part unspecified, and distributed pro-rata to cervix uteri cancer (C53) and corpus uteri cancer (C54).
The populations used in the denominator of the cervical cancer mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
The cervical cancer mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates to the World Health Organization (WHO) World Standard Population.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The estimated value of the age-adjusted cervical cancer mortality rate will depend on the standard population used for its adjustment; therefore, it may differ from each country’s estimates. Another methodological consideration that influences its result is the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the cervical cancer mortality rate requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in that system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Populations for countries:
United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects. Available from: https://population.un.org/wpp/
Indicator 10. Mortality rate due to cervical cancer
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
Cholera cases
The number of cases quantifies the magnitude of the disease, reflecting a population's health status and level of socioeconomic development. It raises awareness of inequities and factors enabling transmission of Vibrio cholerae and it helps identify populations in need of guaranteed access to timely and quality health care, strengthen educational interventions and hygiene measures, and improve cholera surveillance activities.
This indicator is used to monitor countries' progress with the Ending Cholera Global Roadmap to 2030. It supports multisectoral strategies to address the disease, as well as development and assessment of public policies for universal access to drinking water and sanitation, and allocation of resources to sustain these initiatives over time. It is used to detect cholera outbreaks and analyze temporal and geographical trends in a population.
In order not to hinder effective control measures, cholera should be confirmed and reported in national surveillance systems separately from other diarrheal diseases.
World Health Organization (WHO). Cholera prevention and control. World Health Assembly, 71 (WHA71.4, 2018). Available from: https://www.who.int/publications/i/item/10665-279470
Global Task Force on Cholera Control (GTFCC). Ending cholera, a global roadmap to 2030. Available from: https://www.gtfcc.org/wp-content/uploads/2019/10/gtfcc-ending-cholera-a-global-roadmap-to-2030.pdf
Circulatory diseases mortality rate (age-adjusted per 100 000 pop)
Its result is applicable to the design, implementation, and evaluation of health policies on circulatory diseases and the distribution of economic, human, and technological resources for this group of diseases, among others.
Removing the effect of a different age distribution by using a standard population makes it possible to analyze the time trend and geographic distribution of deaths from circulatory diseases, in the same population or across populations.
The underlying causes of death in this category correspond to codes
I00 – I99 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the circulatory diseases mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
The circulatory diseases mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The value of the age-adjusted circulatory diseases mortality rate will depend on the standard population used for adjustment.
The estimated value of this indicator may differ from each country’s estimates due to methodological considerations such as the method used to prepare the population estimates and projections or the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the circulatory diseases mortality rate requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in this system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Cirrhosis mortality rate (age-adjusted per 100 000 pop)
Its result is applicable to the design, implementation, and evaluation of health policies on cirrhosis and other chronic liver diseases and the distribution of economic, human, and technological resources for the prevention, diagnosis, treatment, and control of this group of pathologies, among others. Its applications include, for example, evaluating over time the effectiveness of interventions promoting healthy lifestyles.
The age-adjusted cirrhosis mortality rate allows for the comparison across populations or in the same population over time.
The underlying causes of death correspond to codes K70, K74 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the age-adjusted cirrhosis mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The cirrhosis mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for a given sex, to the World Health Organization (WHO) World Standard Population.
The estimated value of the age-adjusted cirrhosis mortality rate will depend on the standard population used for its adjustment; therefore, it may differ from each country’s estimates. Other methodological considerations that influence its result are the use of a different range of ICD-10 codes and the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating this indicator requires a civil registry system with good coverage. Deaths from this group of pathologies must be recorded in a timely manner in this system, and certification of the cause of death must be of good quality and should include the etiology of the cirrhosis and other chronic liver diseases; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Colorectal cancer mortality rate (age-adjusted per 100 000 pop)
It is applicable to the design, implementation, and evaluation of health policies for the prevention and control of colorectal cancer and the distribution of economic, human, and technological resources for this disease, among others. Its applications include evaluating the effect of the implementation of screening strategies, such as the fecal occult blood test, for reducing mortality from this type of cancer.
Removing the effect of a different age structure by using a standard population makes it possible to analyze the colorectal cancer mortality rate across populations or in the same population over time.
The underlying causes of death correspond to codes C18 – C21 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the colorectal cancer mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The colorectal cancer mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The estimated value of the age-adjusted colorectal cancer mortality rate will depend on the standard population used for adjustment.
The estimated value of this indicator may differ from each country’s estimates due to methodological considerations such as the method used to prepare the population estimates and projections, the use of a different group of ICD-10 codes, or the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the colorectal cancer mortality rate requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in the system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Communicable diseases mortality rate (100 000 pop)
Its result is applicable to the design, implementation and evaluation of health policies for the prevention, diagnosis, and control of communicable diseases and maternal, perinatal and nutritional conditions and the distribution of economic, human and technological resources for this group of pathologies, among others. These applications include planning maternal and child, nutrition and vaccination programs and designing educational interventions and environmental sanitation measures.
It helps identify populations at higher risk of dying from communicable diseases and assess the presence of risk factors, such as deficiencies in basic environmental sanitation or in coverage of immunization programs against immunopreventable diseases.
The underlying causes of death correspond to codes A00 - B99, D50 - D53, D64.9, E00 - E02, E40 - E46, E50 - E64, G00 - G04, G14, H65 - H66, J00 - J22, N70 - N73, O00 - O99, P00 - P96, U04 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator for the mortality rate from communicable diseases are estimates by the United Nations Population Division.
By applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as unhelpful causes (known as garbage code).
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The value of the age-adjusted mortality rate from communicable diseases and maternal, perinatal and nutritional conditions will depend on the standard population used for its adjustment.
The estimated value of this indicator may differ from each country’s calculations due to methodological considerations such as the use of a different group of ICD-10 codes for the underlying cause of death, the method for preparing population forecasts and estimates, or the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the mortality rate requires a civil registry system with good coverage, that deaths be recorded in this system in a timely manner and the certification of cause of death be of good quality, otherwise, the estimates will not be sufficiently accurate.
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Communicable diseases mortality rate (age-adjusted per 100 000 pop)
Its result is applicable to the design, implementation, and evaluation of health policies for the prevention and control of communicable diseases, and maternal, perinatal, and nutritional conditions, and the distribution of economic, human, and technological resources for these diseases, among others. These applications include the planning and evaluation of maternal and child, vaccination and nutrition programs and the design and implementation of environmental sanitation measures.
Adjusting for age allows for the comparison of this indicator across populations or in the same population over time.
The underlying causes of death correspond to codes A00 - B99, D50 - D53, D64.9, E00 - E02, E40 - E46, E50 - E64, G00 - G04, G14, H65 - H66, J00 - J22, N70 - N73, O00 - O99, P00 - P96, U04 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the age-adjusted mortality rate from communicable diseases and maternal, perinatal, and nutritional conditions are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods.pdf?sfvrsn=37bcfacc_5
The mortality rate from communicable diseases and maternal, perinatal, and nutritional conditions is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The value of the age-adjusted mortality rate from communicable diseases and maternal, perinatal, and nutritional conditions will depend on the standard population used for adjustment.
The estimated value of this indicator may differ from each country’s estimates due to methodological considerations, such as the method used to prepare the population estimates and projections or the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the mortality rate from communicable diseases and maternal, perinatal, and nutritional conditions requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in this system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Concentrations of fine particulate matter (PM 2.5)
The indicator makes it possible monitor air quality trends and the result of air pollution control measures. Air quality is related to the climate of the planet and ecosystems around the world. Its result is applicable to guide policies to raise awareness about the risk of air pollution, implement measures to reduce exposure to air pollution and reduce the risks of air pollution as beneficial strategies for climate and health, because in addition to reducing the burden of disease, it helps mitigate climate change in the short and long term.
Concentration of PM2.5 are regularly measured from fixed-site, population-oriented monitors located within the metropolitan areas. High-quality measurements of PM concentration from all the monitors in the metropolitan area can be averaged to develop a single estimate.
Although PM2.5 is measured at many thousands of locations throughout the world, the amount of monitors in different geographical areas vary, with some areas having little or no monitoring. In order to produce global estimates at high resolution (0.1◦ grid‐cells), additional data is required. Annual urban mean concentration of PM2.5 is estimated with improved modelling using data integration from satellite remote sensing, population estimates, topography and ground measurements.
Care should be taken to ensure that the monitors used are not unduly influenced by a single source of pollution (i.e. a power plant, factory or highway); rather, the monitors should reflect exposures over a wide area.
Although it is likely that particulate matter data will be available only for larger cities, residents of agglomerations of less than 100 000 inhabitants and of rural areas are also exposed to PM from local industrial activity, transportation, biomass fuels, open burning and regional haze.
Data from different countries are of limited comparability because of:
(a) Different location of measurement stations;
(b) Different measurement methods;
(c) Different temporal coverage of certain measurements; if only part of the year was covered, the measurement may significantly deviate from the annual mean due to seasonal variability;
(d) Possible inclusion of data which were not eligible for this database due to insufficient information to ensure compliance;
(e) Heterogeneous quality of measurements;
(f) Omission of data which are known to exist, but which could not yet be accessed due to language issues or limited accessibility.
https://www.who.int/data/gho/indicator-metadata-registry
Indicator 11.6.2: Annual mean levels of fine particulate matter (e.g. PM2.5 and PM10) in cities (population weighted)
Available at: https://unstats.un.org/sdgs/metadata/
World Health Organization (WHO). Air Quality data base. Available at: https://www.who.int/data/gho/data/themes/air-pollution/who-air-quality-database
Shaddick G et al (2016). Data Integration Model for Air Quality: A Hierarchical Approach to the Global Estimation of Exposures to Ambient Air Pollution. Royal Statistical Society, arXiv:1609.0014. Available at: https://arxiv.org/abs/1609.00141
World Health Organization (WHO). Road map for an enhanced global response to the adverse health effects of air pollution. World Health Assembly, 71. (2018). Available at:
https://apps.who.int/iris/handle/10665/276321
Contraceptive prevalence use, modern methods (%)
Availability of and access to family planning services with modern methods helps improve maternal and child health by preventing unwanted or poorly spaced pregnancies, which are at greater risk of poor obstetric outcomes.
Modern contraceptive methods include female and male sterilization, intrauterine devices (IUD), implants, injectable methods, oral contraceptive pills, male and female condoms, vaginal barrier methods (including diaphragm, cervical cap, and spermicidal foam, jelly, cream, and sponge), lactation amenorrhea method, emergency contraception, and other modern methods that are not reported separately (e.g., contraceptive patch or vaginal ring).
For more details on methodology, see:
United Nations, Department of Economic and Social Affairs, Population Division (2021). World Contraceptive Use 2021. Available from:
https://www.un.org/development/desa/pd/data/world-contraceptive-use
Sustainable Development Goals (SDG).
Indicator 3.7.1. Proportion of women of reproductive age (aged 15–49 years) who have their need for family planning satisfied with modern methods.
Available from: https://sdgs.un.org/goals
https://opendata.paho.org/en/core-indicators
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from:
https://www.who.int/data/gho/indicator-metadata-registry
United Nations. Population Division. World Contraceptive Use. Available from:
https://www.un.org/development/desa/pd/data/world-contraceptive-use
United Nations. Sustainable Development Goals (SDG). E-Learning tool for SDG Indicator 3.7.1. Available from:
https://www.un.org/development/desa/pd/file/10712
Corpus uteri cancer mortality rate (age-adjusted per 100 000 pop); female
Its result is applicable to the design, implementation, and evaluation of health policies for the prevention, diagnosis, treatment, and control of corpus uteri cancer and the distribution of economic, human, and technological resources, among others. Its applications include, for example, quantifying specialized health personnel and infrastructure needed to address this type of cancer.
It helps to identify groups of women at higher risk of dying from corpus uteri cancer and to assess the presence of specific risk factors for certain population groups and the opportunity for access to timely diagnosis and treatment.
The populations used in the denominator of the corpus uteri cancer mortality rate are from estimates by the United Nations Population Division.
The underlying causes of death correspond to codes C54 of the International Classification of Diseases, Tenth Revision (ICD-10). Deaths assigned to ICD code C55, cancer of the uterus, part unspecified, and distributed pro-rata to cervix uteri cancer (C53) and corpus uteri cancer (C54).
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
The corpus uteri cancer mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates to the World Health Organization (WHO) World Standard Population.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The value of the age-adjusted corpus uteri cancer mortality rate will depend on the standard population used for adjustment.
The estimated value of this indicator may differ from each country’s estimates due to methodological considerations such as the method used to prepare the population estimates and projections or the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the mortality rate from corpus uteri cancer requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in this system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
https://www.who.int/data/global-health-estimates
Populations for countries:
United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects. Available from: https://population.un.org/wpp/
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No.31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
Crude birth rate (1 000 pop)
The crude birth rate is an indicator of population growth. Alongside the crude mortality rate, these indicators evaluate the level of aging in a population and estimate its natural growth.
If based on a standardized reference population, temporal and geographical birth rate trends between different countries or within the same country over time can be evaluated and compared. The indicator can also be applied to make projections on health care.
The crude birth rate of country A for the five-year period 2015–2020 was 19.9 per 1 000 inhabitants. In Country B, it was 40.0 per 1 000 inhabitants. This means that, during this period, country A had 19.9 live births per 1 000 inhabitants, or half of the births of neighboring country B.
The estimated value of this indicator may differ from country statistics due to factors such as methodological differences in developing population estimates and projections.
Its value can be affected by variations in the sex and age structure of the population being analyzed. Because the confounding effect of age persists in this indicator, its value should not be used to make comparisons between different populations or even within the same population over time.
The crude birth rate includes births, which are only one component of population change. As such, this indicator shouldn't be confused with the growth rate, which considers all components of change (births, deaths, and migratory movements).
It should not be compared with the fertility rate, because the latter is not affected by variations in the age structure of the population and considers women in its denominator.
https://www.who.int/data/gho/indicator-metadata-registry
Economic Commission for Latin America and the Caribbean (ECLAC) - CEPALSTAT. Statistical Databases and Publications. Available from:
https://statistics.cepal.org/portal/cepalstat/dashboard.html?lang=en
United Nations, Department of Economic and Social Affairs. 2019 Demographic Yearbook, 70th Issue. New York, 2020. Available from: https://unstats.un.org/unsd/demographic-social/products/dyb/
Pan American Health Organization. Basic Health Indicators in Brazil: concepts and applications, 2nd edition. Brasilia, 2008. Available from:
https://www.paho.org/bra/dmdocuments/indicadores.pdf
Crude death rate (1 000 pop)
Based on a standardized reference population, it is possible to analyze temporal and geographical mortality trends and comparisons between different populations and within the same population over time.
It can be used to estimate natural population growth, or the difference between births and deaths, and is calculated by subtracting the crude mortality rate from the crude birth rate.
The estimated value of this indicator may differ from country statistics due to factors such as methodological differences in developing population estimates and projections.
The crude mortality rate is affected by the age structure of the population. Therefore, to evaluate temporal trends or to compare rates between countries or geographical areas, it must use a standardized reference population.
https://population.un.org/wpp/
https://www.who.int/data/gho/indicator-metadata-registry
Economic Commission for Latin America and the Caribbean (ECLAC) - CEPALSTAT. Statistical Databases and Publications. Available from:
https://statistics.cepal.org/portal/cepalstat/dashboard.html?lang=en
United Nations, Department of Economic and Social Affairs. 2019 Demographic Yearbook, 70th Issue. New York, 2020. Available from: https://unstats.un.org/unsd/demographic-social/products/dyb/
Pan American Health Organization. Basic Health Indicators in Brazil: concepts and applications, 2nd edition. Brasilia, 2008. Available from: https://www.paho.org/bra/dmdocuments/indicadores.pdf
Haupt, A., Kane, T., Haub C. Population Reference Bureau’s Population Handbook (Sixth Edition) Washington, D.C. 2011. Available from:
https://www.prb.org/population-handbook/
Deaths (thousands)
The estimated value of this indicator may differ from country statistics due to factors such as methodological differences in developing population estimates and projections.
Because the number of deaths in a given population is affected by its age structure, the value of this indicator should not be used to make comparisons between different populations or even within the same population over time.
https://population.un.org/wpp/
https://www.who.int/data/gho/indicator-metadata-registry
United Nations, Department of Economic and Social Affairs. 2019 Demographic Yearbook, 70th Issue. New York, 2020. Available from: https://unstats.un.org/unsd/demographic-social/products/dyb/
Deaths due to tetanus in children under age 5
This indicator supports public policy-making aimed at reducing mortality in children under 5. It makes it possible to identify areas that require the establishment or intensification of a tetanus surveillance system and to strengthen the tetanus vaccination program.
This indicator reflects the health status, living conditions, and health and socio-economic development of a population, specifically children. It helps identify health inequities and specific risk factors.
This indicator applies to the design, implementation, and evaluation of health policies for the prevention, treatment, and control of tetanus and to the distribution of economic, human, and technological resources for this disease, among others. Its main applications include promoting vaccination, improving the hygiene of medical and dental procedures, and training health care workers in the prevention and early diagnosis of this disease. It helps strengthen access to quality health care.
This indicator’s value may differ from each country’s calculations due to methodological considerations, such as the application of algorithms to correct underreporting of deaths and births, and methods for redistributing ill-defined causes, among others.
Estimating the number of deaths from tetanus in children under 5 requires a civil registry system with good coverage. Births and deaths must be recorded in a timely manner in this system, and medical certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
https://opendata.paho.org/en/core-indicators
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from:
https://www.who.int/data/gho/indicator-metadata-registry
Deaths due to tetanus neonatorum
Tetanus is an immunopreventable disease that is acquired when spores of the bacterium Clostridium Tetani infect a wound or umbilical stump.
This indicator supports public policy-making aimed at reducing neonatal mortality. It makes it possible to identify areas that require the establishment or intensification of a neonatal tetanus surveillance system and to strengthen the tetanus vaccination program.
This indicator reflects the health status, living conditions, and health and socio-economic development of a population, specifically children. It helps identify health inequities and specific risk factors.
This indicator applies to the design, implementation, and evaluation of health policies for the prevention, treatment, and control of neonatal tetanus and to the distribution of economic, human, and technological resources for this disease, among others.
Its main applications include promoting vaccination, improving the hygiene of procedures for childbirth and newborns, and training health personnel in the prevention of this disease. It helps strengthen access to quality maternal and child health care.
This indicator’s value may differ from each country’s calculations due to methodological considerations, such as the application of algorithms to correct underreporting of deaths and births, and methods for redistributing ill-defined causes, among others.
Estimating the number of deaths due to tetanus neonatorum requires a civil registry system with good coverage. Births and deaths of infant populations must be recorded in a timely manner in this system, and medical certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
https://opendata.paho.org/en/core-indicators
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from:
https://www.who.int/data/gho/indicator-metadata-registry
Deaths from communicable diseases (%)
Its result is applicable to the design, implementation and evaluation of health policies for the prevention and control of communicable diseases and maternal, perinatal, and nutritional conditions and the distribution of economic, human, and technological resources for this pathology, among others. Its applications include planning and evaluation of maternal and child nutrition and vaccination programs and the design and implementation of educational interventions and environmental sanitation measures.
Underlying causes of death correspond to codes A00 - B99, D50 - D53, D64.9, E00 - E02, E40 - E46, E50 - E64, G00 - G04, G14, H65 - H66, J00 - J22, N70 - N73, O00 - O99, P00 - P96, U04 of the International Classification of Diseases, Tenth Revision (ICD-10).
Data for this indicator are from the World Health Organization (WHO) Global Health Estimates (GHE), based on information from multiple sources, such as national civil registry systems, estimates from WHO technical programs, the United Nations and inter-agency groups, the Global Burden of Disease, and other scientific studies.
By applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death. For countries without high-quality death registration data, cause of death estimates are calculated using other data, for example, household surveys with verbal autopsy, sentinel registry systems, or special studies.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods.pdf?sfvrsn=37bcfacc_5
Estimating the proportion of deaths from communicable diseases and maternal, perinatal, and nutritional conditions requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in this system, and certification of cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Deaths from measles
The indicator’s result is applicable to the design, implementation, and evaluation of health policies for the prevention and control of measles and the distribution of economic, human, and technological resources for this disease. Its applications include planning and evaluation of measles vaccination programs and prioritization of health care quality.
This indicator’s estimated value may differ from each country’s calculations due to methodological considerations, such as the application of algorithms to correct underreporting and methods for redistributing ill-defined causes, among others.
Estimating the number of deaths from measles requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in this system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
https://opendata.paho.org/en/core-indicators
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from:
https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). Measles; 2019. Available from: https://www.who.int
ews-room/fact-sheets/detail/measles
World Health Organization (WHO). Global measles and rubella strategic plan: 2012–2020. Available from: http://apps.who.int/iris/bitstream/handle/10665/94384/9789241506236_eng.pdf?sequence=1
Deaths from noncommunicable diseases (%)
This indicator reflects a population’s lifestyles, socioeconomic development, and health status, and is also related to population aging and rapid, poorly planned urbanization. Its analysis makes it possible to identify populations with greater risk factors for dying from noncommunicable diseases and encourage research in this area.
The proportion of deaths from noncommunicable diseases is applicable to the design, implementation, and evaluation of health policies related to this group of diseases and the distribution of economic, human, and technological resources for their prevention, diagnosis, treatment, and control, among others. Its applications include, for example, the identification of populations requiring interventions to promote healthy lifestyles or specific socioeconomic measures to reduce health inequities. It is also used to estimate the infrastructure and number of specialized health personnel required to address this group of pathologies.
The underlying causes of death for this indicator correspond to International Classification of Diseases, Tenth Revision (ICD-10) codes C00 - C97, D00 - D48, D55 - D64 (except D64.9), D65 - D89, E03 - E07, E10 - E34, E65 - E88, F01 - F99, G06 - G98 (except G14), H00 - H61, H68 - H93, I00 - I99, J30 - J98, K00 - K92, L00 - L98, M00 - M99, N00 - N64, N75 - N98, Q00 - Q99, X41 - X42, X44 - X45, R95.
By applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death. For countries without high-quality death registration data, cause of death estimates are calculated using other data, for example, household surveys with verbal autopsy, sentinel registry systems, or special studies.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000–2019. December 2020. Available from: https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods.pdf?sfvrsn=37bcfacc_5
The calculation of the proportion of deaths from noncommunicable diseases requires a civil registry system with good coverage. Deaths from this group of causes must be recorded in the system in a timely manner and certification of cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from:
https://www.who.int/data/gho/indicator-metadata-registry
Deaths from pertussis in children under age 5
This indicator reflects the health status, living conditions, and health and socio-economic development of a population, specifically children. It helps identify health inequities and populations with higher specific risk factors for dying from pertussis. It is directly related to coverage of the pertussis vaccination program.
This indicator is applicable to the design, implementation, and evaluation of health policies for the prevention, treatment, and control of pertussis in children and to the distribution of economic, human, and technological resources for this disease, among others. Its main applications include promoting research related to this disease, planning and evaluating pertussis vaccination programs, and prioritizing access to quality health care in children.
This indicator’s value may differ from each country’s calculations due to methodological considerations, such as the application of algorithms to correct underreporting of deaths and births, and methods for redistributing ill-defined causes, among others.
Estimating the number of deaths from pertussis in children under 5 requires a civil registry system with good coverage. Births and deaths must be recorded in a timely manner in this system, and medical certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
https://opendata.paho.org/en/core-indicators
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from:
https://www.who.int/data/gho/indicator-metadata-registry
Deaths in children under age 5 due to diphtheria
This indicator reflects the health status, living conditions, and health and socio-economic development of a population, specifically children. It helps identify health inequities and populations with higher risk factors for dying from diphtheria. It is directly related to the coverage of the diphtheria vaccination program.
This indicator is applicable to the design, implementation, and evaluation of health policies for the prevention, treatment, and control of diphtheria in children and to the distribution of economic, human, and technological resources for this disease, among other things. Its main applications include planning and evaluation of diphtheria vaccination programs, access to early antimicrobial therapy, and prioritization of the quality of health care in children.
This indicator’s value may differ from each country’s calculations due to methodological considerations, such as the application of algorithms to correct underreporting of deaths and births, and methods for redistributing ill-defined causes, among others.
Estimating the number of deaths due to diphtheria in children under 5 requires a civil registry system with good coverage. Births and deaths of child populations must be recorded in a timely manner in this system, and medical certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
https://opendata.paho.org/en/core-indicators
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from:
https://www.who.int/data/gho/indicator-metadata-registry
Demand for family planning satisfied by any modern method (%)
The numerator in the standard definition of unmet need for family planning includes women who are fertile and sexually active, and who report that they do not want to have (more) children or who report that they want to delay the birth of their next child for at least two years or more, or who are undecided about the time of the next birth but are using a contraceptive method.
The denominator is the total number of women aged 15 to 49 who express the need for family planning, either because they are using a contraceptive method or because they have an unsatisfied need for family planning.
Modern contraceptive methods include female and male sterilization, intrauterine devices (IUD), implants, injectable methods, oral contraceptive pills, male and female condoms, vaginal barrier methods (including diaphragm, cervical cap, and spermicidal foam, jelly, cream, and sponge), lactation amenorrhea method, emergency contraception, and other modern methods that are not reported separately (e.g., contraceptive patch or vaginal ring).
For more details on methodology, see:
United Nations, Department of Economic and Social Affairs, Population Division (2021). World Contraceptive Use 2021. Available from:
https://www.un.org/development/desa/pd/data/world-contraceptive-use
Sustainable Development Goals (SDG).
Indicator 3.7.1. Proportion of women of reproductive age (aged 15–49 years) who have their need for family planning satisfied with modern methods. [Proporción de mujeres en edad reproductiva (de 15 a 49 años de edad) cuyas necesidades de planificación familiar se satisfacen con métodos modernos]
Available from: https://sdgs.un.org/goals
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 2.a Proportion of women of reproductive age (15-49 years) who have their need for family planning satisfied with modern methods
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
https://opendata.paho.org/en/core-indicators
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from:
https://www.who.int/data/gho/indicator-metadata-registry
United Nations. Population Division. World Contraceptive Use. Available from:
https://www.un.org/development/desa/pd/data/world-contraceptive-use
United Nations. Sustainable Development Goals (SDG). E-Learning tool for SDG Indicator 3.7.1. Available from:
https://www.un.org/development/desa/pd/file/10712
Pan American Health Organization. PAHO Strategic Plan 2020-2025 “Equity at the Heart of Health” – Compendium of Outcome Indicators. Available from:
https://www.paho.org/en/documents/paho-strategic-plan-2020-2025-equity-heart-health-compendium-outcome-indicators
Dengue cases
This indicator makes it possible to monitor countries that are planning and implementing strategies to reduce and control Aedes aegypti populations and determine the sustainability of such measures. It helps identify populations in need of strengthened dengue surveillance programs, diagnostic capacity, and health care to address the disease.
PAHO's Strategy for Arboviral Disease Prevention and Control monitors this indicator.
It encourages research and development of new resources for dengue prevention and control. It is also used to promote intersectoral collaboration at the national and international levels and allocate human, technological, and economic resources to fight the disease.
World Health Organization (WHO). Fifty-fifth World Health Assembly Dengue fever and dengue haemorrhagic fever prevention and control. Resolution WHA55.17. May 2002. Available from: https://apps.who.int/iris/bitstream/handle/10665/78534/ewha5517.pdf
World Health Organization (WHO). Dengue and severe dengue. Available from: https://www.who.int/health-topics/dengue-and-severe-dengue#tab=tab_1
Dentists (10 000 pop)
The International Standard Classification of Occupations code for this category is 2261 (2008 revision).
The indicator also contributes to monitoring country progress in implementing the Plan of Action on Human Resources for Universal Access to Health and Universal Health Coverage 2018-2023 (https://iris.paho.org/handle/10665.2/49611?locale-attribute=pt) and the Global Strategy on Human Resources for Health 2030 (https://www.who.int/publications/i/item/9789241511131).
Population figures from the United Nations Population Division are used for the denominator (https://population.un.org/wpp/).
The value of this indicator may differ from figures calculated by each country due to differences such as the populations used as denominator. Another factor to consider, depending on the nature of the original data source, is that the numerator could be limited to actively working dentists or include all registered or licensed to practice professionally, even when their employment status is unknown.
Indicator 3.c.1 Health worker density and distribution
Available from: https://sdgs.un.org/
Pan American Health Organization (PAHO). Strategy on Human Resources for Universal Access to Health and Universal Health Coverage. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/34198
Pan American Health Organization (PAHO). Plan of Action on Human Resources for Universal Access to Health and Universal Health Coverage 2018-2023. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/49611?locale-attribute=pt
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). 2018 Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Geneva, 2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/259951/WHO-HIS-IER-GPM-2018.1-eng.pdf
World Health Organization (WHO). National health workforce accounts: a handbook. Geneva, 2017. Available from: https://apps.who.int/iris/bitstream/handle/10665/259360/9789241513111-eng.pdf
International Labour Organization (ILO). International Standard Classification of Occupations 08 (ISCO-08). Available from: https://unstats.un.org/unsd/classifications/Family/Detail/1067
World Health Organization (WHO). Global Health Workforce statistics database. Available from: https://www.who.int/data/gho/data/themes/topics/health-workforce
Dependency ratio (100 pop)
The higher the dependency rate, the greater the burden for the potentially productive population to sustain the potentially inactive population. This means that the working-age population must support a large proportion of dependents.
The indicator can also be applied to monitor the aging process of a country, territory, or geographical area.
An economically "dependent" population is defined as the sum of the population aged 0 to 14 plus the population aged 65 and over in a given country, territory, or geographical area, at a specific point in time, usually at mid-year (July 1). The population of economically "active or productive" age is the population aged 15 to 64 in the same country, territory, or geographical area, at the same specific point in time.
Formula:
(A/B) x 100
Numerator (A):
Population under 15 years and over 65 years in a given country, territory, or geographical area in year z.
Denominator (B):
Population aged 15 to 64 in a given country, territory, or geographical area in year z.
In 2015, the dependency ratio of country A was 43.8. This means in 2015, there were 43.8 dependent people for every 100 economically active people.
In reality, these are potentially inactive and potentially active populations, because not all people aged 0 to 14 or those aged 65 and over are out of the labor market, nor are all those aged 15 to 64 working.
Because the dependency ratio is affected by factors influencing the labor market, such as including young people and older adults or excluding people of working age, this indicator should be analyzed alongside other economic parameters.
https://population.un.org/wpp/
https://www.who.int/data/gho/indicator-metadata-registry
United Nations, Department of Economic and Social Affairs. 2019 Demographic Yearbook, 70th Issue. New York, 2020. Available from: https://unstats.un.org/unsd/demographic-social/products/dyb/
United States Census Bureau. International Database. Glossary. Available from:
https://www.census.gov/glossary/
United Nations, Department of Economic and Social Affairs, Population Division. Glossary of Demographic Terms. Available from:
https://population.un.org/wpp/GlossaryOfDemographicTerms/
Economic Commission for Latin America and the Caribbean (ECLAC) - CEPALSTAT. Statistical Databases and Publications. Available from:
https://statistics.cepal.org/portal/cepalstat/dashboard.html?lang=en
Pan American Health Organization. Basic Health Indicators in Brazil: concepts and applications, 2nd edition. Brasilia, 2008. Available from: https://www.paho.org/bra/dmdocuments/indicadores.pdf
Haupt, A., Kane, T., Haub C. Population Reference Bureau’s Population Handbook (Sixth Edition) Washington, D.C. 2011. Available from: https://www.prb.org/population-handbook/
Diabetes mellitus mortality rate (age-adjusted per 100 000 pop)
The age-adjusted diabetes mellitus mortality rate allows for the comparison of this indicator across populations or in the same population over time.
The underlying causes of death correspond to codes E10 – E14 (except E10.2, E11.2, E12.2, E13.2, E14.2) of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator for the age-adjusted diabetes mellitus mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The diabetes mellitus mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The value of the age-adjusted diabetes mellitus mortality rate will depend on the standard population used for adjustment.
The estimated value of this indicator may differ from each country’s estimates due to methodological considerations such as the use of a different group of ICD-10 codes for the underlying cause of death, the method for preparing population estimates and projections, or the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the diabetes mellitus mortality rate requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in this system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Diphtheria cases in children under age 5
The number of confirmed cases of diphtheria in children under 5 years of age reflects the impact this disease has on children, despite being an immunopreventable disease. This indicator makes it possible to identify populations with inadequate immunization program coverage. It is applied when designing, implementing, and assessing health policies to prevent, treat, and control diphtheria in children and distribute economic, human, and technological resources to fight the disease, among other purposes. Among its main applications are planning and assessing vaccination programs against diphtheria, providing access to early antimicrobial therapy, and prioritizing quality health care in children.
It quantifies the impact of diphtheria as a public health problem in a given population or geographical area and supports decision making for public policies aimed at reducing morbidity and mortality in children under 5 years of age. Analysis of the disease's temporal and geographical trends can be performed.
This indicator reflects the health status and health and socioeconomic development of a population. It helps to identify health inequities and populations with greater risk factors for transmitting Corynebacterium diphtheriae.
Sustainable Development Goals (SDG).
Indicator 3.b.1 Proportion of the target population covered by all vaccines included in their national programme.
Available from: https://sdgs.un.org/
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). Diphtheria vaccine: WHO position paper. No. 31, August 2017, 92, 417–436. Available from: https://apps.who.int/iris/handle/10665/258683
Indicadores básicos para a saúde no Brasil: conceitos e aplicações, 2ª edição [Core health indicators in Brazil: concepts and applications]. Pan American Health Organization. Brasilia, 2008. Available from: https://www.paho.org/bra/dmdocuments/indicadores.pdf
Estimated infant mortality rate (1 000 lb)
This indicator shows the magnitude of infant deaths as a public health problem for a given population or geographic area and measures infant survival.
This value reflects the risk of infants born alive dying during their first year of life. It makes it possible to identify health inequities and populations with specific risk factors.
The infant mortality rate reflects children’s health status and social, economic, and environmental conditions. It is related to maternal and child health care access, quality, and timeliness. Its applications include strengthening professional childbirth care, breastfeeding, and vaccination programs.
This indicator is useful for designing, implementation, and evaluation of health policies and the distribution of economic, human, and technological resources aimed at improving maternal and child health. Its applications include evaluating time and geographic trends in infant mortality.
According to the data source, the most commonly used sources for estimating the infant mortality rate are:
Civil registry: The number of deaths at age 0 and the population of that age are used to calculate the mortality rate, which is then converted into the age-specific probability of dying.
Censuses and surveys: Indirect method based on asking each woman of reproductive age how many children she has given birth to and how many are still alive. The Brass method and model life tables are then used to provide an estimate of infant mortality.
Surveys: Direct method based on birth history: a series of detailed questions about each child a woman has given birth to over her lifetime. To reduce sampling errors, estimates are generally presented as period rates, for the five or ten years leading up to the survey.
The IGME produces an infant mortality rate (IMR) trend using a standardized methodology by country groups based on the type and quality of available data. For developed countries where the civil registry has full coverage, the IMR is calculated directly from civil registry data if the data for the year to be estimated are available. For countries with an adequate trend of civil registry data, the age pattern between infant mortality and under-5 mortality from the most recent data is used as a standard for the Modified Logit Life Table developed by WHO, to convert the projected under-5 mortality rate applying a weighted regression to a projected infant mortality rate.
For countries with survey-derived data, since infant mortality rates from survey-derived birth histories are exposed to memory bias, infant mortality is obtained from projected under-5 mortality rates converted to infant mortality rates using the Coale-Demeney model life tables.
The Inter-agency Group for Child Mortality Estimation, which includes representatives from UNICEF, WHO, the World Bank, and the United Nations Population Division, is actively working to produce standardized joint estimates.
Pan American Health Organization (PAHO)/World Health Organization (WHO). Core indicators Portal. Available from: https://opendata.paho.org/en/core-indicators
Estimated maternal mortality ratio (100 000 lb)
Maternal deaths: The annual number of female deaths from any cause related to or aggravated by pregnancy or its management (excluding accidental or incidental causes) during pregnancy and childbirth or within 42 days of termination of pregnancy, irrespective of the duration and site of the pregnancy, expressed per 100,000 live births, for a specified time period.
The ratio depicts the risk of maternal death relative to the number of live births and essentially captures the risk of death in a single pregnancy or a single live birth.
In general, the maternal mortality ratio reflects the magnitude of maternal mortality, increases its visibility as a serious public health problem, and contributes to raising societal awareness about the issue. It reflects a population's state of health, as well as its socioeconomic and health development. It allows inequities in health and higher-risk populations to be identified, and highlights the need to focus economic, human, and technological resources to respond appropriately to deficiencies detected.
Its value reflects the risk that a woman has of dying from complications related to pregnancy, childbirth, or the postpartum period, and encourages research in maternal and child issues. Among its applications is the evaluation of geographical and temporal trends in maternal mortality.
This indicator is associated with the quality of women's health care, including family planning, antenatal care, attendance at childbirth, and the postpartum period. It identifies the need for specialized health personnel to prevent and treat complications that occur during pregnancy and childbirth.
MMEIG has developed a method to adjust existing data to consider data quality issues and improve the comparability of different data sources and countries. This method involves assessing underreporting and, where necessary, adjusts for insufficiency and poor classification of deaths while developing estimates through statistical models for countries without reliable data at the national level.
The estimation methods used by MMEIG consider adjustments to correct problems arising from underreporting and misclassification of maternal deaths and to ensure comparability between different data sources and countries.
This indicator’s value is affected by the frequency with which country data is updated, as well as transfer to the Maternal Mortality Estimation Inter-agency Group (MMEIG) for calculation.
Available from: https://mmr2020.srhr.org/homepage
Indicator 3.1.1: Maternal mortality ratio
Target 3.1 of the SDG: By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births.
Available from: https://sdg.data.gov/
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 6. Maternal mortality ratio (MMR) (deaths per 100,000 live births)
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
Available from: https://www.who.int/publications/i/item/9789240068759
Pan American Health Organization (PAHO)/World Health Organization (WHO). Core indicators Portal. Available from:
https://opendata.paho.org/en/core-indicators
Estimated neonatal mortality rate (1 000 lb)
This indicator quantifies the scope of neonatal mortality as a public health problem for a given population or geographic area. It measures the risk of children born alive dying before the age of 28 days.
The estimated neonatal mortality rate reflects health status and the social, economic, and environmental conditions in which a population lives, particularly the infant population. It makes it possible to identify health inequities and populations with specific risk factors and is related to maternal and child health care access, quality, and timeliness.
This indicator is applicable to the design, implementation, and evaluation of health policies and the distribution of economic, human, and technological resources aimed at improving maternal and child health, particularly prenatal and neonatal care. Its result helps strengthen professional care for childbirth, breastfeeding, and the Expanded Program on Immunization.
It allows for analysis of the geographic and time trend of neonatal mortality in a given population.
This indicator is estimated based on data from three sources:
Civil registry: The number of live births and the number of neonatal deaths are used to calculate age-specific rates. This system provides annual data.
Household surveys: Calculations are based on complete birth history, so women are asked the date of birth of each of their children, whether the child is still alive and, if not, the child’s age at the time of death.
To ensure consistency with under-5 mortality rates (U5MR) developed for the United Nations by the Inter-agency Group for Child Mortality Estimation (IGME) and to take into account variation in measurement errors from survey to survey, country data points for U5MR and the neonatal mortality rate (NMR) were rescaled for all years to match the IGME’s latest U5MR time series estimates. This change assumes that the proportional measurement error in NMR and U5MR is equal for each data point. The following multilevel statistical model was then applied to estimate neonatal mortality rates log (NMR / 1000) = α0 + β1 * log (U5MR / 1000) + β2* ([log (U5MR / 1000)]^2) with random effects parameters for both level and trend regression parameters, and random effects parameters influenced by the country itself.
For countries with high-quality civil registry data on neonatal deaths, defined as (i) 100% complete for adults and only civil registry data are used for infant mortality; (ii) population over 800 000; and (iii) with at least three civil registry data points for all subsequent calendar windows 1990–1994, 1995–1999, 2000–2004, 2005 onwards, the same basic equation is used, but with random effects parameters for both level and trend regression parameters and random effects parameters influenced by the country itself.
Indicator 3.2.2 Neonatal mortality rate.
Available from: https://sdgs.un.org/goals
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 3. Neonatal mortality rate
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
Estimated under-five mortality (1 000 lb)
This indicator highlights under-5 deaths as a public health problem for a given population or geographic area. This value makes it possible to identify health inequities and populations with specific risk factors.
It becomes relevant because most causes of death in this age group are preventable and treatable through simple, affordable interventions such as immunization, adequate nutrition, and access to safe water and basic services.
Under-5 mortality reflects children’s health status and social, economic, and environmental conditions and is related to maternal and child health care access, quality, and timeliness.
This indicator is applicable to the design, implementation, and evaluation of health policies and the distribution of economic, human, and technological resources aimed at improving maternal and child health.
Indicator 3.2.1: Under‐5 mortality rate.
Available from: https://sdg.data.gov/
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 4. Under-5 mortality rate
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
Pan American Health Organization (PAHO)/World Health Organization (WHO). Core indicators Portal. Available from: https://opendata.paho.org/en/core-indicators
Exclusive breastfeeding under 6 months (%)
This indicator is part of the global Monitoring Framework for Maternal, Infant and Young Child Nutrition that assesses countries' progress towards global nutrition targets. It also enables follow-up with the Monitoring Framework for Universal Health in the Americas, to measure national progress on implementing policies aimed at strengthening health systems and achieving universal health.
This indicator is applied when developing public policies to encourage exclusive breastfeeding and establish appropriate conditions. It also contributes to research on childhood morbidity and mortality.
Formula:
(A/B) x 100
Numerator (A):
Number of infants 0 to 5 months of age who received only breast milk the previous day, in a given country and year.
Denominator (B):
Total number of infants from 0 to 5 months of age, for the same country and year.
Indicator 14.f Percentage of infants under 6 months of age who are exclusively breastfed
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). Indicators for the Global Monitoring Framework on Maternal, Infant and Young Child Nutrition, 2014. Available from: https://cdn.who.int/media/docs/default-source
utritionlibrary/global-targets-2025/indicators_monitoringframework_miycn_background.pdf?sfvrsn=b1934036_6
World Health Organization (WHO). Maternal, infant, and young child nutrition, December 2019. Available from: https://apps.who.int/gb/ebwha/pdf_files/EB146/B146_24-en.pdf
UNICEF Data: Monitoring the situation of children and women. Available from: https://data.unicef.org/
World Health Organization and the United Nations Children's Fund (UNICEF) Indicators for assessing infant and young child feeding practices: definitions and measurement methods. Geneva: 2021. Available from: https://www.who.int/publications/i/item/9789240018389
External causes mortality rate (age-adjusted per 100 000 pop)
The age-adjusted external causes mortality rate allows for the comparison of this indicator across populations or in the same population over time.
The underlying causes of death correspond to codes V01 - Y89 (except X41-X42, X44 - X45) of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator for the age-adjusted external causes mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The external causes mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The value of the age-adjusted external causes mortality rate will depend on the standard population used for adjustment.
The estimated value of this indicator may differ from each country’s estimates due to methodological considerations, such as: the use of a different group of ICD-10 codes for the underlying cause of death, the method for preparing population estimates and projections, or the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Calculating the external causes mortality rate requires a civil registry system with good coverage. Deaths from this group of causes must be recorded in a timely manner in that system, and certification of the cause of death must be of good quality, including reporting the intentionality and type of event resulting in death; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Falls mortality rate (age-adjusted per 100 000 pop)
The age-adjusted falls mortality rate allows for the comparison of this indicator across populations or in the same population over time.
The underlying causes of death correspond to codes W00 – W19 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the age-adjusted falls mortality rate are estimates by the United Nations Population Division.
By applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The falls mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The value of the age-adjusted falls mortality rate will depend on the standard population used for adjustment.
The estimated value of this indicator may differ from each country’s estimates due to methodological considerations such as the use of a different group of ICD-10 codes for the underlying cause of death, the method for preparing population estimates and projections, or the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Calculating the falls mortality rate requires a civil registry system with good coverage. Deaths from this group of causes must be recorded in a timely manner in that system, and certification of the cause of death must be of good quality, which includes reporting how the fall leading to death occurred; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from:
https://www.who.int/data/gho/indicator-metadata-registry
Fetal mortality rate (1 000 births)
A stillbirth corresponds to the death of the product of conception, before his expulsion or his removal from his mother's body, weighing at least 1 000 g. When the weight cannot be obtained, a full 28 weeks of gestation is used as a reference. Fetal death does not include termination of pregnancy by induction.
This indicator is related to health care during pregnancy and childbirth and to a population’s health status and socioeconomic development. Its value is used to strengthen professional childbirth care.
The fetal mortality rate is applicable to the design, implementation, and evaluation of health policies and the distribution of economic, human, and technological resources aimed at improving maternal and child health.
Formula:
(A/B) x 1 000
Numerator (A):
Number of stillbirths in year z in a given country, territory or geographic area.
Denominator (B):
Total number of births (stillbirths + live births) in year z in the same country, territory or geographic area.
The estimated value of the fetal mortality rate may differ from each country’s value, due to methodological differences such as the definition of stillbirth used or the application of methods to correct underreporting of births and deaths.
WHO, 2016. Making every baby count. Available from: https://www.who.int/docs/default-source/mca-documents/maternal-nb/making-every-baby-count.pdf?Status=Master&sfvrsn=6936f980_2
Pan American Health Organization (PAHO)/World Health Organization (WHO). Core indicators Portal. Available from: https://opendata.paho.org/en/core-indicators
ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Vol 2. Available from: https://icd.who.int/browse10/Content/statichtml/ICD10Volume2_en_2016.pdf
Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Available from: https://score.tools.who.int/fileadmin/uploads/score/Documents/Enable_data_use_for_policy_and_action/100_Core_Health_Indicators
General mortality rate (age-adjusted per 1 000 pop)
The age-adjusted general mortality rate is used to assess changes in the time and geographic trend of mortality and to make comparisons across populations.
Its result is applicable to the design, implementation, and evaluation of public policies in various areas. Its applications include the identification of populations that need to be prioritized in allocating economic, human, and technological resources to increase their life expectancy.
The populations used in the denominator of the age-adjusted general mortality rate are from estimates by the United Nations Population Division.
By applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as ‘garbage codes’.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from:
https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The general mortality rate is adjusted for age through direct standardization: estimated age-specific mortality rates, for both sexes or for a given sex, are applied to the World Health Organization (WHO) World Standard Population.
The value of the age-adjusted general mortality rate will depend on the standard population used for adjustment.
The estimated value of this indicator may differ from each country’s calculations due to methodological considerations, such as the method used to prepare the population estimates and forecasts, or the application of algorithms to correct underreporting, among others.
Calculating the age-adjusted general mortality rate requires a civil registry system with good coverage. Deaths must be recorded in the system in a timely manner; otherwise the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
GINI Index
This indicator is used to analyze temporal variations in a country's income distribution. It reflects the behavior of inequality in its population.
The accuracy of this indicator is affected by the quality of the information used to calculate it. Another aspect to consider is that because household surveys on income or consumption differ in their methodology and in the type of welfare measures collected, the data obtained are not strictly comparable between countries or even within a country in different years. Within these differences, it is the definition of income that varies most frequently in surveys. Variations in household size (number of members), income distribution, consumption needs, and age can also skew comparisons.
The Gini coefficient lacks the property of ‘additive decomposition’, by which a population's income concentration should be equal to the weighted sum of inequality in all its subgroups. Lacking this property, the Gini index is not additive between groups, that is, the total Gini of a society is not equal to the sum of the Gini indices of its subgroups.
https://statistics.cepal.org/portal/cepalstat/dashboard.html?lang=en
Gross domestic product (US$ per capita), current international (PPP-adjusted)
Purchasing Power Parity (PPP) is based on conversion rates between currencies that considers both exchange rate differences and discrepancies in price levels between countries. Therefore, when used to deflate the corresponding aggregate national accounts, they measure the real size of the economies considering the purchasing power of the currency in each country.
This indicator is used to analyze the dynamics of a country’s economy and to evaluate geographical variations in the production and social wellbeing of its inhabitants. It helps to identify gaps in the average national income production and populations with unfavorable living conditions.
Its result is used to generate social and economic policies to respond to identified needs and encourage production in certain areas of the economy.
US$ 9 240, and of country B US$ 6 500. This means that, in this year, the total economic production of Country A adjusted for purchasing power parity was
US$ 9 240 per year for each of its inhabitants and the population of country A has more purchasing power than population B.
GDP per capita adjusted for PPP is an average value, which can be affected by wealth concentration in the highest income strata. This may mask situations of extreme poverty, and is insufficient on its own to reflect the wellbeing and social development of a country.
https://data.worldbank.org/indicator
Available from: https://www.worldbank.org/en/programs/icp
World Bank Open Data. Available from: https://data.worldbank.org/
Economic Commission for Latin America and the Caribbean (ECLAC) - CEPALSTAT. Statistical Databases and Publications. Available from:
https://statistics.cepal.org/portal/cepalstat/dashboard.html?lang=en
Gross national income (US$ per capita), current international (PPP-adjusted)
GNI is the value of the flow of goods and services produced by residents of a country, even if these goods are produced in a foreign country. It includes products made by domestic citizens or companies and excludes foreign products or services made within the country. It is the sum of the value added by all resident producers, plus all taxes on products (minus subsidies) not included in the valuation of the product, plus net inflows of primary income (employee remuneration and property income) from abroad.
Purchasing Power Parity (PPP) is a conversion rate between currencies that considers both exchange rate differences and discrepancies in price levels between countries. Therefore, when used to deflate the corresponding national accounts aggregates, they measure the real size of economies considering the purchasing power of the currency in each country.
It helps to assess the economic growth of a country during a specific period (usually one year) and to quantify inflation or poverty, among other purposes.
Despite its limitations, it is often calculated as an indicator reflecting a population's wellbeing.
Its result is used to generate social and economic policies to respond to identified needs and incentivize productive competition in certain areas of a country.
This indicator does not take into account the cost of living or subsistence levels. Therefore, it provides insufficient information to assess the true wellbeing of a country and must be interpreted alongside other indicators.
Unpaid or informal work is not included the calculations. As such, it may not reflect a country's true income level.
The frequency with which countries update their data and transfer it to the World Bank for calculation affects the result of this indicator.
https://data.worldbank.org/indicator
Economic Commission for Latin America and the Caribbean (ECLAC) - CEPALSTAT. Statistical Databases and Publications. Available from:
https://statistics.cepal.org/portal/cepalstat/dashboard.html?lang=en
Gross national income per capita, Atlas method (current US$)
It helps to assess the economic growth of a country during a specific period (usually one year) and to quantify inflation or poverty, among other purposes.
Despite its limitations, it is often calculated as an indicator reflecting a population's wellbeing.
Its result is used to generate social and economic policies to respond to identified needs and incentivize productive competition in certain areas of a country.
This indicator does not take into account the cost of living or subsistence levels. Therefore, it provides insufficient information to assess the true wellbeing of a country, and it must be interpreted alongside other indicators. Unpaid or informal work is not included in its calculation. As such, it may not reflect a country's true income level.
In some countries the values of GNI and Gross Domestic Product (GDP) are quite similar, however, in others the GNI may be much higher than GDP, due to the economic aid the country receives from abroad.
The frequency with which countries update their data and transfer it to the World Bank for calculation affects the result of this indicator.
https://data.worldbank.org/indicator
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
Pan American Health Organization/World Health Organization, Department of Evidence and Intelligence for Action in Health/Health Analysis, Metrics, and Evidence Unit. Database. Health Trends in the Americas: Core Indicators 2019. Washington, D.C., United States of America, 2019. Available from: https://iris.paho.org/handle/10665.2/51542
Pan American Health Organization. Health Information and Analysis Unit (HA). Regional Core Health Data Initiative; Core Indicators Glossary. Washington DC, June 2015. Available from:
https://www.paho.org/hq/dmdocuments/2015/glossary-eng-2014.pdf
Economic Commission for Latin America and the Caribbean - CEPALSTAT. Statistical Databases and Publications. Available from:
https://statistics.cepal.org/portal/cepalstat/dashboard.html?lang=en
Health technicians (10 000 pop)
They carry out technical and practical tasks to support the activities of promotion, prevention, diagnosis, treatment and rehabilitation of diseases, injuries and disabilities. These occupations are classified into the following subgroups: Dental assistants and therapists, Dental prosthetists, Pharmacy assistants, Diagnostic imaging and therapeutic equipment technicians, Clinical laboratory and pathological anatomy technicians, Environmental and occupational health technicians or inspectors, Opticians, Medical Documentalists / Health Statistics Technicians, Medical Prosthetists, Traditional and Complementary Medicine Associates, Community Health Agents or Community Health Workers, Physician Assistants, Ambulance Technicians. Personnel who have been included in the categories corresponding to nursing and midwifery professionals are excluded.
The definitions of the International Standard Classification of Occupations (ISCO-08) are adapted to the context of the Region of the Americas and its countries.
The indicator also contributes to monitoring country progress in implementing the Plan of Action on Human Resources for Universal Access to Health and Universal Health Coverage 2018-2023 (https://iris.paho.org/handle/10665.2/49611?locale-attribute=pt) and the Global Strategy on Human Resources for Health 2030 (https://www.who.int/publications/i/item/9789241511131).
Population figures from the United Nations Population Division are used for the denominator (https://population.un.org/wpp/).
The value of this indicator may differ from figures calculated by each country due to differences such as the populations used as denominator. Another factor to consider, depending on the nature of the original data source, is that the numerator could be limited to actively working health technicians, or include all registered or licensed, even if their employment status is unknown.
Indicator 3.c.1 Health worker density and distribution
Available from: https://sdgs.un.org/
Pan American Health Organization (PAHO). Strategy on Human Resources for Universal Access to Health and Universal Health Coverage. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/34198
Pan American Health Organization (PAHO). Plan of Action on Human Resources for Universal Access to Health and Universal Health Coverage 2018-2023. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/49611?locale-attribute=pt
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). 2018 Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Geneva, 2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/259951/WHO-HIS-IER-GPM-2018.1-eng.pdf
World Health Organization (WHO). National health workforce accounts: a handbook. Geneva, 2017. Available from: https://apps.who.int/iris/bitstream/handle/10665/259360/9789241513111-eng.pdf
International Labour Organization (ILO). International Standard Classification of Occupations 08 (ISCO-08). Available from: https://unstats.un.org/unsd/classifications/Family/Detail/1067
World Health Organization (WHO). Global Health Workforce statistics database. Available from: https://www.who.int/data/gho/data/themes/topics/health-workforce
HIV/AIDS mortality rate (age-adjusted per 100 000 pop)
Its result is applicable to the design, implementation, and evaluation of public policies related to HIV. Its result contributes, for example, to evaluating access to and timeliness of diagnosis, coverage of antiretroviral therapies and evaluating the effectiveness of health policies aimed at HIV prevention and control.
The age-adjusted HIV mortality rate allows for the comparison of this indicator across populations or in the same population over time.
The underlying causes of death correspond to codes B20 – B24 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the age-adjusted HIV/AIDS mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The HIV/AIDS mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The estimated value of the age-adjusted HIV/AIDS mortality rate will depend on the standard population used for its adjustment; therefore, it may differ from each country’s estimates. Another methodological consideration that influences the estimate is the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating this rate requires a civil registry system with good coverage. HIV/AIDS deaths must be recorded in a timely manner in that system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). Global HIV Programme. HIV data and statistics. Available from: https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/hiv-data-and-statistics
World Health Organization (WHO). Global progress report on HIV, viral hepatitis, and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. Geneva, 2021. Available from: https://www.who.int/publications/i/item/9789240027077
Homicide mortality rate (age-adjusted per 100 000 pop)
Its result is applicable to the design, implementation, and evaluation of public safety policies. Its result contributes, for example, to assessing the levels of violence and public safety in a country or geographic area, along with encouraging research on the causes that give rise to violence.
The age-adjusted homicide mortality rate allows for the comparison of this indicator across populations or in the same population over time.
The underlying causes of death correspond to codes X85 – Y09, Y87.1 of the International Classification of Diseases, Tenth Revision (ICD-10).
The estimation process uses observed data on homicide rates, along with regression models for countries without sufficient data availability or quality, to calculate comparable estimates of homicide rates and numbers across countries.
The populations used in the denominator of the age-adjusted homicide mortality rate are from estimates by the United Nations Population Division.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The homicide mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The estimated value of the age-adjusted homicide mortality rate will depend on the standard population used for its adjustment; therefore, it may differ from each country’s estimates. Another methodological consideration that influences this result is the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the homicide mortality rate requires a civil registry system with good coverage. Homicide deaths must be recorded in a timely manner in that system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Indicator 16.1.1 Number of victims of intentional homicide per 100,000 population, by sex and age
Available from: https://sdgs.un.org/goals
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
United Nations Office on Drugs and Crime (UNODC). Available from: https://www.unodc.org/unodc/en/index.html
Hospital beds ratio (1 000 pop)
Number of hospital beds refers to all hospital beds in public, social and private settings, which are maintained and staffed on a regular basis and are immediately available for the care of admitted patients. They are the sum of the following four categories: (i) Acute care beds; (ii) Rehabilitation beds; (iii) Long-term care beds; and (iv) Other hospital beds. Included: Beds in all general hospitals, mental health hospitals, and other specialized hospitals; Occupied and unoccupied beds. Excluded: Operating room tables, recovery cots, emergency stretchers, beds for same-day care, cribs for healthy infants; Beds in rooms closed for any reason; Temporary beds; Beds in residential long-term care facilities.
Due to methodological differences such as the population used as a denominator, the value of this indicator may differ from the results obtained by the country. It should also be considered that, depending on the source used and the means of monitoring, the data may not be exactly comparable between countries.
https://data.oecd.org/healtheqt/hospital-beds.htm
Pan American Health Organization (PAHO)/World Health Organization (WHO). Core indicators Portal. Available from:
https://opendata.paho.org/en/core-indicators
Hospital ICU beds ratio (100 000 pop)
The number of ICU beds refers to all hospital beds in the public, and private sectors.
The ICU is an organized system for delivering highly complex care to critically ill patients that provides intensive, specialized medical and nursing care, enhanced monitoring capacity, and multiple advanced life-sustaining treatments during a period of acute organ system failure. It includes pediatric, neonatal, and adult ICU beds.
Due to methodological differences such as the population used in the denominator, this indicator’s value may differ from each country’s results. Moreover, depending on the definition, source and monitoring methods used, the data may not be exactly comparable across countries.
https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2021_ae3016b9-en
Pan American Health Organization (PAHO)/World Health Organization (WHO). Core Indicators Portal. Available from:
https://opendata.paho.org/en/core-indicators
Human rabies cases
Rabies is an acute zoonotic disease caused by a Rhabdoviridae virus, leading to progressive and almost certain fatal inflammation of the brain and spinal cord. It is transmitted through the saliva of infected domestic or wild mammals; the most frequent vector for human rabies is the domestic dog. Despite being lethal once clinical signs appear, rabies is totally preventable. Vaccinating dog is the primary and most cost-effective measure to prevent human rabies. Prophylactic treatment exists for humans who are exposed.
The number of cases of human rabies indicates the magnitude of the disease in the population, reflecting its health and socioeconomic development and the effectiveness of human and animal rabies control strategies. The indicator is used to identify at-risk populations in order to focus preventive strategies, especially dog vaccination and control of other mammal vectors (e.g., bats), in addition to strengthening intersectoral collaboration to fight the disease and improving surveillance systems for human and animal rabies. This indicator is also used when allocating economic, human, and technological resources.
Pan American Health Organization (PAHO). Rabies. Available from: https://www.paho.org/en/topics/rabies
Pan American Health Organization (PAHO)/World Health Organization (WHO). Core indicators Portal. Available from: https://opendata.paho.org/en/core-indicators
Ill-defined and unknown causes of death (%)
Ill-defined causes of death refer to conditions that should not be considered as underlying cause (specifically signs, symptoms, or laboratory findings) and do not match the definition of underlying cause (an illness or injury that set off the chain of events directly leading to death, or the accident or violent act that produced the fatal injury). From a public health perspective, it is important to know the underlying cause in order to support prevention programs and design and implement effective policies and strategies.
Among the reasons for selecting this cause as an underlying cause on the death certificate are: insufficient case information from the certifying physician; lack of training among personnel on how to correctly certify the death; and certification authorization given to non-medical personnel that often lack training and information on underlying cause certification. Another reason is failure to train and update mortality coders.
Ill-defined causes impede targeted health interventions. For example, hypovolemic shock (an ill-defined cause) may result from gastrointestinal bleeding, a stab wound (intentional or unintentional), or postpartum obstetric bleeding. Preventive actions differ in each of the three causes, which highlights the importance of correctly specifying the underlying cause of death.
Generally speaking, causes of death statistics are essential when allocating resources to health services and planning and evaluating health policies. As a result, having correct and reliable underlying cause of death information is a public health priority.
The percentage of ill-defined causes of death is calculated by the Pan American Health Organization (PAHO) from data reported by the responsible national institution.
Formula:
(A/B) x 100
Numerator (A):
Number of deaths will ill-defined causes in year z in a given country, territory, or geographic area.
Denominator (B):
Deaths from all causes in year z in a given country, territory, or geographic area.
University of Melbourne. Avoiding ill-defined and unusable underlying causes: The underlying condition responsible for the failure should also be reported. Available from: https://crvsgateway.info/Avoiding-ill-defined-and-unusable-underlying-causes~343
Immunization coverage (%), PCV3
In some countries, the third dose is applied in children under 1 year. In others, children receive the vaccine at 1 year of age. As a result, the denominator selected is 2-year-old children.
Indicator 3.b.1 Proportion of the target population covered by all vaccines included in their national program.
Available from: https://sdgs.un.org/
Pan American Health Organization (PAHO). Pneumococcus: Available from: https://www.paho.org/en/topics/pneumococcus
Pan American Health Organization (PAHO). Immunization. Available from: https://www.paho.org/en/topics/immunization
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
Immunization coverage of 1 year old (%), MMR1
Pan American Health Organization (PAHO). Immunization. Available from: https://www.paho.org/en/topics/immunization
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
Immunization coverage of under-1 year old (%), BCG
Estimates are used to monitor immunization service coverage and to guide efforts to eradicate and eliminate diseases, in this case, tuberculosis. This indicator measures the performance of the health system and the population's access to vaccination programs.
Pan American Health Organization (PAHO). Immunization. Available from:
https://www.paho.org/en/topics/immunization
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
Immunization coverage of under-1 year old (%), DTP3-cv
The indicator is part of the Monitoring Framework for Universal Health in the Americas, which monitors country progress in providing access and universal health coverage.
Indicator 3.b.1 Proportion of the target population covered by all vaccines included in their national program.
Available from: https://sdgs.un.org/
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
Pan American Health Organization (PAHO). Immunization data and statistics. Available from: https://www.paho.org/en/topics/immunization/immunization-data-and-statistics
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
Immunization coverage of under-1 year old (%), Polio 3
Pan American Health Organization (PAHO). Immunization. Available from: https://www.paho.org/en/topics/immunization
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
Immunization coverage of under-1 year old (%), Rotavirus
This indicator is the percentage of children under 1 year of age who received the last dose of rotavirus vaccine. This may be a second or third dose depending on the vaccine used.
Pan American Health Organization (PAHO). Immunization. Available from: https://www.paho.org/en/topics/immunization
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
Incidence of congenital syphilis (1 000 live births)
The incidence of congenital syphilis is considered when evaluating strategies designed and implemented to reduce mother-to-child transmission of syphilis. Its value helps to identify at-risk groups in need of improved prenatal care and surveillance for the disease, analyze temporal and geographical trends, and estimate human, economic, and technological resources to strengthen preventive programs.
This indicator is part of the Monitoring Framework for Universal Health in the Americas, measuring national progress on implementing policies aimed at strengthening health systems and achieving universal health. It is part of efforts to monitor the progress of countries eliminating mother-to-child transmission of syphilis.
As a shared target exists to eliminate mother-to-child transmission of HIV and congenital syphilis, WHO, UNICEF, and UNAIDS provide joint support to assess congenital syphilis incidence and include it in the Progress Report on the Global Response to HIV/AIDS.
The numerator is the number of reported congenital syphilis cases (live births and stillbirths) in the previous 12 months in a specific country, territory, or geographical area. The populations used in the denominator are from estimates by the United Nations Population Division. The incidence is calculated by PAHO.
Formula:
(A/B) x 1 000
Numerator (A):
Number of reported cases of congenital syphilis in year z in a given country, territory, or geographic area.
Denominator (B):
Number of live births in year z in a country, territory, or geographic area.
Possible differences between WHO and the countries regarding their operational definitions of congenital syphilis can be a factor. Although WHO has a global definition for surveillance purposes, the actual definition may vary within or between countries.
https://www.who.int/data/gho/indicator-metadata-registry
Indicator: 18. Incidence rate of congenital syphilis (including stillbirths)
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
World Health Organization (WHO). Methods for surveillance and monitoring of congenital syphilis elimination within existing systems. Geneva, 2011. Available from: https://www.who.int/reproductivehealth/publications/rtis/9789241503020/en/
World Health Organization (WHO). Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV and syphilis. Geneva, 2017. Available from: https://www.paho.org/en
ode/21360
World Health Organization (WHO). Global health sector strategy on Sexually Transmitted Infections, 2016-2021. Towards ending STIs. Geneva, 2016. Available from: https://www.paho.org/en/documents/global-health-sector-strategy-sexually-transmitted-infections-2016-2021-towards-ending#:~:text=The%20present%20global%20health%20sector,goals%2C%20targets%2C%20guiding%20principles%20and
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
Infant mortality rate (1 000 lb)
Live birth means the complete expulsion or extraction from its mother of a product of conception, irrespective of the duration of pregnancy, that, after such expulsion or extraction, breathes or shows any other evidence of life, such as beating of the heart, pulsation of the umbilical cord, or definite movement of voluntary muscles, whether or not the umbilical cord has been cut or the placenta is attached. Each product of such childbirth that meets these conditions is considered a live birth. (ICD-10)
The infant mortality rate reflects children’s health status and social, economic, and environmental conditions. It is related to maternal and child health care access, quality, and timeliness. Its applications include strengthening professional childbirth care, breastfeeding, and vaccination programs.
This indicator is useful for designing, implementation, and evaluation of health policies and the distribution of economic, human, and technological resources aimed at improving maternal and child health. Its applications include evaluating time and geographic trends in infant mortality.
Formula:
(A/B) x 1 000
Numerator (A):
Number of infant deaths in year z in a given country, territory or geographic area
Denominator (B):
Total number of live births in year z in the same country, territory or geographic area
To estimate the indicator by sex, the following formula is applied:
(A/B) x 1 000
Numerator (A):
Number of infant deaths of a given sex in year z in a specific country, territory, or geographic area.
Denominator (B):
Total number of live births of the same sex in year z in the same country, territory, or geographic area.
The value of this indicator may differ from each country’s value due to methodological differences such as the application of algorithms to reassign ill-defined causes of death and methods to correct underreporting of births and deaths.
ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Vol 2. Available from: https://icd.who.int/browse10/Content/statichtml/ICD10Volume2_en_2010.pdf
Inflation (%)
It is one of the indicators used by central banks to set monetary policies, such as interest rates. Analysis of its value includes identifying whether the observed change is due to an increase in demand, the cost of raw materials, or the money supply, among other factors, and implementing measures aimed at controlling it.
Inflation is closely related to a country's fiscal policies, deficit, and unemployment level.
The frequency with which countries update their data and transfer it to the World Bank for calculation affects the result of this indicator.
Injury deaths (%)
The value of this indicator is related to the quality of health care provided for this type of event and the identification of higher-risk populations and geographic areas, suggesting the need for more detailed analysis.
Its result is applicable in the design, implementation, and evaluation of health, transportation, and public safety policies related to injury deaths and in the distribution of economic, human, and technological resources for the prevention of injury deaths, among others.
The underlying causes of death correspond to International Classification of Diseases, Tenth Revision (ICD-10) codes V01 - Y89 (except X41 - X42, X44 - X45).
Data for this indicator are from the World Health Organization (WHO) Global Health Estimates (GHE), based on information from multiple sources, such as national civil registry systems, estimates from WHO technical programs, the United Nations and inter-agency groups, the Global Burden of Disease, and other scientific studies.
By applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death. For countries without high-quality death registration data, cause of death estimates is calculated using other data, for example, household surveys with verbal autopsy, sentinel registry systems, or special studies.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods.pdf?sfvrsn=37bcfacc_5
Calculating the proportion of injury deaths requires a civil registry system with good coverage. Deaths from this group of causes must be recorded in that system in a timely manner and certification of cause of death must be of good quality. This must include reporting deliberate acts resulting in death; otherwise, the estimates will not be sufficiently accurate.
https://www.who.int/data/global-health-estimates
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from:
https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). Global status report on road safety 2018. Geneva, 2018. Available from: https://www.who.int/publications/i/item/9789241565684
Ischemic heart diseases mortality rate (age-adjusted per 100 000 pop)
Its result is applicable to the design, implementation, and evaluation of health policies on ischemic heart diseases and the distribution of economic, human, and technological resources for the prevention, diagnosis, treatment, and control of this group of pathologies, among others. Its applications include, for example, evaluating over time the effectiveness of interventions to promote healthy lifestyles or myocardial revascularization.
The age-adjusted ischemic heart diseases mortality rate allows for the comparison of this indicator across populations or in the same population over time.
The underlying causes of death correspond to codes I20 – I25 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the age-adjusted ischemic heart diseases mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The ischemic heart diseases mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The estimated value of the age-adjusted ischemic heart diseases mortality rate will depend on the standard population used for its adjustment; therefore, it may differ from each country’s estimates. Other methodological considerations that influence its result are the use of a different group of ICD-10 codes and the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the ischemic heart diseases mortality rate requires a civil registry system with good coverage. Deaths from ischemic heart diseases must be recorded in a timely manner in that system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Kuznets ratio
Along with other macroeconomic indicators, such as the Gini coefficient, the Kuznets index is used to analyze changes in a country's economic inequality over time. It is used to design socioeconomic policies to address poverty.
Formula:
(A/B) x 100
Numerator (A):
Total income of the richest quintile
Denominator (B):
Total income of the richest quintile
No adjustments are made for spatial differences in the cost of living within countries, because the data needed for such calculations are generally not available.
Low frequency and lack of comparability among surveys due to methodological differences are other factors that hinder monitoring poverty.
The frequency with which countries update their data and transfer it to the World Bank for calculation affects the result of this indicator.
Leprosy cases in treatment
This indicator is used to monitor disease elimination. It helps identify vulnerable populations in need of strengthened national surveillance systems, improve detection among those affected, ensure treatment, and intensify leprosy elimination campaigns in line with the Global Leprosy (Hansen disease) Strategy 2021–2030.
Leprosy was eliminated globally as a public health problem (defined as a recorded prevalence of less than 1 case per 10 000 pop) in 2000.
WHO. Weekly Epidemiological Record. Global leprosy (Hansen disease) update, 2020: impact of COVID-19 on global leprosy control. Available from: https://www.who.int/publications/i/item/who-wer9636-421-444
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/data/themes/topics/leprosy-hansens-disease
World Health Organization (WHO). Elimination of leprosy as a public health problem. Resolution WHA51.15. May 1998. Available from: https://apps.who.int/iris/handle/10665/79814
Leptospirosis cases
The number of cases of leptospirosis makes it possible to quantify the magnitude of this disease in the population, analyze its temporal and geographic trend, and identify areas and groups at greatest risk for transmission. This indicator contributes to the design and evaluation of strategies for the prevention and control of leptospirosis in the community and to the allocation of resources to control it.
World Health Organization (WHO). The Global Health Observatory (GHO). Available from:
https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). Human leptospirosis: guidance for diagnosis, surveillance, and control. Geneva, 2003. Available from:
https://apps.who.int/iris/handle/10665/42667
Life expectancy at birth (years)
Unlike the crude mortality rate, it is independent of the population's age structure, which allows comparisons to be made between different populations and within the same population over time.
Life tables are used in the multi-step calculation of life expectancy at birth, based on age- and sex- specific mortality rates. Their values represent mid-year estimates.
Whenever vital records systems with full coverage are not available or the accuracy of the data is inadequate, life expectancy at birth should be estimated using indirect demographic methods, applicable to large geographical areas.
Life expectancy at birth may differ depending on the method used to draw up the life table.
Life expectancy changes as a person ages, changing according to potential shifts in mortality trends and the health conditions of the population in which they live.
https://population.un.org/wpp/
Indicator 2. Health-adjusted life expectancy (HALE)
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
https://www.who.int/data/gho/indicator-metadata-registry
United Nations, Department of Economic and Social Affairs. 2019 Demographic Yearbook, 70th Issue. New York, 2020. Available from: https://unstats.un.org/unsd/demographic-social/products/dyb/
United States Census Bureau. International Database. Glossary. Available from: https://www.census.gov/glossary/
United Nations, Department of Economic and Social Affairs, Population Division. Glossary of Demographic Terms. Available from:
https://population.un.org/wpp/GlossaryOfDemographicTerms/
Economic Commission for Latin America and the Caribbean (ECLAC) - CEPALSTAT. Statistical Databases and Publications. Available from:
https://statistics.cepal.org/portal/cepalstat/dashboard.html?lang=en
Pan American Health Organization. Basic Health Indicators in Brazil: concepts and applications, 2nd edition. Brasilia, 2008. Available from: https://www.paho.org/bra/dmdocuments/indicadores.pdf
Haupt, A., Kane, T., Haub C. Population Reference Bureau’s Population Handbook (Sixth Edition) Washington, D.C. 2011. Available from: https://www.prb.org/population-handbook/
Low birthweight (<2 500 g) (%)
The newborn’s weight measured for the first time after birth is known as birth weight. With live births, birth weight should be taken during the first hour of life, before significant postpartum weight loss occurs.
This indicator is related to the quality of maternal and child health care and social vulnerability. It allows at-risk populations to be identified and focuses strategies to strengthen access to timely and quality health and nutritional interventions. Research is incentivized to identify risk factors for low birth weight and propose appropriate interventions.
The percentage of low-weight newborns is part of the indicators of the Global Nutrition Monitoring Framework on Maternal, Infant, and Young Child Nutrition. These indicators monitor progress made by countries towards global nutrition targets. They also allow monitoring of the Monitoring Framework for Universal Health in the Americas, to measure national progress on implementing policies aimed at strengthening health systems and achieving universal health.
Formula:
(A/B) x 100 live births
Numerator (A):
Number of live newborns with birth weight lower than 2 500 g, in a given country, country, territory, or geographical area and year.
Denominator (B):
Total number of live births in the same country and year.
https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). Indicators for the Global Monitoring Framework on Maternal, Infant and Young Child Nutrition, 2014. Available from:
https://www.who.int
ews-room/events/detail/2014/11/24/default-calendar/indicators-for-the-global-monitoring-framework-on-maternal-infant-and-young-child-nutrition
World Health Organization (WHO). Maternal, infant and young child nutrition, March 2018. Available from:
https://apps.who.int/gb/ebwha/pdf_files/WHA71/A71_22-en.pdf
UNICEF Data: Monitoring the situation of children and women. Available from: https://data.unicef.org/
Lower respiratory infection mortality rate (age-adjusted per 100 000 pop)
Its result is applicable to the design, implementation, and evaluation of health policies on lower respiratory infections and the distribution of economic, human, and technological resources for the prevention, diagnosis, treatment, and control of this group of pathologies, among others. Its applications include, for example, analyzing the effect of immunoprevention interventions and strategies for promoting healthy lifestyles on mortality from lower respiratory infections.
Adjusting for age allows for the comparison of this indicator across populations or in the same population over time.
The underlying causes of death correspond to codes J09 - J22, P23, U04 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the age-adjusted lower respiratory infection mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The lower respiratory infection mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The estimated value of the age-adjusted lower respiratory infection mortality rate will depend on the standard population used for its adjustment; therefore, it may differ from each country’s estimates. Other methodological considerations that influence its result are the use of a different range of ICD-10 codes and the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the lower respiratory infection mortality rate requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in that system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Lung cancer incidence rate (age-adjusted per 100 000 pop)
The data used to estimate this indicator come from cancer registries that identify new cases occurring in a well-defined population, generating statistics to evaluate and control the impact of these diseases in the population.
The age-adjusted trachea, bronchial, and lung cancer incidence rate provides an estimate of the average risk the population has of developing these types of cancer in a particular country, territory, or geographic area. Its results are used to planning and allocating economic, human, and technological resources to fight lung cancer. It can be applied, for example, to evaluate the effectiveness of smoking restrictions.
As the trachea, bronchial, and lung cancer incidence rate is age-adjusted, comparisons can be made both within and between populations over time. It helps to identify at-risk groups, determine the presence of specific risk factors for different groups, and assess timely access to diagnosis and treatment.
This indicator supports public policy-making and is essential for planning and evaluating trachea, bronchial, and lung cancer screening, early diagnosis, treatment, and control programs. It helps to focus efforts such as identifying the need to strengthen and implement cancer registries in a given population.
The methods used to estimate the trachea, bronchial, and lung cancer incidence rate in a specific country depend on the available data sources. These include projections of observed incidence rates at the national level, statistical models derived from incidence rates in the country's cancer registries or neighboring country registries, and average incidence rates in neighboring countries, among other metrics.
The trachea, bronchial, and lung cancer incidence rate is age-standardized and results are based on rates in populations with a standard age structure.
The age-standardized rate is a summary measure of the rate that would have been observed in a population with a standard age structure. Standardization is necessary when comparing several populations that differ in age, as age is a major factor when determining cancer risk. An age-standardized rate is a weighted average of age-specific rates based on a standard population distribution.
In addition, the age-adjusted trachea, bronchial, and lung cancer incidence rate is not a real value. Its main purpose is to allow comparisons over time between different populations or within the same population. It reflects the average risk of developing these types of cancer in a particular country. This should not be interpreted as the individual risk of developing these cancers.
The estimated value of the age-adjusted trachea, bronchial, and lung cancer incidence rate depends on the standard population used for its adjustment; it may therefore differ from the calculations made by each country.
Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J, editors (2021). Cancer Incidence in Five Continents, Vol. XI. IARC Scientific Publication No. 166. Lyon: International Agency for Research on Cancer. Available from:
https://publications.iarc.fr/597
Pan American Health Organization (PAHO)/World Health Organization (WHO). Core indicators Portal. Available from: https://opendata.paho.org/en/core-indicators
Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Available from: https://apps.who.int/iris/handle/10665/259951
Lung cancer mortality rate (age-adjusted per 100 000 pop)
Its result is applicable to the design, implementation, and evaluation of health policies for the prevention and control of cancer of the trachea, bronchus and lung and the distribution of economic, human, and technological resources for this disease, among others. Its applications include, for example, evaluating the effectiveness of smoking restriction measures in closed spaces.
Removing the effect of a different age distribution by using a standard population makes it possible to analyze the time trend and geographic distribution of deaths from cancer of the trachea, bronchus and lung, in the same population or across populations.
The underlying causes of death correspond to codes C33 – C34 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the mortality rate from cancer of lung are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The mortality rate from cancer of lung is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The estimated value of the age-adjusted mortality rate from cancer of the lung will depend on the standard population used for adjustment.
The estimated value of this indicator may differ from each country’s estimates due to methodological considerations such as the method used to prepare the population estimates and projections, the use of a different range of ICD-10 codes, or the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the mortality rate from cancer of the lung requires a civil registry system with good coverage. Deaths must be recorded in this system in a timely manner, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Malaria cases
A case of malaria is defined as the presence of malarial parasite infection in a person's blood, confirmed by diagnostic examination.
This indicator is used to monitor countries progressing towards targets established in the Global Technical Strategy for Malaria 2016–2030. It also contributes to monitoring national progress on the objectives of the Monitoring Framework for Universal Health in the Americas.
The indicator makes it possible to assess the temporal and geographical trends of malaria and identify at-risk populations in need of strengthened surveillance programs, malaria elimination activities, and access to interventions, especially integrated and quality diagnosis and treatment. The value of the indicator is considered when allocating economic, human, and technological resources.
In the Americas, there are 18 endemic countries and territories (as of 2021):
Belize, Bolivia, Brazil, Colombia, Costa Rica, Dominican Republic, Ecuador, French Guiana, Guatemala, Guyana, Haiti, Honduras, Mexico, Nicaragua, Panama, Peru, Suriname, and Venezuela.
Information from non-endemic countries is reported directly to PAHO/WHO and classified as 'imported'.
Imported cases are transmitted by mosquitoes and contracted outside the area where diagnosis took place, in an area known to have malaria transmission, or areas visited by the patient outside the elimination zone.
Sustainable Development Goals (SDG)
Indicator 3.3.3: Malaria incidence per 1 000 population
Available from: https://sdg.data.gov/
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 21. Incidence rate of malaria
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
World Health Organization (WHO). The Seventy-fourth World Health Assembly. Recommitting to accelerate progress towards malaria elimination. Draft Resolution A74/B/CONF./2. May 2021. Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA74/A74_BCONF2-en.pdf
World Health Organization (WHO). WHO malaria terminology. Geneva, 2022. Updated in November 2021. Available from: https://www.who.int/publications/i/item/9789240038400
Global Technical Strategy for Malaria 2016–2030. Available from: https://www.paho.org/en/documents/global-technical-strategy-malaria-2016-2030
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C.; 2021. License: CC BY-NC-SA 3.0 IGO. Available from: https://iris.paho.org/handle/10665.2/53918
Malignant neoplasms mortality rate (age-adjusted per 100 000 pop)
Its result is applicable to the design, implementation, and evaluation of health policies for the prevention and control of malignant neoplasms and the distribution of economic, human, and technological resources, among others. Its applications include evaluating screening and early diagnosis strategies over time.
Removing the effect of differences in the age distribution by using a single standard population makes it possible to analyze the time trend and geographic distribution of deaths from malignant neoplasms in the same population or across populations.
The underlying causes of death correspond to codes C00 – C97 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the malignant neoplasms mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The malignant neoplasms mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
Due to the application of advanced statistical models, estimates may differ from each country’s results. The estimated value of the age-adjusted malignant neoplasms mortality rate will depend on the standard population used for its adjustment; therefore, it may differ from each country’s estimates. Other methodological considerations that influence its result are the use of a different range of ICD-10 codes and the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the malignant neoplasms mortality rate requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in this system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Maternal mortality ratio (100 000 lb)
Maternal death is defined as the death of a woman while pregnant or within 42 days following termination of pregnancy, regardless of the duration and anatomical site of the pregnancy, related to or aggravated by pregnancy or its management (excluding accidental or incidental causes) (ICD-10).
Live birth refers to the complete expulsion or extraction from its mother of a product of conception, regardless of the duration of the pregnancy, which, after such separation, breathes or shows any other evidence of life, (e.g., beating heart, pulsating umbilical cord, or definite movement of voluntary muscles) whether or not the umbilical cord has been cut or the placenta is attached. Each product of such childbirth that meets these conditions is considered as a live birth. (ICD-10)
The maternal mortality ratio reflects the magnitude of maternal mortality, increases its visibility as a serious public health problem, and contributes to raising societal awareness about the issue. It reflects a population's state of health, as well as its socioeconomic and health development. It allows inequities in health and higher-risk populations to be identified, and highlights the need to focus economic, human, and technological resources to respond appropriately to deficiencies detected.
Its value reflects the risk that a woman has of dying from complications related to pregnancy, childbirth, or the postpartum period, and encourages research in maternal and child issues.
This indicator is associated with access to and quality of women's health care, including family planning, antenatal care, attendance at childbirth, and the postpartum period. It identifies the need for specialized health personnel to prevent and treat complications that occur during pregnancy and childbirth.
The maternal mortality ratio is calculated using as a numerator the deaths of women occurring during pregnancy, childbirth, or the postpartum period, reported by the national health authority of a given country, territory, or geographical area in a specific calendar year, and as denominator the total number of live births for the same population and year. [ICD-10: A34, O00-O95, O98-O99]
Formula:
(A/B) x 100 000
Numerator (A):
Number of maternal deaths (direct or indirect obstetric causes) in a given country, territory or geographical area in year z
Denominator (B):
Number of maternal deaths (direct or indirect obstetric causes) in a given country, territory or geographical area in year z
For the purpose of international reporting of maternal mortality, only those maternal deaths occurring before the end of the 42-day reference period should be included in the calculation of the various ratios and rates.
It is recommended to monitor late maternal deaths at the national level.
Indicator 3.1.1: Maternal mortality ratio
SDG Target 3.1: By 2030, reduce the global maternal mortality ratio to less than 70 per 100 000 live births.
Available from: https://sdg.data.gov/
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 6. Maternal mortality ratio (MMR) (deaths per 100,000 live births)
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
https://opendata.paho.org/en/core-indicators
ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Vol 2. Available from:
https://apps.who.int/iris/handle/10665/42980
Mean years of schooling (years)
It allows evaluation of temporal and geographical trends in schooling between different populations and identification of at-risk groups in order to focus strategies to strengthen education. It is related to a country's educational system coverage and helps characterize its human capital. It is associated with a population's access to employment and income level.
As parents' educational level is directly related to the health status of their children, this is one of the indicators used to analyze child health and to plan strategies and interventions for health promotion, protection, and recovery.
Because the World Bank obtains income data through household surveys, the accuracy of this indicator is affected by the timeliness, frequency, quality, and comparability of the surveys used.
http://uis.unesco.org/
Measles cases
The number of measles cases quantifies the magnitude of this disease as a public health problem for a given population or geographic area. This indicator makes it possible to monitor the elimination of the disease, identify vulnerable populations, strengthen national surveillance systems, and enhance the identification of sick people to prevent further transmission through urgent vaccination of the population.
Monitoring this indicator tracks the progress of the Global Measles and Rubella Strategic Plan.
This indicator’s result is applicable to the design, implementation, and evaluation of health policies for the prevention and control of measles and the distribution of economic, human, and technological resources for this disease. Its applications include planning and evaluation of measles vaccination programs and prioritization of health care quality.
https://opendata.paho.org/en/core-indicators
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from:
https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). Measles; 2019. Available from: https://www.who.int
ews-room/fact-sheets/detail/measles
World Health Organization (WHO). Global Measles and Rubella Strategic Plan 2012–2020. Available from: http://apps.who.int/iris/bitstream/handle/10665/94384/9789241506236_eng.pdf?sequence=1
Median age (years)
In 2018, the median age in country A was 29 years. In country B, it was 35 years. This indicates that the latter country has an older population.
The estimated value of this indicator may differ from country statistics due to factors such as methodological differences in developing population estimates and projections.
https://population.un.org/wpp/
https://www.census.gov/programs-surveys/international-programs/about/glossary.html
United Nations, Department of Economic and Social Affairs, Statistics Division. Demographic and Social Statistics. Glossary of Demographic Terms. Available from:
https://population.un.org/wpp/GlossaryOfDemographicTerms/
United Nations, Department of Economic and Social Affairs, Statistics Division. Demographic and Social Statistics. Statistical Products and Databases. Available from:
https://unstats.un.org/unsd/demographic-social/products/
Haupt, A., Kane, T., Haub C. Population Reference Bureau’s Population Handbook (Sixth Edition) Washington, D.C. 2011. Available from:
https://www.prb.org/population-handbook/
Midwives (10 000 pop)
Professionals who plan, manage, provide and evaluate midwifery care and services before, during and after pregnancy and childbirth, both in the health services and in the community.
The International Standard Classification of Occupations code for this category is 2222 and 3222 (2008 revision). Physicians and nursing professionals are not included.
The indicator also contributes to monitoring country progress in implementing the Plan of Action on Human Resources for Universal Access to Health and Universal Health Coverage 2018-2023 (https://iris.paho.org/handle/10665.2/49611?locale-attribute=pt) and the Global Strategy on Human Resources for Health 2030 (https://www.who.int/publications/i/item/9789241511131).
Population figures from the United Nations Population Division are used for the denominator (https://population.un.org/wpp/)
The value of this indicator may differ from figures calculated by each country due to differences, such as the populations used as denominator. Another factor to consider, depending on the nature of the original data source, is that the numerator could be limited to actively working professional midwives, or include all registered or licensed, even if their employment status is unknown.
It is important to consider that there are countries in the Region that do not have this professional.
Indicator 3.c.1 Health worker density and distribution
Available from: https://sdgs.un.org/
Pan American Health Organization (PAHO). Strategy on Human Resources for Universal Access to Health and Universal Health Coverage. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/34198
Pan American Health Organization (PAHO). Plan of Action on Human Resources for Universal Access to Health and Universal Health Coverage 2018-2023. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/49611?locale-attribute=pt
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). 2018 Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Geneva, 2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/259951/WHO-HIS-IER-GPM-2018.1-eng.pdf
World Health Organization (WHO). National health workforce accounts: a handbook. Geneva, 2017. Available from: https://apps.who.int/iris/bitstream/handle/10665/259360/9789241513111-eng.pdf
International Labour Organization (ILO). International Standard Classification of Occupations 08 (ISCO-08). Available from: https://unstats.un.org/unsd/classifications/Family/Detail/1067
World Health Organization (WHO). Global Health Workforce statistics database. Available from: https://www.who.int/data/gho/data/themes/topics/health-workforce
International Confederation of Midwives (ICM). Available from: https://www.internationalmidwives.org/
Mortality attributable to household and ambient air pollution (age-adjusted per 100 000 pop)
The causes of death considered in this indicator are acute respiratory infections in children under 5, cerebrovascular diseases, ischemic heart disease, chronic obstructive pulmonary disease, and lung cancer in the population aged 25 years or older.
This indicator is part of a group of indicators used at the international level that makes it possible to monitor countries’ progress in addressing the health risks of air pollution. Its value is applicable to strengthening the systems, structures, and processes needed to support monitoring and reporting on health trends associated with air pollution and its sources. This indicator is part of the Monitoring Framework for Universal Health in the Americas, to measure national progress in implementing policies aimed at strengthening health systems and achieving universal health.
This indicator’s value is applicable to multidisciplinary research on environmental pollution. It helps evaluate the effectiveness of strategies aimed at increasing equitable access to clean, safe energy sources.
Estimates of mortality attributable to air pollution combine data on the increased (or relative) risk of a disease resulting from exposure, with information on the duration of the population’s exposure. These data are used to estimate the "population attributable fraction" (PAF), which is the fraction of disease in a given population that can be attributed to the exposure, in this case, both the annual mean concentration of particulate matter and exposure to solid fuels for cooking. Applying this fraction to the total disease burden yields the total number of deaths resulting from exposure to ambient and household air pollution.
Mortality attributed to ambient and household air pollution is estimated based on the calculation of attributable fractions of the combined population assuming independently distributed exposures and independent risks. PAF for ambient air pollution and PAF for home air pollution are evaluated separately.
More details on the methodology in:
World Health Organization (WHO). Burden of disease from household air pollution for 2016. Description of method. May 2018. Available from:
https://cdn.who.int/media/docs/default-source/air-quality-database/aqd-2018/hap_bod_methods_may2018.pdf?sfvrsn=d277d739_3
Ezzati M, Hoorn SV, Rodgers A, et al. Comparative Risk Assessment Collaborating Group. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet. 2003; 362(9380):271–80. Available from:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(03)13968-2/fulltext
Due to the application of advanced statistical methods, this indicator’s estimated value may differ from each country’s calculations. These differences may be due to the use of different exposure data, exposure-risk estimates, and mortality data.
Since one of the necessary inputs for estimating the mortality rate attributable to air pollution is deaths, the accuracy of this indicator requires a civil registry system with complete coverage. Deaths must have medical certification of the cause of death and must be recorded in a timely manner in this system.
https://www.who.int/data/gho/indicator-metadata-registry
Indicator 3.9.1 Mortality rate attributed to household and ambient air pollution
Available from: https://sdgs.un.org/
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 26. Mortality rate attributed to household and ambient air pollution
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). WHO indoor air quality guidelines: household fuel combustion. Geneva, 2021. Available from:
https://www.who.int/publications/i/item/9789241548885
World Health Organization (WHO). Burden of disease from the joint effects of household and ambient air pollution for 2016. Available from:
https://cdn.who.int/media/docs/default-source/air-quality-database/aqd-2018/ap_joint_effect_bod_results_may2018.pdf?sfvrsn=4dc44c26_3
World Health Organization (WHO). Road map for an enhanced global response to the adverse health effects of air pollution. World Health Assembly, 71. (2018). Available from:
https://apps.who.int/iris/handle/10665/276321
Mortality garbage codes (%)
Garbage codes refers to intermediate causes and terminal or unspecific complications that do not match the definition of underlying cause (an illness or injury that set off the chain of events directly leading to death, or the accident or violent act that produced the fatal injury). From a public health perspective, it is important to know the underlying cause in order to support prevention programs and design and implement effective policies and strategies.
Among the reasons for assigning these codes on the death certificate are: insufficient case information from the certifying physician; lack of training among personnel on how to correctly certify the death; and authorization given to non-medical personnel that often lack training and information on certification of underlying causes. Other reasons include failure to train and update mortality coders. This practice also inflates comorbidity at the time of death, complicating identification of the cause that set off the sequence of events leading to death. Garbage codes hide the true cause of death.
Generally speaking, cause-of-death statistics are essential when allocating resources to health services and planning and evaluating health policies. As a result, having correct and reliable underlying cause of death information is a public health priority.
The percentage of garbage codes is calculated by the Pan American Health Organization (PAHO) from data reported by responsible national institutions.
Formula:
(A/B) x 100
Numerator (A):
Number of deaths assigned garbage codes in year z in a given country, territory, or geographic area.
Denominator (B):
Deaths from all causes in year z in a given country, territory, or geographic area.
PAHO garbage codes list (ICD-10):
A31.1, A40-A41, A48.0, A48.3, A49.9, A59, A60.0, A63.0, A71-A74, B00.0, B07, B08.1, B08.8, B30, B35-B36, B83.9, B94.8, B94.9, B99, C26, C39, C57.9, C63.9, C76, C80, D00-D13, D16-D18, D20-D24, D28-D48, D65, E85.3-E85.9, E86-E87, E88.9, F32-F33, F40-F42, F45-F48, F51-F53, F60-F98, G43-G45, G47-G52, G54, G56-G58, G80-G83, G91.1, G91.3-G91.8, G92, G93.1-G93.6, H00-H04, H05.2-H69, H71-H80, H83-H93, I10, I15, I26, I27.1, I44-I46, I49-I50, I51, I70, I74, I81, I99, J30, J33, J34.2, J35, J69, J80-J81, J86, J90, J93.8-J93.9, J94, J96, J98.1-J98.3, K00-K11, K14, K65-K66, K71-K72, (except K71.7), K75, K76.0-K76.4, K92.0-K92.2, L04-L08, L20-L25, L28-L87, L90-L92, L94, L98.0-L98.3, L98.5-L98.9, M03, M07, M09-M12, M14-M25, M35.3, M40, M43.6-M43.9, M45, M47-M60, M63-M71, M73-M79, M86, M95-M99, N14, N17-N19, N39.3, N40, N46,N60, N84-N93, N97, Q10-Q18, Q36, Q38.1, Q54, Q65-Q74, Q82-Q84, X59, Y10-Y34, Y86,Y87.2, Y89.
Naghavi, M., Makela, S., Foreman, K. et al. Algorithms for enhancing public health utility of national causes-of-death data. Population Health Metrics 8, 9 (2010). Available from: https://pophealthmetrics.biomedcentral.com/articles/10.1186/1478-7954-8-9
Mortality under-registration (%)
Generally speaking, complete, timely, and quality death statistics are essential for designing and evaluating targeted public policies to meet the needs of the population.
The indicator makes inequalities and barriers in access to registration systems visible and facilitates analysis of temporal and geographical trends. It helps to identify areas in need of improved civil registration systems and vital statistics coverage and implement and evaluate specific interventions to enhance deaths registration.
For the denominator, population estimates and projections of the United Nations Population Division are used.
Formula:
(A/B) x 100
Numerator (A):
Number of registered deaths in a given country, territory or geographic area in year z.
Denominator (B):
Number of estimated deaths in a given country, territory or geographic area in year z.
There are countries in the Region that by law register deaths in the year of occurrence, while other countries register deaths in the year they are reported.
National health authority
Denominator:
Deaths estimated by international agencies
World Health Organization (WHO). Rapid assessment of national civil registration and vital statistics systems, WHO REFERENCE NUMBER: WHO/IER/HSI/STM/2010.1, 2010. Available from: https://www.who.int/publications/i/item/rapid-assessment-of-national-civil-registration-and-vital-statistics-systems
UNSTATS. Handbook on Civil Registration and Vital Statistics Systems: Management, Operation and Maintenance, Revision 1, NY, 2018. Available from: https://unstats.un.org/unsd/demographic-social/Standards-and-Methods/files/Handbooks/crvs/crvs-mgt-E.pdf
Municipalities with DTP3 coverage ≥ 95%
Municipalities are defined as the third administrative level of a country, with the country level being the first, unless otherwise indicated.
Spatial analysis of immunization program coverage is a critical tool for obtaining new information and making informed decisions. Spatial analysis is used when obtaining estimates, detecting patterns and variations in time, and interpreting observed changes.
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
Pan American Health Organization (PAHO). Immunization data and statistics. Available from: https://www.paho.org/en/topics/immunization/immunization-data-and-statistics
Neonatal mortality rate (1 000 lb)
Live birth means the complete expulsion or extraction from its mother of a product of conception, irrespective of the duration of pregnancy, that, after such expulsion or extraction, breathes or shows any other evidence of life, such as beating of the heart, pulsation of the umbilical cord, or definite movement of voluntary muscles, whether or not the umbilical cord has been cut or the placenta is attached. Each product of such childbirth that meets these conditions is considered a live birth.
The estimated neonatal mortality rate reflects a population’s health status and social, economic, and environmental conditions. It makes it possible to identify health inequities and populations with specific risk factors and is related to maternal and child health care access, quality, and timeliness.
This indicator is applicable to the design, implementation, and evaluation of health policies and the distribution of economic, human, and technological resources aimed at improving maternal and child health, particularly prenatal and neonatal care. Its result helps strengthen professional care for childbirth, breastfeeding, and the Expanded Program on Immunization.
It allows for analysis of the geographic and time trend of neonatal mortality in a given population.
Formula:
(A/B) x 1 000 live births
Numerator (A):
Number of children born alive who died before the age of 28 days in a given country, territory and geographic area during year z
Denominator (B):
Total number of live births in the same population during year z
To estimate the indicator by sex, the following formula is applied:
(A/B) x 1 000 live births
Numerator (A):
Number of children born alive of a given sex, who died before the age of 28 days, in a specific country, territory, or geographic area during year z
Denominator (B):
Total number of live births in the same population during year z
The value of this indicator may differ from each country’s value due to methodological differences such as the application of methods to correct underreporting of births and deaths.
Indicator 3.2.2 Neonatal mortality rate.
Available from: https://sdgs.un.org/goals
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 3. Neonatal mortality rate
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Vol 2. Available from: https://icd.who.int/browse10/Content/statichtml/ICD10Volume2_en_2010.pdf
Pan American Health Organization (PAHO)/World Health Organization (WHO). Core indicators Portal. Available from: https://opendata.paho.org/en/core-indicators
New HIV diagnoses rate (100 000 pop)
The indicator is used to monitor the epidemic’s trends and dynamics within a country or territory and assess access to diagnosis.
This indicator is one of the inputs applied when estimating the HIV burden. It contributes to public health policy-making, planning and allocation of economic, human, and technological resources to respond to the disease. This metric, disaggregated by sex and age, identifies populations in need of direct preventive and surveillance strategies, communication campaigns, and access to diagnosis and early antiretroviral treatment to reduce impact on the immune system and transmission. It is also considered when implementing counseling and accompaniment programs for patients with HIV.
Indicator: 16. Incidence rate of HIV infections
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Data 2017. Available from: https://www.unaids.org/en
World Health Organization (WHO). Consolidated strategic information guidelines for HIV in the health sector. Geneva, 2015. Available from: http://apps.who.int/iris/bitstream/handle/10665/164716/9789241508759_eng.pdf
World Health Organization (WHO). HIV/AIDS. Available from: https://www.who.int/health-topics/hiv-aids#tab=tab_1
New HIV diagnoses; sex ratio (male:female)
The indicator is applied to monitor the differences between men and women in the trends and dynamics of the epidemic within a country or territory. Its value reflects the differentiated results of infection prevention and control strategies by sex.
This indicator is one of the inputs to estimate the HIV burden. It contributes to public health policy-making with a gender approach and for planning and allocation of economic, human, and technological resources to respond to the disease. This metric, disaggregated by sex and age, identifies populations in need of direct preventive and surveillance strategies, communication campaigns, and access to diagnosis and early antiretroviral treatment to reduce impact on the immune system and transmission. The indicator contributes to implementing counseling and accompaniment programs for patients with HIV.
The sex ratio is calculated by PAHO.
https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). Consolidated strategic information guidelines for HIV in the health sector. Geneva, 2015. Available from: http://apps.who.int/iris/bitstream/handle/10665/164716/9789241508759_eng.pdf
Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Data 2017. Available from: https://www.unaids.org/en
World Health Organization (WHO). HIV/AIDS. Available from: https://www.who.int/health-topics/hiv-aids#tab=tab_1
Noncommunicable diseases mortality rate (age-adjusted per 100 000 pop)
Its result is applicable to the design, implementation, and evaluation of health policies on noncommunicable diseases and the distribution of economic, human, and technological resources for the prevention, diagnosis, treatment, and control of this group of pathologies, among others. Its applications include, for example, evaluating over time the effectiveness of interventions promoting healthy lifestyles and socio-economic measures to reduce health inequities and increase timely access to care.
Removing the effect of differences in the age distribution by using a standard population makes it possible to analyze the time trend and geographic distribution of deaths from noncommunicable diseases, in the same population or across populations.
The underlying causes of death correspond to codes C00 - C97, D00 - D48, D55 - D64 (except D64.9), D65 - D89, E03 - E07, E10 - E34, E65 - E88, F01 - F99, G06 - G98 (except G14), H00 - H61, H68 - H93, I00 - I99, J30 - J98, K00 - K92, L00 - L98, M00 - M99, N00 - N64, N75 - N98, Q00 - Q99, X41 - X42, X44 - X45, R95 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the noncommunicable diseases mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The noncommunicable diseases mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The estimated value of the age-adjusted noncommunicable diseases mortality rate will depend on the standard population used for its adjustment; therefore it may differ from each country’s estimates. Other methodological considerations that influence its result are the use of a different group of ICD-10 codes and the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the noncommunicable diseases mortality rate requires a civil registry system with good coverage. Death from this group of pathologies must be recorded in a timely manner in this system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Nursing associates professionals (10 000 pop)
Nursing associates professionals provide basic nursing care and health advice, monitor health status of users, and carry out pre-established care and treatment plans under supervision.
The definitions of the International Standard Classification of Occupations (ISCO-08) are adapted to the context of the Region of the Americas and its countries.
This indicator also contributes to monitoring country progress in implementing the Plan of Action on Human Resources for Universal Access to Health and Universal Health Coverage 2018-2023 (https://iris.paho.org/handle/10665.2/49611?locale-attribute=pt) and the Global Strategy on Human Resources for Health 2030 (https://www.who.int/publications/i/item/9789241511131).
This data is collected from secondary sources, such as health workers records or databases, aggregated data from health facilities (routine administrative records, health management information systems, censuses, and surveys from the district health information system), records of councils/chambers/professional associations, active population surveys, workforce surveys, national censuses, among other verifiable sources (official scientific articles, unpublished publications, central bank accounts).
Population figures from the United Nations Population Division are used for the denominator (https://population.un.org/wpp/).
The value of this indicator may differ from figures calculated by each country due to differences, such as the populations used as denominator. Another factor to consider, depending on the nature of the original data source, is that the numerator could be limited to actively working nursing associate professionals, or include all registered or licensed, even if their employment status is unknown.
Indicator 3.c.1 Health worker density and distribution
Available from: https://sdgs.un.org/
Pan American Health Organization (PAHO). Strategy on Human Resources for Universal Access to Health and Universal Health Coverage. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/34198
Pan American Health Organization (PAHO). Plan of Action on Human Resources for Universal Access to Health and Universal Health Coverage 2018-2023. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/49611?locale-attribute=pt
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). 2018 Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Geneva, 2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/259951/WHO-HIS-IER-GPM-2018.1-eng.pdf
World Health Organization (WHO). National health workforce accounts: a handbook. Geneva, 2017. Available from: https://apps.who.int/iris/bitstream/handle/10665/259360/9789241513111-eng.pdf
International Labour Organization (ILO). International Standard Classification of Occupations 08 (ISCO-08). Available from: https://unstats.un.org/unsd/classifications/Family/Detail/1067
World Health Organization (WHO). Global Health Workforce statistics database. Available from: https://www.who.int/data/gho/data/themes/topics/health-workforce
Nursing professionals (10 000 pop)
Professionals who provide prevention, promotion, treatment and rehabilitation services to people who need health care. They are responsible for planning and managing the care of users, including supervision of other health workers. They work autonomously or in a team, both in the field of health services and in the community. Includes: Professional Nurse, Registered Nurse, Specialist Nurse, Advanced Practice Nurse, Clinical Nurse, Public Health Nurse, Nursing Technician, Nursing Technologist.
The definitions of the International Standard Classification of Occupations (ISCO-08) are adapted to the context of the Region of the Americas and its countries.
The indicator also contributes to monitoring country progress in implementing the Plan of Action on Human Resources for Universal Access to Health and Universal Health Coverage 2018-2023 (https://iris.paho.org/handle/10665.2/49611?locale-attribute=pt) and the Global Strategy on Human Resources for Health 2030 (https://www.who.int/publications/i/item/9789241511131).
Population figures from the United Nations Population Division are used for the denominator (https://population.un.org/wpp/).
The value of this indicator may differ from figures calculated by each country due to differences, such as the populations used as denominator. Another factor to consider, depending on the nature of the original data source, is that the numerator could be limited to actively working nursing professionals, or include all registered or licensed, even if their employment status is unknown.
Indicator 3.c.1 Health worker density and distribution
Available from: https://sdgs.un.org/
Pan American Health Organization (PAHO). Strategy on Human Resources for Universal Access to Health and Universal Health Coverage. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/34198
Pan American Health Organization (PAHO). Plan of Action on Human Resources for Universal Access to Health and Universal Health Coverage 2018-2023. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/49611?locale-attribute=pt
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). 2018 Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Geneva, 2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/259951/WHO-HIS-IER-GPM-2018.1-eng.pdf
World Health Organization (WHO). National health workforce accounts: a handbook. Geneva, 2017. Available from: https://apps.who.int/iris/bitstream/handle/10665/259360/9789241513111-eng.pdf
International Labour Organization (ILO). International Standard Classification of Occupations 08 (ISCO-08). Available from: https://unstats.un.org/unsd/classifications/Family/Detail/1067
World Health Organization (WHO). Global Health Workforce statistics database. Available from: https://www.who.int/data/gho/data/themes/topics/health-workforce
International Council of Nurses (ICN). Available from: https://www.icn.ch/
Out-of-pocket expenditure as % of current health expenditure
The indicator is also used to evaluate changes in out-of-pocket expenditure over time, its relationship to total household expenditure, and the factors that determine out-of-pocket expenditure in a household.
Missing values are estimated using various accounting techniques based on the data available for each country. The main international references come from financial statistics from the International Monetary Fund (IMF), health data from the Organisation for Economic Cooperation and Development (OECD), and national accounts statistics from the United Nations. National sources include NHA reports, national accounts reports, comprehensive financing studies, Classification of Individual Consumption According to Purpose (COICOP) reports, and institutional reports from private entities involved in providing or financing health care, in actuarial and financial reports from private companies and health insurance agencies. Additional sources include household and business surveys, and economic censuses. Ad hoc surveys are another potential source of data.
Data collected by WHO feed into its Global Health Expenditure Database (GHED), which serves as a global benchmark for information on health expenditures in WHO Member States.
For more details on methodology, see:
OECD/Eurostat/WHO (2017). A System of Health Accounts 2011: Revised edition, OECD Publishing, Paris, System of Health Accounts 2011 (SHA 2011). Available from: https://www.oecd.org/publications/a-system-of-health-accounts-2011-9789264270985-en.htm
World Health Organization (WHO) Methodology for the update of the Global Health Expenditure Database, 2000–2018. Technical note. Version December 2020. Available from: https://apps.who.int
ha/database/DocumentationCentre/Index/en
Due to the methodology used, the value of the indicator estimated by WHO may differ from the results obtained by each country.
ha/database/Home/Index/en
Sustainable Development Goals (SDG).
Indicator 3.8.2: Proportion of population with large household expenditures on health as a share of total household expenditure or income
Available from: https://unstats.un.org/sdgs/metadata/?Text=&Goal=3&Target=3.8
ha/database/Home/Index/en
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
Organisation for Economic Cooperation and Development (OECD).
Health Expenditure. Available from: https://www.oecd.org/els/health-systems/health-expenditure.htm#:~:text=Latest%20OECD%20estimates%20point%20to,previous%20years%20at%20around%208.8%25.
Pancreas cancer mortality rate (age-adjusted per 100 000 pop)
The age-adjusted mortality rate from pancreas cancer is applicable to the design, implementation, and evaluation of health policies for the prevention and control of pancreas cancer and the distribution of economic, human, and technological resources for this disease, among others. Its applications include, for example, evaluating the impact of strategies to prevent harmful alcohol consumption on mortality from pancreatic cancer.
Removing the effect of the different age distribution by using a standard population makes it possible to analyze the time trend and geographic distribution of deaths from pancreas cancer, in the same population or across populations.
The underlying cause of death corresponds to code C25 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the pancreas cancer mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The pancreas cancer mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The value of the age-adjusted pancreas cancer mortality rate will depend on the standard population used for adjustment.
The estimated value of this indicator may differ from each country’s estimates due to methodological considerations such as the method used to prepare the population estimates and projections or the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the pancreas cancer mortality rate requires a civil registry system with good coverage. Deaths must be recorded in this system in a timely manner, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Pertussis cases in children under age 5
The number of confirmed cases of pertussis in children under 5 years of age reflects the impact of this disease on the child population and allows the temporal and geographical trends of this disease to be analyzed. It quantifies the impact of pertussis as a public health problem in a given population or geographical area and supports decision making for public policies aimed at reducing morbidity and mortality in children under 5 years of age.
This indicator reflects the health status and health and socioeconomic development of a population. It helps to identify health inequities and populations with greater risk factors for transmitting Bordetella pertussis.
It is applied for designing, implementing, and assessing health policies to prevent, treat, and control pertussis in children and distribute economic, human, and technological resources to fight the disease, among other purposes. Among its main applications are planning and assessing vaccination programs against pertussis and prioritizing quality health care in children.
Sustainable Development Goals (SDG).
Indicator 3.b.1 Proportion of the target population covered by all vaccines included in their national programme. Available from: https://sdgs.un.org/
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
Pinell-McNamara V., Acosta A., Pedreira M et al. Expanding Pertussis Epidemiology in 6 Latin America Countries through the Latin American Pertussis Project. Emerg Infect Dis. 2017 Dec; 23 (Suppl 1): S94–S100. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711316/
Indicadores básicos para a saúde no Brasil: conceitos e aplicações, 2ª edição [Core health indicators in Brazil: concepts and applications]. Pan American Health Organization. Brasilia, 2008. Available from: https://www.paho.org/bra/dmdocuments/indicadores.pdf
Pharmacists (10 000 pop)
The International Standard Classification of Occupations code for this category is 2262 (2008 revision).
The indicator also contributes to monitoring country progress in implementing the Plan of Action on Human Resources for Universal Access to Health and Universal Health Coverage 2018-2023 (https://iris.paho.org/handle/10665.2/49611?locale-attribute=pt) and the Global Strategy on Human Resources for Health 2030 (https://www.who.int/publications/i/item/9789241511131).
Population figures from the United Nations Population Division are used for the denominator. (https://population.un.org/wpp/).
The value of this indicator may differ from figures calculated by each country due to differences such as the populations used as denominator. Another factor to consider, depending on the nature of the original data source, is that the numerator could be limited to actively working pharmacists or include all registered or licensed to practice professionally, even when their employment status is unknown.
Indicator 3.c.1 Health worker density and distribution
Available from: https://sdgs.un.org/
Pan American Health Organization (PAHO). Strategy on Human Resources for Universal Access to Health and Universal Health Coverage. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/34198
Pan American Health Organization (PAHO). Plan of Action on Human Resources for Universal Access to Health and Universal Health Coverage 2018-2023. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/49611?locale-attribute=pt
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). 2018 Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Geneva, 2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/259951/WHO-HIS-IER-GPM-2018.1-eng.pdf
World Health Organization (WHO). National health workforce accounts: a handbook. Geneva, 2017. Available from: https://apps.who.int/iris/bitstream/handle/10665/259360/9789241513111-eng.pdf
International Labour Organization (ILO). International Standard Classification of Occupations 08 (ISCO-08). Available from: https://unstats.un.org/unsd/classifications/Family/Detail/1067
World Health Organization (WHO). Global Health Workforce statistics database. Available from: https://www.who.int/data/gho/data/themes/topics/health-workforce
Physicians (10 000 pop)
The International Standard Classification of Occupations codes (2008 revision) included in this category are: 221 (2211, and 2212).
The indicator also contributes to monitoring country progress in implementing the Plan of Action on Human Resources for Universal Access to Health and Universal Health Coverage 2018-2023 (https://iris.paho.org/handle/10665.2/49611?locale-attribute=pt) and the Global Strategy on Human Resources for Health 2030 (https://www.who.int/publications/i/item/9789241511131).
Population figures from the United Nations Population Division are used for the denominator (https://population.un.org/wpp/).
The value of this indicator may differ from figures calculated by each country due to differences, such as the populations used as denominator. Another factor to consider, depending on the nature of the original data source, is that the numerator could be limited to actively working physicians or include all registered or licensed to practice professionally, even when their employment status is unknown.
Indicator 3.c.1 Health worker density and distribution
Available from: https://sdgs.un.org/
Pan American Health Organization (PAHO). Strategy on Human Resources for Universal Access to Health and Universal Health Coverage. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/34198
Pan American Health Organization (PAHO). Plan of Action on Human Resources for Universal Access to Health and Universal Health Coverage 2018-2023. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/49611?locale-attribute=pt
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). 2018 Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Geneva, 2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/259951/WHO-HIS-IER-GPM-2018.1-eng.pdf
World Health Organization (WHO). National health workforce accounts: a handbook. Geneva, 2017. Available from: https://apps.who.int/iris/bitstream/handle/10665/259360/9789241513111-eng.pdf
International Labour Organization (ILO). International Standard Classification of Occupations 08 (ISCO-08). Available from: https://unstats.un.org/unsd/classifications/Family/Detail/1067
World Health Organization (WHO). Global Health Workforce statistics database. Available from: https://www.who.int/data/gho/data/themes/topics/health-workforce
Population aged < 15 years (%)
It is also used to analyze the geographical distribution and temporal trends of this population segment, which is useful information for planning and evaluating health and educational policies, among others.
The share of the population <15 (%) by sex is calculated based on the total population of the respective sex. The proportion was calculated by PAHO
The estimated value of this indicator may differ from country statistics due to factors such as methodological differences in developing population estimates and projections.
https://population.un.org/wpp/
https://opendata.paho.org/en/core-indicators
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from:
https://www.who.int/data/gho/indicator-metadata-registry
United Nations, Department of Economic and Social Affairs. 2019 Demographic Yearbook, 70th Issue. New York, 2020. Available from: https://unstats.un.org/unsd/demographic-social/products/dyb/
United States Census Bureau. International Database. Glossary. Available from: https://www.census.gov/glossary/
United Nations, Department of Economic and Social Affairs, Population Division. Glossary of Demographic Terms. Available from:
https://population.un.org/wpp/GlossaryOfDemographicTerms/
Economic Commission for Latin America and the Caribbean (ECLAC) - CEPALSTAT. Statistical Databases and Publications. Available from: https://statistics.cepal.org/portal/cepalstat/dashboard.html?lang=en
Population aged 65 and over (%)
It reflects aging in a given country or geographical area.
The indicator is used for planning, management, and evaluation of public policies related to health and social security, specifically for older adults.
The share of the population 65 years and over by sex is calculated based on the total population of the respective sex. The proportion was calculated by PAHO.
The estimated value of this indicator may differ from country statistics due to factors such as methodological differences in developing population estimates and projections.
https://population.un.org/wpp/
https://opendata.paho.org/en/core-indicators
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Avaiable from:
https://www.who.int/data/gho/indicator-metadata-registry
United Nations, Department of Economic and Social Affairs. 2019 Demographic Yearbook, 70th Issue. New York, 2020. Available from: https://unstats.un.org/unsd/demographic-social/products/dyb/
United States Census Bureau. International Database. Glossary. Available from: https://www.census.gov/glossary/
United Nations, Department of Economic and Social Affairs, Population Division. Glossary of Demographic Terms. Available from:
https://population.un.org/wpp/GlossaryOfDemographicTerms/
Pan American Health Organization. Basic Health Indicators in Brazil: concepts and applications, 2nd edition. Brasilia, 2008. Available from: https://www.paho.org/bra/dmdocuments/indicadores.pdf
Population at risk of malaria (%)
This indicator provides an estimate of exposure to malaria risk in the population. For a vector-borne disease such as malaria, the at-risk population is determined by the human population exposed to the risk of malaria infection.
This indicator is used to monitor countries progressing towards targets established in the Global Technical Strategy for Malaria 2016–2030 and the objectives of the Monitoring Framework for Universal Health in the Americas.
The indicator is used to make maps of endemic areas and assess the temporal and geographical trends of the disease, identifying at-risk populations in need of strengthened surveillance programs, disease elimination activities, and access to interventions, especially integrated and quality diagnosis and treatment.
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). The Seventy-fourth World Health Assembly. Recommitting to accelerate progress towards malaria elimination. Draft Resolution A74/B/CONF./2. May 2021. Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA74/A74_BCONF2-en.pdf
World Health Organization (WHO). WHO malaria terminology. Geneva, 2022. Updated in November 2021. Available from: https://www.who.int/publications/i/item/9789240038400
Population using clean fuels and technology (%)
Clean fuels and technologies are defined according to the World Health Organization (WHO) indoor air quality guidelines: combustion of household fuel. This includes households that rely primarily on electricity, biogas, natural gas, liquefied petroleum gas (LPG), solar fuels, or alcohol for cooking.
The percentage of the population that uses clean fuels and technologies in the home is an indicator of a population’s health status, level of human development, and degree of well-being. Monitoring this indicator makes it possible to track countries’ progress towards universal access to energy, i.e., electricity and clean fuels and technologies for cooking, heating, and lighting.
This indicator’s value is applicable to the design and evaluation of public policies that promote and facilitate access to clean energy sources and strategies aimed at reducing pollution inside and outside the home.
More background on the methodology in:
Stoner O, Shaddick G, Economou T, et al. Global household energy model: a multivariate hierarchical approach to estimating trends in the use of polluting and clean fuels for cooking. Journal of the Royal Statistical Society Series C: Applied Statistics, 2020. Vol 69: 815–839. Available from:
https://rss.onlinelibrary.wiley.com/doi/full/10.1111/rssc.12428
Applying advanced statistical methods to estimate this indicator may determine that its value differs from each country’s calculation. Other influencing factors are the quality and periodicity of the surveys and population censuses used as a data source.
https://www.who.int/data/gho/data/indicators/indicator-details/GHO/gho-phe-primary-reliance-on-clean-fuels-and-technologies-proportion
Indicator 7.1.2 Proportion of population with primary reliance on clean fuels and technology.
Available from: https://sdgs.un.org/
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 18.e Proportion of population with primary reliance on clean fuels and technology
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). WHO indoor air quality guidelines: household fuel combustion. Geneva, 2014. Available from:
https://www.who.int/health-topics/air-pollution#tab=tab_1
World Health Organization (WHO). Road map for an enhanced global response to the adverse health effects of air pollution. World Health Assembly, 71. (2018). Available from: https://apps.who.int/iris/handle/10665/276321
Population using improved sanitation facilities; safely managed (%)
Improved sanitation facilities are those designed to hygienically separate excreta from human contact. They include discharge or dumping into a sewer system, septic tanks or pit latrines, pit latrines with slabs (including ventilated pit latrines), and composting toilets.
This indicator reflects a population’s living conditions and level of well-being and social and economic development. A lack of adequate sanitation services is a marker of poverty; it has a variety of consequences, such as anxiety, risk of sexual assault, and loss of educational opportunities.
The percentage of the population that uses an improved sanitation facility makes it possible to monitor the effectiveness of public policies aimed at reducing poverty and morbidity and mortality in the population and provides evidence for more efficiently distributing economic, human, and technological resources.
The proportion of the population using improved sanitation facilities, as well as the proportion who defecate in the open, are estimated through linear regression modeling. Regressions are also created to estimate the population using improved sanitation facilities connected to sewers and septic tanks. The regressions are extrapolated for two years beyond the last available data point, after which coverage remains constant for four years. Estimates for urban and rural areas are done independently, and national estimates are generated as weighted averages of the two.
After data are collected and prior to publication, the JMP formally sends preliminary estimates to the countries for consultation and review.
More background on the methodology in:
The WHO/UNICEF Joint Monitoring Programme (JMP). Methods.
Available from: https://washdata.org/monitoring/methods
Another aspect influencing the estimates is that, in some countries, sewerage connection and septic tank estimates are only available at the national level, while improved sanitation can be calculated in rural and urban areas. This involves using a weighted average of the national estimate of improved sanitation (not shared), and it is divided into sewer system, septic tanks and improved latrines, and others.
https://washdata.org/
Indicator 6.2.1 Proportion of population using (a) safely managed sanitation services and (b) a hand-washing facility with soap and water [Proporción de la población que utiliza: a) servicios de saneamiento gestionados sin riesgos y b) instalaciones para el lavado de manos con agua y jabón].
Available from: https://sdgs.un.org/
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 18.d Proportion of population using safely managed sanitation services, including a hand-washing facility with soap and water
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
https://iris.paho.org/handle/10665.2/53918
WHO/UNICEF. WASH in the 2030 Agenda, 2017. Available from:
https://data.unicef.org/resources/wash-2030-agenda
United Nations. UN Water. Available from:
https://www.unwater.org/
World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF). Progress on drinking water, sanitation, and hygiene: 2017 update and SDG baselines. Geneva, 2017. Available from:
https://data.unicef.org/resources/progress-drinking-water-sanitation-hygiene-2017-update-sdg-baselines/
Population using improved water supplies; safely managed (%)
Improved water supplies are those that, by the nature of their design and construction, have the potential to supply drinking water. They include running water, boreholes or tube wells, protected dug wells, protected springs, and bottled or distributed water.
Searching for a water supply adversely impacts health and a variety of other areas. Women and children generally perform this task, which takes up time that could be spent on other activities, such as education, childcare, labor market participation, and rest and recreation, among others.
This indicator reflects a population’s living conditions and level of development. It reflects progress in the fight against poverty, diseases, and death. Depending on the case, it can boost economic productivity.
This indicator is part of the Monitoring Framework for Universal Health in the Americas, to measure national progress in implementing policies aimed at strengthening health systems and achieving universal health.
The population using improved water supplies and the proportion with improved water supplies on-site are estimated using linear regression. Additionally, regressions are created to independently estimate three parameters of the level of service: (1) the proportion of the population that drinks water from improved water supplies that are accessible on-site; (2) the proportion of the population that drinks water from improved water supplies that are available when needed (i.e., households can access sufficient amounts of water when needed); and (3) the proportion of the population that drinks water from improved water supplies that meet relevant national or local standards (if no standards are available, the WHO Guidelines for Drinking Water Quality are used). Estimates for urban and rural areas are done independently. National estimates are generated as weighted averages of urban and rural estimates, using population data from the most recent United Nations Population Division report.
Applying this standard classification and estimation method allows the JMP to compare progress across countries, regions, and the world. The JMP routinely consults with national authorities before publishing country estimates.
More background on the methodology in:
The WHO/UNICEF Joint Monitoring Programme (JMP). Methods. Available from:
https://washdata.org/monitoring/methods
https://washdata.org/
Indicator 6.1.1 Proportion of population using safely managed drinking water services.
Available from: https://sdgs.un.org/
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 18.c Proportion of population using safely managed drinking water services
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
https://iris.paho.org/handle/10665.2/53918
WHO/UNICEF. WASH in the 2030 Agenda, 2017. Available from:
https://data.unicef.org/resources/wash-2030-agenda/
United Nations. UN Water. Available from:
https://www.unwater.org/
World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF). Progress on drinking water, sanitation, and hygiene: 2017 update and SDG baselines. Geneva, 2017. Available from:
https://data.unicef.org/resources/progress-drinking-water-sanitation-hygiene-2017-update-sdg-baselines/
Postneonatal mortality rate (1 000 lb)
Live birth means the complete expulsion or extraction from its mother of a product of conception, irrespective of the duration of pregnancy, that, after such expulsion or extraction, breathes or shows any other evidence of life, such as beating of the heart, pulsation of the umbilical cord, or definite movement of voluntary muscles, whether or not the umbilical cord has been cut or the placenta is attached. Each product of such childbirth that meets these conditions is considered a live birth.
The estimated postneonatal mortality rate reflects the health status and social, economic, and environmental conditions in which a population lives, particularly the infant population. It makes it possible to identify health inequities and populations with specific risk factors such as environmental risks, malnutrition, or multidimensional poverty and is related to maternal and child health care access, quality, and timeliness.
This indicator is applicable to the design, implementation, and evaluation of health policies and the distribution of economic, human, and technological resources aimed at improving maternal and child health, particularly prenatal and neonatal care. Its value helps strengthen professional care for childbirth, breastfeeding, and the Expanded Program on Immunization.
It allows for analysis of the geographic and time trend of neonatal mortality in a given population.
Formula:
(A/B) x 1 000 live births
Numerator (A):
Number of children born alive who died between the age of 28 and 364 days in a given country, territory and geographic area during year z
Denominator (B):
Total number of live births in the same population, during year z
The value of this indicator may differ from each country’s value due to methodological differences, such as the application of methods to correct underreporting of births and deaths.
Indicator 3.2.2 Neonatal mortality rate.
Available from: https://sdgs.un.org/goals
ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Vol 2. Available from: https://icd.who.int/browse10/Content/statichtml/ICD10Volume2_en_2010.pdf
Pan American Health Organization (PAHO)/World Health Organization (WHO). Core indicators Portal. Available from: https://opendata.paho.org/en/core-indicators
Pan American Health Organization, Health Information and Analysis Unit (HA). Regional Core Health Data Initiative. Glossary of Indicators. Washington D.C., June 2015. Available from: https://www.paho.org/hq/dmdocuments/2015/glossary-eng-2014.pdf
Poverty headcount ratio at $ 2.15 day (2017 PPP) (% of population)
Purchasing Power Parity (PPP) is a conversion rate between currencies that considers both exchange rate differences and discrepancies in price levels between countries. Therefore, when used to deflate the corresponding national accounts aggregates, they measure the real size of economies considering the purchasing power of the currency in each country.
Monitoring poverty allows assessment of the socioeconomic wellbeing of a population and the impact of implementing socioeconomic policies designed to reduce poverty at the international level. It helps to focus efforts and implement specific measures for the poorest population.
One of the factors hindering the comparability of international poverty estimates is countries’ different definitions of poverty. Local poverty lines tend to have higher purchasing power in rich countries, which use more generous standards than poor countries.
Because the World Bank obtains income data through household surveys, the accuracy of this indicator is affected by the timeliness, frequency, quality, and comparability of the surveys used. Another factor affecting estimates is the low availability of monitoring data, which complicates analysis of changes in poverty in some countries.
The frequency with which countries update their data and transfer it to the World Bank for calculation affects the result of this indicator.
Indicator 1.1.1 Proportion of the population living below the international poverty line by sex, age, employment status and geographic location (urban/rural)
Available from: https://sdgs.un.org/goals
https://www.worldbank.org/en/topic/poverty
Poverty headcount ratio at national poverty line (% of population)
Monitoring poverty allows us to assess the socioeconomic wellbeing of a population and the impact of implementing socioeconomic policies designed to reduce poverty at the national level. It helps to focus efforts and implement specific measures for the poorest population.
Almost all national poverty lines in developing economies are based on the cost of a basic food basket that meets the nutritional needs of the population. This basket also considers consumption habits, the effective availability of food in the country and its relative prices, and an estimate of the resources required by households to meet a set of basic non-food needs. Some countries define the extreme poverty line by taking into account only the cost of the basic food basket (i.e., excluding basic non-food needs).
Estimation methodologies and the definition of poverty line differ from one country to another, so national estimates should not be compared between countries. Another factor complicating comparison is that national poverty lines generally rise alongside a country's average income, and therefore do not provide a uniform measure for comparing poverty rates between countries.
Because diets and consumption baskets change over time, national poverty lines must be recalculated periodically using updated data from new household surveys. The new poverty lines need to be adjusted so that inflation between survey years remains constant in real terms, allowing valid comparisons of poverty over time.
Poverty lines are theoretical limits that allow the population to be classified based on monetary aspects of consumption and income, therefore, the number of inhabitants in poverty will increase or decrease depending on where this line is set.
Indicator 1.2.1 Proportion of population living below the national poverty line, by sex and age
Available from: https://sdgs.un.org/goals
https://www.worldbank.org/en/topic/poverty
Prevalence of anemia in women of reproductive age
The prevalence of anemia in women of childbearing age highlights this disease as a public health problem and makes it possible to identify populations at higher risk that should be targeted by prevention and control strategies.
This indicator is part of the Global Nutrition Surveillance Framework that monitors countries’ progress towards achieving the targets set out in the Comprehensive Implementation Plan on Maternal Infant and Young Child Nutrition, which include reducing anemia in women of childbearing age by 50%.
utrition-and-food-safety/databases/vitamin-and-mineral-nutrition-information-system), which also has data on other micronutrients in the population.
Hemoglobin distribution is estimated by applying hierarchical Bayesian models, which are also used to analyze missing data, nonlinear temporal trends, and data representativeness. The model calculates estimates for each country and year, informed by data from that country and year, if available, and by data from other years in the same country and from other countries with data for similar time periods, especially countries in the same region.
Hemoglobin values should be adjusted downwards for smokers or people who live more than 1000 meters above sea level, because hemoglobin rises in both cases and could lead to underestimating the prevalence of anemia in these populations.
Before the results are published, they are sent to the countries for consultation, together with an explanation of the methodology used.
More details on the methodology in:
Stevens G., Finucane M., and on behalf of Nutrition Impact Model Study Group (Anaemia). Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. Lancet Glob Health. Jul 1 (1): e16-e25. Available from:
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(13)70001-9/fulltext
Indicator 2.2.3 Prevalence of anaemia in women aged 15 to 49, by pregnancy status (percentage).
Available from: https://sdgs.un.org/
https://opendata.paho.org/en/core-indicators
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C. 2021. Available from:
https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). Global nutrition monitoring framework: operational guidance for tracking progress in meeting targets for 2025. Geneva, 2018. Available from:
https://www.who.int/es/publications/i/item/9789241513609
World Health Organization (WHO). Comprehensive implementation plan on maternal, infant, and young child nutrition. Geneva, 2014. Available from: https://apps.who.int/iris/bitstream/handle/10665/113048/WHO_NMH_NHD_14.1_eng.pdf
Prevalence of children under age 5 who are stunted (%)
This indicator reflects the health status of a population, enabling identification of disadvantaged populations and inequalities in human development. It contributes to designing and evaluating public policies aimed at reducing health inequities, especially in maternal and child nutrition.
The percentage of stunted children is one of the indicators of the Global Nutrition Surveillance Framework (GNMF) on maternal, infant, and child nutrition. It is used to monitor countries' progress towards achieving the World Health Assembly nutrition targets and implementing the Comprehensive Implementation Plan on Maternal, Infant, and Young Child Nutrition.
UNICEF, WHO, and the World Bank Group are jointly reviewing new data sources to update country-level estimates. These sources include the WHO Global Database on Child Growth and Malnutrition [https://www.who.int/teams
utrition-and-food-safety/databases
utgrowthdb], Country Reporting on Indicators for Goals (CRING), and the World Bank's Living Standard Measurement Surveys (LSMS) [https://www.worldbank.org/en/programs/lsms]. Each of these sources of information involves advanced statistical methods that enable reliable and internationally comparable data.
Further details on the estimation method:
UNICEF-WHO-The World Bank Group. 2021 Joint child malnutrition estimates - Levels and trends in child malnutrition. Available from: https://www.who.int/publications/i/item/9789240025257
De Onis, Bloessner M. The World Health Organization Global Database on Child Growth and Malnutrition: methodology and applications. International Journal of Epidemiology. 2003; 32:518–26. Available from: https://academic.oup.com/ije/article/32/4/518/666947?login=false
De Onis M, Blössner M, Borghi E, Morris R, Frongillo EA. Methodology for estimating regional and global trends of child malnutrition. International Journal of Epidemiology. 2004;33: 1260–70. Available from: https://academic.oup.com/ije/article/33/6/1260/866406
Further background on child growth patterns:
World Health Organization (WHO). Child growth standards. Available from: https://www.who.int/toolkits/child-growth-standards
Advanced statistical methods were applied to estimate this indicator; therefore, its value may differ from the calculations made by each country.
Indicator 2.2.1: Prevalence of stunting (height for age <-2 standard deviation from the median of the World Health Organization (WHO) Child Growth Standards) among children under 5 years of age
Available from: https://sdg.data.gov/
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 14.a Prevalence of stunting in children under 5 years of age
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). Indicators for the Global Monitoring Framework on Maternal, Infant and Young Child Nutrition, 2014. Available from: https://cdn.who.int/media/docs/default-source
utritionlibrary/global-targets-2025/indicators_monitoringframework_miycn_background.pdf?sfvrsn=b1934036_6
World Health Organization (WHO). Global Nutrition Monitoring Framework – Operational guidance for tracking progress in meeting targets for 2025. Geneva, 2018. Available from: https://www.who.int/publications/i/item/9789241513609
World Health Organization (WHO). Maternal, infant, and young child nutrition, December 2019. Available from: https://apps.who.int/gb/ebwha/pdf_files/EB146/B146_24-en.pdf
UNICEF Data: Monitoring the situation of children and women. Available from: https://data.unicef.org/
Prevalence of current tobacco use in adolescents (%)
Adolescents are defined as students aged 13 to 15 or according to the definition of each country.
"Smoked tobacco products" include cigarettes, beedis, cigars, pipes, water pipes (hookah, shisha), finely cut smoking tobacco (roll-your-own cigarettes), kreteks, or any other form of smoking tobacco.
"Smokeless tobacco" includes moist tobacco, creamy tobacco, solvents, dry tobacco, gul, loose leaves, red tooth powder, snus, chimo, gutka, khaini, gudakhu, zarda, qiwam, dohra, tuibur, nasway, naas
aswar, shammah, betel quid, toombak, pan (betel quid), iq'mik, mishri, tapkeer, tombol, and any other tobacco product that is inhaled, kept in the mouth, or chewed.
Also included as tobacco products are heated tobacco products (HTPs, known by the brands Iqos, glo, Ploom TECH).
Electronic nicotine delivery or non-nicotine delivery systems known as "e-cigarettes," "e-hookahs," JUUL, and "e-pipes" are not classified as tobacco products because they do not contain this substance.
This indicator is part of the Global Monitoring Framework on NCDs. It allows country progress on implementing strategies and national plans to control noncommunicable diseases to be monitored. It is also used to monitor the impact of implementing the Framework Convention of the World Health Organization (WHO) for Tobacco Control or tobacco control policies in countries not yet party to this convention, and to monitor country progress on achieving the Sustainable Health Agenda for the Americas 2018–2030.
Its result contributes to developing public policies to prevent and control noncommunicable diseases and to allocate human, economic, and technological resources to this field. The indicator contributes to multidisciplinary research in the field of noncommunicable diseases.
Calculation with data from each country
Formula:
(A/B) x 100%
Numerator (A):
Number of adolescent students who respond to the survey and who currently use* tobacco (daily or less frequently).
*"Current users" include students who have used smoked or smokeless tobacco at any time in the 30 days prior to the survey.
Denominator (B):
Total number of adolescents (students) who respond to the survey.
Further background on the methodology:
WHO global report on trends in prevalence of tobacco use 2000–2025, third edition. Geneva: World Health Organization; 2019. Available from: https://www.who.int/publications/i/item/who-global-report-on-trends-in-prevalence-of-tobacco-use-2000-2025-third-edition
Although several countries collect data on youth tobacco use through the GYTS, and the survey uses a protocol with sampling methodology and standardized questionnaire, estimates between countries should be compared with caution.
Global Tobacco Surveillance System (GTSS). Available from: https://www.cdc.gov/tobacco/global/gtss/gtssdata/index.html
Youth surveys tobacco use and smoking. Available from:
https://www.who.int/publications/i/item/WHO-HEP-HPR-TFI-2021.11.3
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C. 2021. Available from: https://iris.paho.org/handle/10665.2/53918
Noncommunicable Diseases Surveillance, Monitoring and Reporting. NCD Global Monitoring Framework. Available from: https://www.who.int/teams
cds/surveillance/monitoring-capacity/gmf
World Health Organization (WHO). Noncommunicable Diseases Surveillance, Monitoring and Reporting. Global Youth Tobbaco Survey. Disponible en: https://www.who.int/teams
oncommunicable-diseases/surveillance/systems-tools/global-youth-tobacco-survey
Prevalence of current tobacco use in adults (%)
"Smoked tobacco products" include cigarettes, beedis, cigars, pipes, water pipes (hookah, shisha), finely cut smoking tobacco (roll-your-own cigarettes), kreteks, or any other form of smoking tobacco.
"Smokeless tobacco" includes moist tobacco, creamy tobacco, solvents, dry tobacco, gul, loose leaves, red tooth powder, snus, chimo, gutka, khaini, gudakhu, zarda, qiwam, dohra, tuibur, nasway, naas
aswar, shammah, betel quid, toombak, pan (betel quid), iq'mik, mishri, tapkeer, tombol, and any other tobacco product that is inhaled, kept in the mouth, or chewed.
Also included as tobacco products are heated tobacco products (HTPs, known by the brands Iqos, glo, Ploom TECH).
Electronic nicotine delivery or non-nicotine delivery systems known as "e-cigarettes," "e-hookahs," JUUL, and "e-pipes" are not classified as tobacco products because they do not contain this substance.
As the calculations adjust for age and other variables that can skew the results, the value of the indicator is used to make comparisons between countries or within the same country over time. The indicator contributes to multidisciplinary research in the field of noncommunicable diseases.
Adjusting the model also makes it possible to estimate trends and projections of the indicator between 1990 and 2030. Depending on the completeness of survey data from a given country, data from other countries in the same UN subregion may be used to fill in information gaps. The resulting trend lines are used to derive estimates for individual years, so that a number can be reported even if the country did not conduct a survey in that year. Results are weighted by population size and standardized by age based on the WHO standard population.
Further background on the methodology:
Bilano V, Gilmour S, Moffiet T, et al. Global trends and projections for tobacco use, 1990–2025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control. Lancet. 2015 Mar 14;385(9972):966–76. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60264-1/fulltext
Because advanced statistical methods are applied to estimate current tobacco use in adults in order to make results comparable between countries and over time, the value of this indicator may differ from the results obtained by each country. Another factor impacting results is the standard population used for age adjustment. It is also worth noting that estimates for countries with irregular surveys or with many data gaps will have large ranges of uncertainty, so the results should be interpreted with caution.
The current prevalence of tobacco use in adults is an age-standardized rate whose objective is to compare the indicator between different countries. However, it is a hypothetical value that could differ considerably from the crude prevalence and not fully reflect the real magnitude of the problem in a given country, especially if the country's age structure differs greatly from the standard WHO population structure.
Indicator 3.a.1 Age-standardized prevalence of current tobacco use among persons aged 15 years and older.
Available from: https://sdg.data.gov/
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 13.a Age-standardized prevalence of current tobacco use among persons aged 15 years and older
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C. 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). Noncommunicable Diseases Surveillance, Monitoring and Reporting. NCD Global Monitoring Framework. Available from: https://www.who.int/teams
cds/surveillance/monitoring-capacity/gmf
WHO global report on trends in prevalence of tobacco use 2000–2025, third edition. Geneva: World Health Organization; 2019. Available from: https://www.who.int/publications/i/item/who-global-report-on-trends-in-prevalence-of-tobacco-use-2000-2025-third-edition
Prevalence of insufficient physical activity in adolescents (%)
Adolescents are defined as people between the ages of 11 and 17, or according to the definition of the country.
Since the calculation of this indicator is adjusted for age and other variables that can skew the results, its value is used to make comparisons between countries or within the same country over time.
The indicator is part of the Global Monitoring Framework on NCDs and the Monitoring Framework for Universal Health in the Americas. It can also be used in conjunction with the Monitoring Framework for Universal Health in the Americas and the Sustainable Health Agenda for the Americas 2018–2030. It is used to monitor the progress made by countries in implementing national strategies and plans to control noncommunicable diseases.
Estimates use advanced statistical methods to standardize the definition of physical activity (if different than the definition used in the indicator) and to adjust for age, over-reporting of physical activity on the IPAQ, and survey coverage (if applied only in urban areas). The estimates are weighted according to the population size of each country.
In order to make results comparable between countries and over time, advanced statistical methods are applied to estimate insufficient physical activity prevalence in adults. Therefore, the value of this indicator may differ from the results obtained by each country.
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). Noncommunicable Diseases Surveillance, Monitoring and Reporting. NCD Global Monitoring Framework. Available from: https://www.who.int/teams
cds/surveillance/monitoring-capacity/gmf
World Health Organization (WHO). Global school-based student health survey (GSHS). Available from: https://www.who.int
cds/surveillance/gshs/en/
Prevalence of insufficient physical activity in adults (%)
Since the calculation of this indicator is adjusted for age and other variables that can skew the results, its value is used to make comparisons between countries or within the same country over time.
Prevalence of insufficient physical activity is included in the Global Monitoring Framework on NCDs and the Monitoring Framework for Universal Health in the Americas. The indicator is used to monitor the progress made by countries in implementing national strategies and plans to control noncommunicable diseases. The metrics allows also the monitoring of the Sustainable Health Agenda for the Americas 2018–2030 and the Monitoring Framework for Universal Health in the Americas.
MET is the metabolic equivalent of task. It is the relationship between a person's working and resting metabolic rates. MET is defined as the energy expended while sitting quietly and is equivalent to a caloric intake of 1 Kcal/kg/hour. Physical activities are often classified by their intensity, using MET as a reference.
The value of this indicator comes from estimates made by the World Health Organization (WHO) based on data from national, subnational, or community surveys that include self-reporting of physical activity, including the Global Physical Activity Questionnaire (GPAQ), the International Physical Activity Questionnaire (IPAQ), the STEPS Survey or similar questionnaires covering physical activity performed at work, at home, for transportation, and during leisure time.
The estimation method uses advanced statistical methods to standardize the definition of physical activity (if different from the definition used in the indicator) and to adjust for age, over-reporting of physical activity on the IPAQ, and survey coverage. The estimates are weighted according to the population of each country. The WHO Global Standard Population is used for age adjustment.
In order to make results comparable between countries and over time, advanced statistical methods are applied to estimate insufficient physical activity prevalence in adults. Therefore, the value of this indicator may differ from the results obtained by each country. Another element impacting results is the standard population used for age adjustment.
Indicator 13.e Age-standardized prevalence of insufficiently physically active persons aged 18+ years
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). Noncommunicable Diseases Surveillance, Monitoring and Reporting. NCD Global Monitoring Framework. Available from: https://www.who.int/teams
cds/surveillance/monitoring-capacity/gmf
Prevalence of obesity in children/adolescents aged 10-19 years (%)
Because estimates of this indicator apply advanced statistical methods to control for some variables that could skew the results, its values are comparable between countries and within the same country over time. The indicator is used to analyze temporal and geographical trends of childhood and adolescent obesity, identifying populations in need of improved access to health care and focused interventions to prevent and treat obesity, and prevention and early detection of complications (insulin resistance, dyslipidemia, arterial hypertension, among others).
It is part of the Global Monitoring Framework on NCDs and the Monitoring Framework for Universal Health in the Americas. It can also be used in conjunction with the Monitoring Framework for Universal Health in the Americas and the Sustainable Health Agenda for the Americas 2018–2030. It is used to monitor the progress made by countries in implementing national strategies and plans to control noncommunicable diseases.
Estimates of the indicator apply advanced statistical models to adjust for different variables that could skew the results, such as survey coverage and year of distribution. The models are also used to estimate the trend of this indicator in different countries and years.
Further background on the methodology:
NCD-RisC. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. The Lancet, December 2017, vol 390. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32129-3/fulltext
Further background on child growth patterns:
de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bulletin World Health Organization. 2007; 85: 660–66. Available from: https://apps.who.int/iris/handle/10665/270023
In order to make results comparable between countries and over time, advanced statistical methods are applied to estimate prevalence of obesity. Therefore, the value of this indicator may differ from the results obtained by each country. Another element impacting results is the standard population used for age adjustment.
Indicator 14.d Prevalence of childhood and adolescent obesity (5-19 years of age)
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). Noncommunicable Diseases Global Monitoring Framework: Indicator Definitions and Specifications. Available from: https://cdn.who.int/media/docs/default-source/inaugural-who-partners-forum/gmf_indicator_definitions_version_nov2014438a791b-16d3-46f3-a398-88dee12e796b.pdf?sfvrsn=4b337764_1&download=true
Prevalence of overweight and obesity in adults (%)
Because estimates of this indicator apply advanced statistical methods to control for some variables that could skew the results, its values are comparable between countries and within the same country over time. The indicator is used to analyze temporal and geographical trends of childhood and adolescent obesity, because it allows to identify populations in need of improved access to health care and focused interventions to prevent and treat obesity and overweight, and prevention and early detection of complications (insulin resistance, dyslipidemia, arterial hypertension, among others).
The indicator is part of the Global Monitoring Framework on NCDs and the Monitoring Framework for Universal Health in the Americas. It can also be used in conjunction with the Monitoring Framework for Universal Health in the Americas, to measure national progress in implementing policies aimed at strengthening health systems and achieving universal health.
Estimates of the indicator apply advanced statistical models to adjust for different variables that could skew the results, such as survey coverage and the year of distribution. Models are also used to estimate the trend of this indicator in different countries and years. The WHO Global Standard Population is used for age adjustment.
Further background on the methodology:
NCD-RisC. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. The Lancet, December 2017, vol 390. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32129-3/fulltext
In order to make results comparable between countries and over time, advanced statistical methods are applied to estimate prevalence of overweight and obesity in adults. Therefore, the value may differ from the results obtained by each country. Another element impacting results is the standard population used for age adjustment.
Indicator 14.e Prevalence of overweight and obesity in persons 18+ years of age
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). Noncommunicable Diseases Surveillance, Monitoring and Reporting. NCD Global Monitoring Framework. Available from: https://www.who.int/teams
cds/surveillance/monitoring-capacity/gmf
Prevalence of overweight in children under age 5 (%)
This indicator is used to analyze geographic and temporal trends of overweight in children from 0 to 5 years old. It is applied to identify at-risk groups in order to focus resources to increase access to health care, implement surveillance systems, and encourage multidisciplinary research.
Further background on the methodology:
WHO Global Database on Child Growth and Malnutrition. Available from: https://www.who.int/teams
utrition-and-food-safety/databases
utgrowthdb
UNICEF-WHO-The World Bank: Joint child malnutrition estimates. Available from: https://data.unicef.org/resources/jme-report-2021/
De Onis et al. Estimates of global prevalence of childhood underweight in 1990 and 2015. JAMA. 2004;291(21):2600–2606. Available from: https://jamanetwork.com/journals/jama/fullarticle/198842
De Onis, Bloessner M. The World Health Organization Global Database on Child Growth and Malnutrition: methodology and applications. International Journal of Epidemiology 2003; 32: 518–526. Available from: https://academic.oup.com/ije/article/32/4/518/666947
World Health Organization (WHO) child growth standards: Available from: https://www.who.int/toolkits/child-growth-standards
In order to make results comparable between countries and over time, advanced statistical methods are applied to estimate insufficient physical activity prevalence in adults. Therefore, the value of this indicator may differ from the results obtained by each country.
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/gho-jme-country-children-aged-5-years-overweight-(-weight-for-height-2-sd)
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C., 2021. Available from:
https://iris.paho.org/handle/10665.2/53918
Prevalence of raised blood glucose/diabetes in adults (%)
Since the calculation of this indicator is adjusted for age and other variables that can skew the results, its value is used to analyze geographical and temporal trends in diabetes mellitus and to compare situations between countries or within the same country over time.
This indicator is part of the Global Monitoring Framework on NCDs and the Monitoring Framework for Universal Health in the Americas. It is used to monitor the progress made by countries in implementing national strategies and plans to control noncommunicable diseases, and implementing policies to strengthen health systems and achieve universal health.
More background on the methodology used:
NCD-RisC. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. 2016. The Lancet 387 (10027), 1513–1530. Available from: https://doi.org/10.1016/S0140-6736(16)00618-8
As advanced statistical methods are applied to calculate diabetes prevalence in adults, the value of this indicator may differ from the results obtained by each country. Another factor that may lead to differences is that WHO estimates the indicator based on biomarkers for diabetes mellitus and not on self-reporting of the condition. The value obtained will also vary according to the reference population used for age adjustment.
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). Noncommunicable Disease, Surveillance, Monitoring and Reporting: NCD global monitoring framework. Available from: https://www.who.int/teams
cds/surveillance/monitoring-capacity/gmf
Prevalence of raised blood pressure in adults (%)
The indicator reflects the health status of a given population and contributes to planning, implementing, and evaluating strategies to prevent and control raised blood pressure.
Since the calculation of this indicator is adjusted for age and other variables that can skew the results, its value is used to analyze geographical and temporal trends in blood pressure and to compare situations between countries or within the same country over time.
The indicator is used to develop targeted strategies promoting healthy lifestyles and to allocate economic, human, and technological resources to treat raised blood pressure and prevent associated conditions.
It is part of the Global Monitoring Framework on NCDs and the Monitoring Framework for Universal Health in the Americas and is used to monitor the progress made by countries in implementing national strategies and plans to control noncommunicable diseases, and in implementing policies to strengthen health systems and achieve universal health.
Advanced statistical models are applied when estimating the prevalence of raised blood pressure to control for different variables that could skew the results and to include covariables that help predict blood pressure, such as educational level, the proportion of the national population living in urban areas, and a summary measure of the availability of different types of food for human consumption. These models are also applied to estimate blood pressure trends in countries. The WHO Global Standard Population is used for age adjustment.
More background on the methodology used:
NCD-RisC. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants.2017. The Lancet 389 (10064), 37–55. Available from: https://doi.org/10.1016/S0140-6736(16)00618-8
As advanced statistical methods are applied to calculate raised blood pressure prevalence in adults, the value of this indicator may differ from the results obtained by each country. Another factor that may lead to differences is that WHO estimates the indicator based on blood pressure measurements and not on self-reporting of the condition. The value obtained will also vary according to the reference population used for age adjustment.
https://www.who.int/data/gho/data/indicators/indicator-details/GHO/raised-blood-pressure-(sbp-=140-or-dbp-=90)-(age-standardized-estimate)
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). Noncommunicable Disease, Surveillance, Monitoring and Reporting: NCD global monitoring framework. Available from: https://www.who.int/teams
cds/surveillance/monitoring-capacity/gmf
Private health expenditure as % of GDP
Missing values are estimated using various accounting techniques based on the data available for each country. The main international references come from financial statistics from the International Monetary Fund (IMF), health data from the Organisation for Economic Cooperation and Development (OECD), and national accounts statistics from the United Nations. National sources include HA reports, national accounts reports, comprehensive financing studies, Classification of Individual Consumption According to Purpose (COICOP) reports, and institutional reports from private entities that provide or finance health care, in actuarial and financial reports from private companies and health insurance agencies. Additional sources include household and business surveys, and economic censuses. Ad hoc surveys are another possible source of data.
The indicator is known as domestic private health expenditure (PVT-D), expressed as a percentage of GDP.
Data collected by WHO feeds into its Global Health Expenditure Database (GHED), which serves as a global benchmark for information on health expenditure in WHO Member States.
Formula:
(AxB)/ 100
Numerator (A):
Current Health Expenditure (CHE) as % Gross Domestic Product (GDP)
Denominator (B):
Domestic Private Health Expenditure (PVT-D) as % Current Health Expenditure (CHE)
For more details on methodology, see:
World Health Organization (WHO) Methodology for the update of the Global Health Expenditure Database, 2000–2018. Technical note. Version December 2020. Available from: https://apps.who.int
ha/database/DocumentationCentre/Index/en
OECD/Eurostat/WHO (2017). A System of Health Accounts 2011: Revised edition, OECD Publishing, Paris, System of Health Accounts 2011 (SHA 2011). Available from: https://www.oecd.org/publications/a-system-of-health-accounts-2011-9789264270985-en.htm
Note: OECD member States: Mexico, Chile, Colombia, Costa Rica, and Argentina; Associate member: Brazil.
Due to the methodology used, the value of the indicator estimated by WHO may differ from the results obtained by each country.
ha/database/Home/Index/en
Sustainable Development Goals (SDG).
Indicator 3.8.2: Proportion of population with large household expenditures on health as a share of total household expenditure or income
Available from: https://unstats.un.org/sdgs/metadata/?Text=&Goal=3&Target=3.8
ha/database/Home/Index/en
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
Organisation for Economic Cooperation and Development (OECD).
Health Expenditure. Available from: https://www.oecd.org/els/health-systems/health-expenditure.htm#:~:text=Latest%20OECD%20estimates%20point%20to,previous%20years%20at%20around%208.8%25.
Proportion of population with HIV who receive ART
This indicator assesses progress in providing ART to all people with HIV.
The proportion of people receiving antiretroviral therapy among those living with HIV in the same age group serves as a benchmark for monitoring global goals over time and comparing progress across countries. It helps analyze progress towards ART coverage, visualize trends, and identify at-risk populations in need of strengthened access to ART. The indicator is applied when determining the economic, human, and technological resources necessary to address HIV.
Formula:
(A/B) x 100
Numerator (A):
People receiving antiretroviral therapy in a given country, territory or geographic area.
Denominator (B):
People living with HIV in a given country, territory or geographic area.
This metric only monitors the number of people receiving ART. It does not consider treatment cost, quality, efficacy, or adherence, all of which vary within and between countries.
Indicator 4.b Antiretroviral treatment (ART) coverage among persons living with HIV
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
World Health Organization (WHO). The Global Health Observatory (GHO). Available from:
https://www.who.int/data/gho/indicator-metadata-registry
UNAIDS. 90–90-90: Treatment for all. Available from: https://www.unaids.org/en/resources/909090
UNAIDS. Global AIDS monitoring 2021. Indicators and questions for monitoring progress on the 2021 United Nations Political Declaration on HIV and AIDS. Available from: https://www.unaids.org/sites/default/files/media_asset/global-aids-monitoring_en.pdf
Quick Start Guide for Spectrum. Available from: https://www.unaids.org/sites/default/files/media_asset/QuickStartGuide_Spectrum_en.pdf
Proportion of voluntary non remunerated blood donation (%)
This indicator reflects awareness among the population about voluntary and unpaid blood donation, as well as the level of community solidarity and social cohesion. It also indicates the availability of well-organized and coordinated blood collection and transfusion services. The indicator is applied when developing and prioritizing health policies that favor increased blood collection through voluntary unpaid blood donation.
World Health Organization (WHO) / Pan American Health Organization (PAHO). CD58/INF/8 - Plan of Action for Universal Access to Safe Blood: Final Report. September 2020. Available from: https://www.paho.org/en/documents/cd58inf8-plan-action-universal-access-safe-blood-final-report
Prostate cancer mortality rate (age-adjusted per 100 000 pop); male
Its result is applicable to the design, implementation, and evaluation of health policies for the prevention, diagnosis, treatment, and control of prostate cancer and the distribution of economic, human, and technological resources for this disease, among others.
Removing the effect of differences in the age distribution by using a standard population makes it possible to analyze the time trend and geographic distribution of deaths from prostate cancer, in the same population or across populations.
The underlying cause of death corresponds to code C61 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the prostate cancer mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
The prostate cancer mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates to the World Health Organization (WHO) World Standard Population.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The value of the age-adjusted prostate cancer mortality rate will depend on the standard population used for adjustment.
The estimated value of this indicator may differ from each country’s estimates due to methodological considerations such as the method used to prepare the population estimates and projections or the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the prostate cancer mortality rate requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in that system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Public health expenditure as % of GDP
This indicator reflects the importance of the health sector in a country’s economy and helps to identify inequalities and populations in need of strengthened health financing. It facilitates monitoring of country progress toward achieving universal coverage and, in combination with private expenditure, gives an idea of the level of expenditure and adequacy of public financing.
The indicator is known as domestic general government health expenditure (GGHE-D), expressed as a percentage of GDP.
Data collected by WHO feed into its Global Health Expenditure Database (GHED), which serves as a global benchmark for information on health expenditures in WHO Member States.
For more details on methodology, see:
OECD/Eurostat/WHO (2017). A System of Health Accounts 2011: Revised edition, OECD Publishing, Paris, System of Health Accounts 2011 (SHA 2011). Available from: https://www.oecd.org/publications/a-system-of-health-accounts-2011-9789264270985-en.htm
World Health Organization (WHO) Methodology for the update of the Global Health Expenditure Database, 2000–2018. Technical note. Version December 2020. Available from: https://apps.who.int
ha/database/DocumentationCentre/Index/en
Due to the methodology used, the value of the indicator estimated by WHO may differ from the results obtained by each country.
ha/database/Home/Index/en
ha/database/Home/Index/en
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
Organisation for Economic Cooperation and Development. Health Expenditure. Available from: https://www.oecd.org/els/health-systems/health-expenditure.htm#:~:text=Latest%20OECD%20estimates%20point%20to,previous%20years%20at%20around%208.8%25
OECD/Eurostat/WHO (2017). A System of Health Accounts 2011: Revised edition, OECD Publishing, Paris, System of Health Accounts 2011 (SHA 2011). Available from: https://www.oecd.org/publications/a-system-of-health-accounts-2011-9789264270985-en.htm
Respiratory diseases mortality rate (age-adjusted per 100 000 pop)
Its result is applicable to the design, implementation, and evaluation of health policies related to respiratory diseases and the distribution of economic, human, and technological resources for this group of pathologies, among others. Its applications include, for example, evaluating the impact of strategies to reduce smoking on mortality from respiratory diseases.
Removing the effect of differences in the age distribution by using a standard population makes it possible to analyze the time trend and geographic distribution of deaths from respiratory diseases, in the same population or across populations.
The underlying causes of death correspond to codes J30 – J98 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the respiratory diseases mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
The respiratory diseases mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The value of the age-adjusted respiratory diseases mortality rate will depend on the standard population used for adjustment.
The estimated value of this indicator may differ from each country’s estimates due to methodological considerations such as the method used to prepare the population estimates and projections or the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the respiratory diseases mortality rate requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in this system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Road injury mortality rate (age-adjusted per 100 000 pop)
This indicator makes it possible to identify populations with greater risk factors for this cause of death and to encourage interdisciplinary research in this area, for example, by analyzing the relationship between the road injury mortality rate and a population’s consumption of alcohol and other drugs.
Its result is applicable to the design, implementation, and evaluation of public policies aimed at evaluating the safety of modes of land transportation and promoting road safety, public safety, and effective urban planning.
The age-adjusted road injury mortality rate allows for the comparison of this indicator across populations or in the same population over time.
The underlying causes of death correspond to codes V01 - V04, V06, V09 - V80, V87, V89, and V99 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the age-adjusted road injury mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from:
https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The road injury mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The estimated value of the age-adjusted road injury mortality rate will depend on the standard population used for its adjustment; therefore, it may differ from each country’s estimates. Other methodological considerations that influence its result are the use of a different group of ICD-10 codes and the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating this indicator requires a civil registry system with good coverage. Deaths from this group of causes must be recorded in a timely manner in that system, and certification of the cause of death must be of good quality, including the type of accident; otherwise, the estimates will not be sufficiently accurate.
Indicator 3.6.1 Death rate due to road traffic injuries.
Available from: https://sdgs.un.org/goals
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). Global status report on road safety 2018. Geneva, 2018. Available from:https://www.who.int/publications/i/item/9789241565684
Stomach cancer incidence rate (age-adjusted per 100 000 pop)
The data used to estimate this indicator come from cancer registries that identify new cases occurring in a well-defined population, generating statistics to evaluate and control the impact of the disease in the population.
The age-adjusted stomach cancer incidence rate provides an estimate of the average risk the population has of developing this type of cancer in a particular country, territory, or geographic area. Results of the indicator are used to planning and allocating economic, human, and technological resources to fight stomach cancer.
As the stomach cancer incidence rate is age-adjusted, comparisons can be made both within and between populations over time. It helps to identify at-risk populations, determine the presence of specific risk factors such as those associated with diet, environment, or lifestyle, and assess access to timely diagnosis and treatment.
This indicator is essential for planning and evaluating stomach cancer screening, early diagnosis, treatment, and control programs. It helps to focus efforts such as identifying the need to strengthen and implement cancer registries in a given population.
The methods used to estimate the stomach cancer incidence rate in a specific country depend on the data sources available. These include projections on observed incidence rates at the national level, statistical models derived from incidence rates in the country's cancer registries or neighboring country registries, and average incidence rates in neighboring countries, among other metrics.
The stomach cancer incidence rate is age-standardized, and results are based on rates in populations with a standard age structure.
The age-standardized rate is a summary measure of the rate that would have been observed in a population with a standard age structure. Standardization is necessary when comparing several populations that differ in age, as age is a major factor when determining cancer risk. An age-standardized rate is a weighted average of age-specific rates based on a standard population distribution.
In addition, the age-adjusted stomach cancer incidence rate is not a real value. Its main purpose is to allow comparisons over time between different populations or within the same population. It reflects the average risk of developing this type of cancer in a particular country. This should not be interpreted as the individual risk of developing the cancer.
The estimated value of the age-adjusted stomach cancer incidence rate depends on the standard population used for its adjustment; it may therefore differ from the calculations made by each country.
Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J, editors (2021). Cancer Incidence in Five Continents, Vol. XI. IARC Scientific Publication No. 166. Lyon: International Agency for Research on Cancer. Available from:
https://publications.iarc.fr/597
Pan American Health Organization (PAHO)/World Health Organization (WHO). Core indicators Portal. Available from: https://opendata.paho.org/en/core-indicators
Global Reference List of 100 Core Health Indicators (plus health-related SDGs). Disponible en: https://apps.who.int/iris/handle/10665/259951
Stomach cancer mortality rate (age-adjusted per 100 000 pop)
The age-adjusted stomach cancer mortality rate is applicable to the design, implementation, and evaluation of health policies on stomach cancer and the distribution of economic, human, and technological resources for this disease, among others.
Removing the effect of a different age distribution by using a standard population makes it possible to analyze the time trend and geographic distribution of deaths from stomach cancer, in the same population or across populations.
The underlying causes of death correspond to code C16 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the stomach cancer mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The stomach cancer mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The value of the age-adjusted stomach cancer mortality rate will depend on the standard population used for adjustment.
The estimated value of this indicator may differ from each country’s estimates due to methodological considerations such as the method used to prepare the population estimates and projections or the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the stomach cancer mortality rate requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in this system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Stroke diseases mortality rate (age-adjusted per 100 000 pop)
Its result is applicable to the design, implementation, and evaluation of health policies on stroke diseases and the distribution of economic, human, and technological resources for this disease, among others. Its applications include evaluating, over time, the effect of media campaigns on recognizing strokes early and in reducing mortality from this cause.
Removing the effect of differences in the age distribution by using a standard population makes it possible to analyze the time trend and geographic distribution of deaths from stroke diseases, in the same population or across populations.
The underlying causes of death correspond to codes I60 – I69 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the stroke diseases mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The stroke diseases mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The value of the age-adjusted stroke diseases mortality rate will depend on the standard population used for adjustment.
The estimated value of this indicator may differ from each country’s estimates due to methodological considerations, such as the method used to prepare the population estimates and projections or the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the stroke diseases mortality rate requires a civil registry system with good coverage. Deaths must be recorded in a timely manner in this system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Suicide mortality rate (age-adjusted per 100 000 pop)
Its result is applicable to the design, implementation, and evaluation of health policies and the distribution of economic, human, and technological resources for the prevention, diagnosis, treatment, and rehabilitation of this group of causes, among others. Its applications include, for example, evaluating over time the effectiveness of mental health interventions, of early diagnostic strategies aimed at identifying suicide risk behaviors, and of rehabilitation from such events.
Adjusting for age allows for the comparison of this indicator across populations or in the same population over time.
The underlying causes of death correspond to codes X60 - X84, Y870 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods.pdf?sfvrsn=37bcfacc_5
The suicide mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The estimated value of the age-adjusted suicide mortality rate will depend on the standard population used for its adjustment; therefore, it may differ from each country’s estimates. Other methodological considerations that influence its result are the method for making population estimates and projections, the use of a different group of ICD-10 codes, and the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the suicide mortality rate requires a civil registry system with good coverage. Deaths from this group of causes must be recorded in a timely manner in that system, and certification of the cause of death must be of good quality and include the method of suicide; otherwise, the estimates will not be sufficiently accurate.
Indicator 3.4.2 Suicide mortality rate.
Available from: https://sdgs.un.org/goals
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 14. Mortality rate due to suicide
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
Tetanus neonatorum cases
It supports decision making in public policies aimed at improving maternal and child health. It helps identify areas that require new or improved neonatal tetanus surveillance systems and strengthened tetanus vaccination programs.
This indicator reflects the health status and health and socioeconomic development of a population. It helps to identify health inequities and risk factors for Clostridium tetani infection.
The indicator is applied for designing, implementing, and assessing health policies to prevent, treat, and control neonatal tetanus and distribute economic, human, and technological resources to fight the disease, as well as other purposes.
Among its main applications are promoting vaccination, improving childbirth and postpartum hygiene, and training health workers in disease prevention. It helps strengthen access to quality maternal and child health care.
Sustainable Development Goals (SDG).
Indicator 3.b.1 Proportion of the target population covered by all vaccines included in their national programme.
Available from: https://sdgs.un.org/
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho
Total alcohol per capita (age 15+ years) consumption
Recorded alcohol consumption (recorded APC) refers to official statistics (production, import, export, and sales or taxes). Unrecorded alcohol consumption refers to untaxable alcohol that does not go through quality control measures. As such, it is generally not regulated or subject to State control (informal production, smuggling, alcohol not intended for human consumption, cross-border purchases). Tourism consumption considers tourists visiting the country and the country’s population travelling abroad.
APC is a key indicator for estimating the disease burden and deaths attributable to alcohol. This indicator is part of the Global Monitoring Framework on NCDs and the Monitoring Framework for Universal Health in the Americas. It is used to monitor countries and their efforts to implement national alcohol-related strategies and plans. It is also one of the indicators used in SDG 3.5 (3.5.2), to foster prevention and coverage of treatment for disorders due to alcohol consumption.
Unrecorded APC is estimated as a proportion of total consumption. Unrecorded consumption at the national level is estimated using regression analysis. Unrecorded consumption estimates were calculated from four sources: 1) a WHO survey collecting expert opinions on whether any change in unrecorded consumption has occurred since 2010 (since the publication of the WHO Global Status Report on Alcohol and Health 2014), as well as the magnitude and documentation of these changes; 2) a survey conducted by WHO and the PAHO/WHO Collaborating Centre CAMH (Center for Addiction and Mental Health) with selected experts and using the 2013 Delphi methodology to assess the proportion of unrecorded consumption in 46 WHO Member States (response rate: 74%) in which unrecorded consumption was relatively high; (3) a second WHO/CAMH survey with experts from 49 Member States (response rate 86%); and (4) WHO STEPwise approach to surveillance surveys.
Based on these data, the proportion of unrecorded consumption was calculated with a regression analysis. Data for tourism consumption estimates come from the Institute for Health Metrics and Evaluation (IHME). Its calculations are based on data from the United Nations World Tourism Organization (UNWTO) (World Tourism Organization, 2016; www.healthdata.org). The liters of alcohol consumed by tourists in a country are derived from the number of tourists visiting a country, average time spent in the country, and how much the tourists consume, on average, in their own countries of origin. In addition, tourist alcohol consumption includes the people of the country in question who consume alcohol when travelling abroad (based on the average time spent abroad and alcohol consumption in the country of origin). These estimates assume the following: 1) tourists drink the same amount of alcohol as when they are in their own countries, and 2) total global tourist consumption equals 0 (meaning consumption by tourists can be negative or positive) (WHO, 2018).
Formula:
(A/B)
Three-year average from consecutive years.
Numerator (A):
The sum of recorded and unrecorded alcohol consumption in the population of a country during a calendar year.
Denominator (B):
Number of inhabitants of the same country 15 years of age or older. Data obtained from the United Nations Population Division.
Correct interpretation of this indicator requires the use of additional indicators derived from population surveys, such as the prevalence of alcohol consumption.
Indicator 3.5.2: Alcohol per capita consumption (aged 15 years and older) within a calendar year in litres of pure alcohol.
Available from: https://sdg.data.gov/
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 13.b Total (recorded and unrecorded) alcohol per capita (APC) consumption among persons 15+ years of age within a calendar year in liters of pure alcohol, adjusted for tourist consumption
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
Pan American Health Organization (PAHO). Monitoring Framework for Universal Health in the Americas. Washington, D.C., 2021. Available from: https://iris.paho.org/handle/10665.2/53918
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). Global status report on alcohol and health 2018. Geneva: World Health Organization; 2018. Available from: https://www.who.int/publications/i/item/9789241565639
Total fertility rate (live births per woman)
The overall fertility rate is a synthetic measure that expresses, in a single figure, the fertility of all women during a given stage.
The indicator is used to produce population estimates and projections.
It contributes to public policies on health, education, work, and social security.
A specific fertility rate by age or age group is calculated as the ratio between the annual number of births to women of a certain age or age group and the population of women of the same age or age group, in the same year, in a given country, territory, or geographical area.
The value of this indicator comes from United Nations estimates, based on data representing estimated mid-year values, obtained by linear interpolation of the corresponding United Nations five-year medium-variant population projections.
The calculation of this indicator assumes that fertility rates by age remain constant over time, however, they actually gradually fluctuate year by year, which may reflect changes in the pace of births, rather than changes in the average number of children women have. Other factors influencing these fluctuations are the health of the population, level of urbanization, educational level, availability and use of contraceptive methods, infant mortality, and women's participation in the labor force.
The estimated value of this indicator may differ from country statistics due to factors, such as methodological differences in developing population estimates and projections.
https://population.un.org/wpp/
https://www.who.int/data/gho/indicator-metadata-registry
United Nations, Department of Economic and Social Affairs. 2019 Demographic Yearbook, 70th Issue. New York, 2020. Available from: https://unstats.un.org/unsd/demographic-social/products/dyb/
United States Census Bureau. International Database. Glossary. Available from: https://www.census.gov/glossary/
United Nations, Department of Economic and Social Affairs, Population Division. Glossary of Demographic Terms. Available from:
https://population.un.org/wpp/GlossaryOfDemographicTerms/
Economic Commission for Latin America and the Caribbean (ECLAC) - CEPALSTAT. Statistical Databases and Publications. Available from:
https://statistics.cepal.org/portal/cepalstat/dashboard.html?lang=en
Pan American Health Organization. Basic Health Indicators in Brazil: concepts and applications, 2nd edition. Brasilia, 2008. Available from: https://www.paho.org/bra/dmdocuments/indicadores.pdf
Total population (thousands)
This indicator helps determine the size of the target population receiving government actions and services, and contributes to budgetary allocation and planning, management, and evaluation of public policies related to health, education, work, and social security.
The estimated population is calculated using a change model component that incorporates information on the natural increase (births, deaths) and net migration (net national migration, net international migration) in an area since the last decennial census.
The de facto population is taken on 1 July, assuming that the reference period is year z and that births are evenly distributed throughout that period. The average population will be represented by a mid-year estimate on 1 July.
By age: 0–1 year
1-4 years
5-14 years
15-24 years
25-44 years
45-64 years
65-74 years
75+ years
The estimated value of this indicator may differ from country statistics due to factors such as methodological differences in developing population estimates and projections.
https://population.un.org/wpp/
https://www.who.int/data/gho/indicator-metadata-registry
United Nations, Department of Economic and Social Affairs. 2019 Demographic Yearbook, 70th Issue. New York, 2020. Available from: https://unstats.un.org/unsd/demographic-social/products/dyb/
United States Census Bureau. International Database. Available from:
https://www.census.gov/glossary/
United Nations, Department of Economic and Social Affairs, Population Division. Glossary of Demographic Terms. Available from:
https://population.un.org/wpp/GlossaryOfDemographicTerms/
Pan American Health Organization. Basic Health Indicators in Brazil: concepts and applications, 2nd edition. Brasilia, 2008. Available from:
https://www.paho.org/bra/dmdocuments/indicadores.pdf
Tuberculosis incidence rate (100 000 pop)
The incidence of TB indicates a population's level of health and development, reflects the intensity of the impact of the disease in any of its clinical forms on the population, helps to identify persistent risk factors that facilitate transmission, and focuses targeted preventive and control strategies. These strategies include strengthening TB vaccination programs and surveillance activities.
This indicator makes it possible to monitor country progress toward achieving the goals of the Global End TB Strategy 2016-2035. Its value is applied when analyzing temporal and geographical TB trends in a population, planning and assessing public policies to fight the disease, and allocating economic, human, and technological resources.
Incidence estimates for each country are calculated using one or more of the following approaches, depending on the available data:
1. Incidence= reported cases / estimated proportion of detected cases
2. Capture-recapture modelling
3. Incidence = prevalence / duration of the illness
The TB incidence rate represents the best estimates that WHO can obtain. All estimates are communicated to countries prior to publication. The process of revising estimates is based on the comments provided by the countries. The final set is reviewed by WHO prior to publication to verify compliance with specific international standards and to harmonize breakdowns by age group and sex.
For more details on methodology, see:
World Health Organization (WHO). Policy and recommendations for how to assess the epidemiological burden of TB and the impact of TB control. Geneva, 2009. Available from: https://apps.who.int/iris/handle/10665/44231
World Health Organization (WHO). Global tuberculosis reports. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports
The value of this indicator may differ from country estimates due to small methodological differences, such as different sources of information used to obtain the total population of each country.
One factor to consider when interpreting this indicator is that people can acquire the infection several years before developing the disease. As a result, the effect of tuberculosis control strategies on incidence is less rapid than the effect on prevalence or mortality. It should be kept in mind that the value of the TB incidence rate may shift due to changes in the rate at which people become infected with M. tuberculosis or the rate at which infected persons develop TB disease.
Indicator 3.3.2 Tuberculosis incidence per 100 000 population
Available from: https://sdgs.un.org/
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 20. Incidence rate of tuberculosis
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
Tuberculosis mortality rate (age-adjusted per 100 000 pop)
Its result is applicable to the design, implementation, and evaluation of health policies on tuberculosis and the distribution of economic, human, and technological resources for the prevention, diagnosis, treatment, and rehabilitation of this disease, among others. Its applications include, for example, evaluating over time the effectiveness of antimicrobial therapies, early diagnostic strategies, and the evolution of human immunodeficiency virus (HIV) co-infection.
Adjusting for age allows for the comparison of this indicator across populations or in the same population over time.
The underlying causes of death correspond to codes A15 - A19, B90 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the age-adjusted tuberculosis mortality rate are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods.pdf?sfvrsn=37bcfacc_5
The tuberculosis mortality rate is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The estimated value of the age-adjusted tuberculosis mortality rate will depend on the standard population used for its adjustment; therefore, it may differ from each country’s estimates. Other methodological considerations that influence its result are the method used for making population estimates and projections, the use of a different group of ICD-10 codes, and the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the tuberculosis mortality rate requires a civil registry system with good coverage. Deaths from this disease must be recorded in a timely manner in that system, and certification of the cause of death must be of good quality; otherwise, the estimates will not be sufficiently accurate.
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). Global tuberculosis report 2020. Geneva, 2020. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports
Under age 5 deaths due to acute respiratory infections (%)
It reflects the health status and socio-economic development of a population, and makes it possible to identify inequities in health.
Its result is applicable to the design, implementation, and evaluation of health policies for the prevention, treatment, and control of acute respiratory infections in children and the distribution of economic, human, and technological resources for this group of pathologies, among others. These applications include the planning and evaluation of programs on vaccination, nutrition, and prioritization of timely access, as well as coverage and quality of health care for children.
Underlying causes of death correspond to codes J00 – J22 of the International Classification of Diseases, Tenth Revision.
Data for this indicator are from the World Health Organization (WHO) Global Health Estimates (GHE), based on information from multiple sources, such as national civil registry systems, estimates from WHO technical programs, the United Nations and inter-agency groups, the Global Burden of Disease, and other scientific studies.
By applying advanced statistical models and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death. For countries without high-quality death registration data, estimates of the cause of death are calculated using other data, for example, household surveys with verbal autopsy, sentinel registry systems, or special studies.
Formula
(A/B) x 100
Numerator (A):
Number of deaths in children < 5 from ARI during year z in a given country, territory or geographic area.
Denominator (B):
Total number of deaths in children < 5 during year z in a given country, territory or geographic area.
Estimating the proportion of deaths from acute respiratory infections in children under 5 requires a civil registry system with good coverage. Births and deaths must be recorded in a timely manner in this system and information on causes of death must be recorded; otherwise the estimates will not be sufficiently accurate.
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods.pdf?sfvrsn=37bcfacc_5
Under age 5 deaths due to infectious intestinal disease (%)
It reflects the health status and socio-economic development of a population and makes it possible to identify inequities in health.
Its result is applicable to the design, implementation, and evaluation of health policies for the prevention, treatment, and control of infectious intestinal disease in children and the distribution of economic, human, and technological resources for this group of pathologies, among others. These applications include the planning and evaluation of programs on nutrition, access to safe drinking water, environmental sanitation and hygiene, and prioritization of timely access, as well as coverage and quality of health care for children.
Underlying causes of death correspond to codes A00, A01, A03, A04, A06-A09 of the International Classification of Diseases, Tenth Revision.
Data for this indicator are from the World Health Organization (WHO) Global Health Estimates (GHE), based on information from multiple sources, such as national civil registry systems, estimates from WHO technical programs, the United Nations and inter-agency groups, the Global Burden of Disease, and other scientific studies.
By applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death. For countries without high-quality death registration data, estimates of the cause of death are calculated using other data, for example, household surveys with verbal autopsy, sentinel registry systems, or special studies.
Formula
(A/B) x 100
Numerator (A):
Number of deaths in children < 5 from ADD during year z in a given country, territory or geographic area.
Denominator (B):
Total number of deaths in children < 5 during year z in a given country, territory or geographic area.
Estimating the proportion of deaths from infectious intestinal disease in children under 5 requires a civil registry system with good coverage. Births and deaths must be recorded in a timely manner in this system and information on causes of death must be recorded; otherwise, the estimates will not be sufficiently accurate.
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods.pdf?sfvrsn=37bcfacc_5
Under-five mortality (1 000 lb)
It becomes relevant because most causes of death in this age group are preventable and treatable through simple, affordable interventions, such as immunization, adequate nutrition, professional childbirth, breastfeeding, and access to safe water and basic services.
Under-5 mortality reflects children’s health status and social, economic, and environmental conditions and is related to maternal and child health care access, quality, and timeliness.
This indicator is applicable to the design, implementation, and evaluation of health policies and the distribution of economic, human, and technological resources aimed at improving maternal and child health.
Calculated with data from each country
Formula:
(A/B) x 1 000 live births
Numerator (A):
Number of deaths in children under five years of age in a given country territory, or geographic area during year z.
Denominator (B):
Total number of live births in the same population during year z.
To estimate the indicator by sex, the following formula is applied:
(A/B) x 1 000 live births
Numerator (A):
Number of deaths in children under five years of age of a given sex, in a specific country, territory, or geographic area during year z.
Denominator (B):
Total number of live births in the same population during year z.
The value of this indicator may differ from each country’s value due to methodological differences such as the application of methods to correct underreporting of births and deaths.
Indicator 3.2.1: Under‐5 mortality rate.
Available from: https://sdg.data.gov/
Pan American Health Organization. Strategic Plan of the Pan American Health Organization 2020-2025.
Indicator 4. Under-5 mortality rate
Available from: https://www.paho.org/en/documents/paho-strategic-plan-2020-2025
Pan American Health Organization (PAHO)/World Health Organization (WHO). Core indicators Portal. Available from: https://opendata.paho.org/en/core-indicators
ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Vol 2. Available from: https://icd.who.int/browse10/Content/statichtml/ICD10Volume2_en_2010.pdf
Unemployment rate (%)
An unemployed person is defined as one who is out of work, who was recently seeking work, and who is currently available to work. This includes people who lost their job or left voluntarily. People not looking for work but who have arrangements for future employment are also counted as unemployed.
Its value allows analysis of the temporal and geographical trends in unemployment in a population and identification of at-risk groups for public policies promoting employment, health, education and social protection. It contributes to evaluating the effectiveness of labor insertion strategies and encourages research in this area.
One of the factors affecting the value of the unemployment rate is the difficulty in quantifying informal employment in the absence of regulations, records, and tracking data. Another factor is the exclusion of people who want to work but are not looking for work (often called the "hidden unemployed" or "discouraged workers"), as this affects the unemployment numbers.
The value of the unemployment rate is affected by the timing of the household survey used to obtain the data. Agriculture, for example, is subject to seasonal variations in the level of unemployment.
The accuracy of this indicator depends on the timeliness, frequency, quality, and comparability of household surveys. The frequency with which countries update their data and transfer it to the World Bank for calculation affects the result of this indicator.
Indicator 8.5.2 Unemployment rate, by sex, age and persons with disabilities
Available from: https://sdgs.un.org/goals
International Labour Organization (ILOSTAT). Available from:
https://ilostat.ilo.org/data/
Unintentional poisoning mortality rate (age-adjusted per 100 000 pop)
Its result is applicable to the design, implementation, and evaluation of health policies on unintentional poisoning and exposure to harmful substances and to the distribution of economic, human, and technological resources for the prevention, diagnosis, treatment, and rehabilitation of this group of causes, among others. Its applications include, for example, evaluating over time the effectiveness of interventions to reduce environmental pollution and of early diagnostic strategies aimed at reducing morbidity and mortality from unintentional poisoning.
Adjusting for age allows for the comparison of the unintentional poisoning mortality rate across populations or in the same population over time.
The underlying causes of death correspond to codes X40, X43, X46 - X48, X49 of the International Classification of Diseases, Tenth Revision (ICD-10).
The populations used in the denominator of the age-adjusted mortality rate from unintentional poisoning and exposure of harmful substances are from estimates by the United Nations Population Division.
Applying advanced statistical models, and depending on the data source used and its quality, adjustments are made to avoid bias and ensure compliance with standards and comparability of results across countries. If the data are from civil registry systems, adjustments include, but are not limited to, underreporting of deaths, unknown age and sex, and ill-defined causes of death, as well as garbage codes.
For more details on methodology, see:
World Health Organization (WHO). Division of Data, Analytics and Delivery for Impact (DDI). WHO methods and data sources for country-level causes of death 2000-2019. December 2020. Available from: https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods
The mortality rate from unintentional poisoning and exposure to harmful substances is adjusted for age by direct standardization, applying estimated age-specific mortality rates, for both sexes or for a given sex, to the World Health Organization (WHO) World Standard Population.
The estimated value of the age-adjusted unintentional poisoning mortality rate will depend on the standard population used for its adjustment; therefore, it may differ from each country’s estimates. Other methodological considerations that influence its result are the method for making population estimates and projections, the use of a different group of ICD-10 codes, and the application of algorithms to correct underreporting and redistribute ill-defined causes, among others.
Estimating the unintentional poisoning mortality rate requires a civil registry system with good coverage. Deaths from this group of pathologies must be recorded in a timely manner in that system, and certification of the cause of death must be of good quality and must include the substance responsible for the poisoning; otherwise, the estimates will not be sufficiently accurate. Another limitation is the low percentage of countries with poison centers.
Indicator 3.9.3 Mortality rate attributed to unintentional poisoning.
Available from: https://sdgs.un.org/goals
Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001. Available from: https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard
World Health Organization (WHO). World Health Data Platform. The Global Health Observatory. Indicators. Available from: https://www.who.int/data/gho/indicator-metadata-registry
World Health Organization (WHO). International Programme on Chemical Safety. The WHO Global Chemicals and Health Network. Available from: https://www.who.int/publications/m/item/global-chemicals-and-health-network-flyer
World Health Organization (WHO). International Programme on Chemical Safety. WHO Chemicals Road Map and Workbook. Available from: https://www.who.int/publications/i/item/9789241513630
Urban Population (%)
Alongside the proportion of the population residing in rural areas, this indicator makes it possible to assess the effects of migratory flows by analyzing changes in the territorial and temporal population distribution.
Countries determine what areas are "urban" as part of their census procedures, and no single definition can be applied to all countries. It refers essentially to cities, towns, and other densely populated areas, also considering other criteria such as the size of the population in each location, the distance between common areas, the predominant economic activity, administrative or legal boundaries, and availability of and access to basic services.
The international comparability of this indicator may be limited by factors such as the quality of population censuses, demographic surveys, and national civil registration systems used to calculate estimates.
The estimated value of this indicator may differ from country statistics due to factors such as methodological differences in developing population estimates and projections.
https://population.un.org/wup/
United Nations, Department of Economic and Social Affairs, Population Division. Glossary of Demographic Terms. Available from:
https://population.un.org/wpp/GlossaryOfDemographicTerms/
Economic Commission for Latin America and the Caribbean (ECLAC) - CEPALSTAT. Statistical Databases and Publications. Available from:
https://statistics.cepal.org/portal/cepalstat/dashboard.html?lang=en
Wild poliomyelities cases
The number of cases of wild poliovirus reflects the health status and health and socioeconomic development of a population. It helps to identify health inequities and populations with greater risk factors for endemic transmission of wild poliovirus.
The indicator is applied for designing, implementing, and assessing health policies to prevent, treat, and control polio in children and distribute economic, human, and technological resources to fight the disease, among other purposes. Among its main purposes is strengthening immunization programs.
Sustainable Development Goals (SDG).
Indicator 3.b.1 Proportion of the target population covered by all vaccines included in their national programme.
Available from: https://sdgs.un.org/
World Health Organization (WHO). The Global Health Observatory (GHO). Available from: https://www.who.int/data/gho/indicator-metadata-registry
Indicadores básicos para a saúde no Brasil: conceitos e aplicações, 2ª edição [Core health indicators in Brazil: concepts and applications]. Pan American Health Organization. Brasilia, 2008. Available from: https://www.paho.org/bra/dmdocuments/indicadores.pdf
Women accessing prenatal care since the first trimester (%)
This indicator makes it possible to identify populations that need increased coverage, availability, and access to maternal and child health services, and raises awareness of inequities in health. It can be applied during planning, management, and evaluation of health policies and maternal and child health services.
Denominator: Total number women with a live birth during the same period, in a given year.
The data comes from countries' routine information systems.
The outcome of this indicator is limited by the country's ability to record in a timely manner all births and live births that occurred during a given period. The definition of live birth may differ between countries.
https://opendata.paho.org/en/core-indicators
World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva, 2016. Available from: https://www.who.int/publications/i/item/9789241549912
UNICEF. Antenatal care. Available from: https://data.unicef.org/topic/maternal-health/antenatal-care/
Yellow fever cases
The number of cases reflects the intensity of the disease in a population. The indicator is used to analyze the disease's temporal and geographical trends, identify areas in need of intensified vector control strategies, and strengthen immunization programs and environmental and epidemiological surveillance. It facilitates allocation of economic, human, and technological resources to control yellow fever.
The indicator is part of the monitoring framework of the WHO Global Strategy to Eliminate Yellow Fever Epidemics (EYE).
Endemic countries in the Americas are: Bolivia, Brazil, Colombia, French Guiana, Guyana, Panama, Paraguay, Peru, Venezuela, Suriname, Trinidad and Tobago, and Venezuela.
ode/57737
World Health Organization (WHO). A global strategy to eliminate yellow fever epidemics (EYE) 2017–2026. Available from: https://apps.who.int/iris/handle/10665/272408
World Health Organization (WHO). Vaccine-Preventable Diseases. Surveillance Standard. Yellow Fever. 2020. Available from:
https://cdn.who.int/media/docs/default-source/immunization/vpd_surveillance/vpd-surveillance-standards-publication/who-surveillancevaccinepreventable-23-yellowfever-r1.pdf?sfvrsn=a8d50bc6_10&download=true
Youth literacy rate (%)
Literacy offers potential for intellectual improvement and contributes to a society's economic and sociocultural development. It is essential for promoting and extending sustainable development, enhancing the capacity to achieve their goals, develop their knowledge and potential, to address environmental and development issues, and improving effective participation in decision-making in their communities and societies.
Literacy deficits highlight the need to focus efforts on expanding literacy to the rest of the illiterate population.
Youth illiteracy is defined as the percentage of the population aged 15 to 24 years that cannot read, write, or understand a short, simple text about their daily life.
The youth literacy rate is obtained from data collected by the United Nations Educational, Scientific, and Cultural Organization (UNESCO), primarily national population censuses and household/active population surveys.
The definition of literacy rate is in line with the revised recommendations on the International Standardization of Educational Statistics, adopted by UNESCO. Data on literacy rates are derived from estimated values at mid-year.
The outcome of the literacy rate is based on the standard definition of literacy, however, the definitions and criteria of literacy used in some countries may differ from established international standards or be subject to changes between population censuses, which may skew the results. Bias when self-reporting on literacy is another factor that influences the accuracy of this indicator. Estimating literacy rate require conducting censuses and surveys under controlled conditions, since literacy is difficult to measure.
In countries where almost all people have completed basic education, the literacy rate provides limited information about the variation in literacy skills in the population.
The frequency with which countries update their data and transfer it to UNESCO for calculation affects the result of this indicator.
UNESCO. Quick Guide to Education Indicators for SDG 4. Available from: http://uis.unesco.org/sites/default/files/documents/quick-guide-education-indicators-sdg4-2018-en.pdf
UNESCO. Glossary. Available from: http://uis.unesco.org/en/glossary